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Genetics of male infertility
Male infertility involves a heterozygous group of conditions that either consists of 
an abnormality in sperm count (oligozoospermia), motility (asthenozoospermia), 
morphology (teratozoospermia) or a combination of these three factors. Although 
couples affected by male infertility can be treated by Intra Cytoplasmic Sperm 
Injection (ICSI), which was introduced in 1992 [1], the diminished production or 
poor quality of sperm cannot be cured yet. The impact of the male factor in 
infertility is substantial: for more than 50% of the infertile couples, sperm 
production is impaired. Nowadays in the western world, about 60 % in vitro 
treatments consist of ICSI, achieving similar and sometimes even better results 
than conventional IVF [2]. Although ICSI has proven to be an effective technique to 
solve the poor fertility capacity of the sperm, there are still some concerns about 
the safety of this treatment, specially the long-term risks. There is some evidence of 
an increased risk of minor and major congenital malformations in ICSI children 
[3, 4]. The major malformation rate varies between 0.7 and 9.1 % in comparison to 
0.5- 7.2 % in naturally conceived children [4-7]. While the follow-up studies on ICSI 
children are reassuring up to adolescence [8], the risk towards late-onset disease 
manifestations is unknown. In addition, it is still unclear whether the prevalence 
of male infertility is affected by forcing fertilization by ICSI, which would allow the 
propagation of possible underlying genetic defects to the next generation. Although 
not all cases of male infertility have a genetic origin, the massive implementation 
of ICSI may lead to accumulation of mutations that would otherwise have 
disappeared from the population. Interestingly, after the successful introduction of 
ICSI, many clinicians and researchers doubted about the need of continuing 
andrologic research: where male infertility cannot be solved, the presence of sperm 
in ejaculates, epididymis or testis is sufficient to treat male infertility. With the 
advance of technology many investigators, including ourselves, have focused to 
find a genetic cause for OAT (defined as <1 *106 spermatozoa/ ml) other than the 
already few known. Known causes are numerical chromosomal abnormalities 
such as Klinefelter (XXY) and Robertsonion translocations, which account for up to 
10% in severe OAT or azoospermia. DNA microdeletions in the Y chromosome, e.g. 
in the AZF region are responsible for 5-15% of oligozoospermic men [9]. A recessive 
CFTR mutation can cause azoospermia by a congenital bilateral absence of the 
vas deferens (CBAVD) and accounts for 1-2 % of the subfertility cases[9].
(Re-)search for genetic causes
In the search for genes responsible for male infertility, our group started a search 
for genetic mutations. Until now, our research group has used two methods to 
perform this search. 
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Screening for genetic aberrations in known genetic factors  
in male infertility
In order to find mutations in known genes that are involved in spermatogenesis, 
our Radboudumc research group screened groups of subfertile men, mostly 
ICSI-patients [10]. We screened the DAZLA gene (Deleted in Azoospermia 
Like Autosomal), that is proven to be involved in spermatogenesis in mice [11] 
and testis specifically expressed, as well as homologous to DAZ (Deleted in 
Azoospermia), that is found to be deleted in some cases of severe oligozoospermia 
and azoospermia [12]. Unfortunately we found no mutations in 44 subfertile 
men. We then focused on increased length of the CAG repeats in the androgen 
receptor (AR), which might be associated with male subfertility. However, 
analysis of the AR gene in 75 subfertile men, ranging from azoospermia to 
severe OAT, did not reveal an association between the CAG repeat length and 
subfertility in our cohort [10].
 
Familial male fertility
The methodology used by our group in Radboudumc prior to the start of this 
thesis was to locate and investigate families in which several members were 
affected with male infertility. During this research we managed to establish that 
male infertility occurs more often in brothers and maternal uncles, suggesting 
either X-linked or autosomal dominant inheritance with sex-limited expression 
of the phenotype [13]u. In fact, linkage analysis in a Dutch family with multiple 
subfertile males provided evidence for sex-limited expression of an autosomal 
trait [14]. X-linked inheritance was excluded in this family consisting of six 
siblings and a maternal uncle that suffered from azoospermia by genotyping 
with X-chromosomal markers and by performing X-chromosome-specific array 
Comparative Genomic Hybridization (ArrayCGH). Unfortunately, we did not 
manage to find any candidate gene that could explain the OAT (not published). 
In the course of these investigations we encountered several pitfalls in studying 
male infertility. First, not the whole process of spermatogenesis has been yet 
elucidated. Second, male infertility is heterogeneous in phenotype and (genetic) 
cause. Therefore, it was decided to focus my thesis research on morphological 
uniformity of the sperm cells of subfertile men in order to increase the chance of 
identifying a common genetic aetiology. 
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BOX 1  A family with globozoospermia.
In the search for families with several members suffering from the same type 
of male subfertility we identified a consanguineous family (figure 1) in which 
several male members appeared to suffer from globozoospermia (round headed 
sperm cells). 
 The proband suffered from severe OAT (concentration (C): 2.6-11 * 106 sperm 
cells/ml; motility (M): 10-30%: normal morphology (Morph): 0% and an increased 
amount of acrosomeless sperm cells (88-96%: Figure 2). He and his wife managed 
to conceive after one ICSI cycle, upon which she delivered a healthy son. 
 The parents of the proband, as well as two maternal uncles, also underwent 
assisted reproductive techniques. The parents of the proband were first cousins, 
as were the maternal parents. In addition, there was a possible consanguineous 
loop via the paternal parents as well. Together, the pedigree structure is 
suggestive of an autosomal recessive gene defect underlying the OAT in this 
family, although autosomal dominant or X-linked inheritance cannot be 
excluded. The parents of the proband underwent in vitro fertilisation (IVF) 
because of a tubal obstruction (double tubectomy because of multiple ectopic 
pregnancies) in order to conceive the younger brother of the proband. The father 
had normal semen parameters (C: 135*106/ml; M: 80%; Morph: 42%). The first 
maternal uncle suffered from a fertility problem for 8 years. His first child was 
conceived by Intra uterine insemination (IUI), he had normal semen parameters 
(C: 64*106/ml: M: 30%, Morph: unknown). His other 3 children were conceived 
in a natural way. The second maternal uncle suffered from disturbed semen 
parameters as well (C: 11-60*106/ml; M: 20-60%; Morph: 1%) as well as 75% 
acrosomeless sperm cells. He and his wife underwent ICSI-treatments in order 
to conceive their first three children; the fourth and last child was conceived in 
a natural way. The third and youngest maternal uncle also suffered from this 
dysmorphic sperm syndrome (C: 35*106/ml; M: 30%; Morph: 18%; 26% 
acrosomeless sperm cells). He and his wife conceived in a natural way with a 
prolonged time to pregnancy of 18 months. Because of the consanguinity, we 
assumed that this sperm morphology disorder was caused by an autosomal 
recessive condition. The family was therefore subjected to linkage analysis, 
which unfortunately did not reveal any common homozygous regions shared 
by the affected males, which could help to locate candidate genes. As time 
progressed, a 10 K SNP array was used for homozygosity mapping, but also this 
did not reveal homozygous candidate regions in the family. Our last option was 
to involve the younger brother of the proband in the study, who reached 
maturity during the time of research, but he was unwilling to cooperate. At that 
point we decided to cease our research in this specific family.
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Figure 1  Family tree of the family with partial globozoospermia described in Box 1.
Figure 2  Partial globozoospermia, TEM image.
In this image an example of a malformed acrosome with invagination is shown as example of the acrosomic 
malformations that occur in partial globozoospermia.
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PARTIAL GLOBOZOOSPERMIA
The story in Box 1 is typical for genetic research in male infertility: major efforts 
with minor results. The observations in the specific morphological syndrome 
in these patients led however to further studies. These patients namely did not 
suffer from total globozoospermia (100% acrosomeless) as described by Schirren et al. 
[15] but had a mild form of globozoospermia (called partial globozoospermia) 
in which only a variable part of the spermatozoa was round-headed and 
acrosomeless (Figure 2). Although this particular morphology has already been 
mentioned in literature[16], it has never been described properly. In our experience, 
partial globozoospermia occurs more often than total globozoospermia, which 
 is a rare condition that occurs in less than < 0.1 % in cases of male infertility. 
I therefore decided to continue my research on partial globozoospermia.
BOX 2  Spermatogenesis, spermiogenesis and acrosome function.
Spermatogenesis (Figure 3) is the whole process that transforms spermatogonial 
stem cells into a spermatozoon. The whole process takes 74 days. It takes place 
within the germinal epithelium of the seminiferous tubules where germ cells are 
arranged along the wall of tubules in a well-defined combination of various 
developmental stages (Figure  4). At first, the mitotic phase takes place at the 
basal membrane, where the Type A spermatogonia on the base membrane 
divide asymmetrically into another Type A spermatogonia and Type B 
spermatogonia. The type B spermatogonia go into a phase of proliferation and 
transform into primary spermatocytes, which go into meiosis I. The resulting 
diploid secondary spermatocytes go into meiose II to become haploid round 
spermatids. Finally, there is a gradual remodeling of the chromatin and 
cellular components of round spermatids during transformation into sperm 
cells by a process referred to as spermiogenesis [17].
 Spermiogenesis is thus the process by which the final sperm shape is 
reached. This last phase of spermatogenesis has been described by Clermont 
et al (1963) as a complex process that is divided in six steps (Sa, Sb-1, Sb-2, Sc, 
Sd-1, Sd-2) and four phases (table 1). [17, 18].
 In the Golgi-phase (Sa), acrosome formation starts with the formation of 
acrosomic vesicles that are produced by the Golgi apparatus (Figure 4). These 
vesicles land on and align with the acroplaxome, an actin-keratin- containing 
cytoskeletal plate that acts as a scaffold that anchors the developing acrosome 
to the nuclear envelope [19]. 
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BOX 2  Continued.
 In the Cap-phase (Sb1-2) the fusing of the acrosomic vesicles takes place. 
A perinuclear ring is formed in which a manchette of microtubules is anchored 
to provide transport of golgi-derived acrosomal and non-acrosomal vesicles 
that play a role in sperm head elongation. On the contralateral side the 
centrioles migrate to form the axoneme, from which the tail is formed. 
Subsequently, the acrosomic granule enlarges, starts to flatten and is separated 
from the Golgi apparatus. The process of chromatin condensation is observed 
from step Sa onwards. This specific process serves the purpose to protect the 
paternal genome during transport through the female genital tract. The 
process consists of several steps in which somatic histones are replaced by 
sperm histones, to be replaced by transitions proteins 1 and 2 (TP) and finally 
by protamines 1 and 2 for 85% [20]. Chromatin condensation starts at the 
apical (acrosomal) pole of the spermatid nucleus by acetylation and 
deacetylation of histone H4, which is needed to start protamination [21, 22]. 
Transition protein 2 is already observed from step Sa [20]. Transient DNA 
strand breaks occurs to allow the replacement of histones and transition 
proteins by protamines, a phenomenon which has been observed using 
TUNEL in step Sb2, but not in the following steps, suggesting this phenomenon 
to be a part of chromatin condensation [23]. 
 During the Acrosomal phase (Sc) the acrosome becomes hemispherical and 
chromatin condensation continues. Protamines further condense the DNA 
strand and form the donut-shaped packaging units called toroids. In human, 
5-15% of the histones are retained. Protamines (P1 and P2) are normally 
expressed equally (1:1) in fertile sperm [24]. These sperm-specific proteins 
have an arginine core, that cause a positive charge that facilitates a strong 
DNA binding, and cysteine residues, that facilitate disulfide bonds within and 
in between the protamines, thus creating a condensed chromatin packaging. 
Protamine 2 contains less cysteine and therefore a low P1/P2 ratio is associated 
with infertility [24]. The retained histones are not randomly distributed and 
may have an important role during fertilization and the first cell divisions [25]. 
 In the final Maturation phase (Sd1-2) the acrosome condenses, the 
mitochondria are arranged around the midpiece to provide the energy needed 
for the tail. The remaining cell organelles are discarded with the cytoplasmic 
body. H4 acelylation stops at Sd-1, as proven by in situ hybridisation [21]. The 
sperm is released into the lumen of the seminiferous tubule and leads to the 
epididymis for the process of epididymal maturation to become a motile 
spermatozoon [26].
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BOX 2  Continued.
The acrosome is built in about 14 days and plays an important role in sperm-egg 
binding during the fertilisation process [17]. It is considered a secretory 
granule that consists of a acrosomal matrix that contains proacrosin as well as 
the acrosomal content that contains acrosin and other enzymes. When released 
at ejaculation into the female genital tract, the spermatozoon is subjected to 
capacitation, a process in which, amongst others, the proteins and glycoproteins 
of the seminal fluid are removed, and the sperm surface molecules are 
reorganized in order to induce an increased fluidity in permeability of the 
sperm plasma membrane. This process, which is not yet completely 
understood, prepares the spermatozoon to be responsive for the acrosome 
reaction. This calcium dependent induced reaction is initiated in (the proximity) 
of the cumulus cells. On binding to the zona pellucida, the sperm undergoes 
acrosomal reaction. The acrosome content is released in order to be able to 
penetrate the zona pellucida of the oocyte and expose the inner acrosomal 
membrane to fuse with the oolema. Needless to say that the acrosome plays a 
crucial role in natural fertilisation, without this step, no sperm-oocyte fusion 
can be achieved [17].
Figure 3  Spermatogenesis.
In this image a crossection of a part of the seminiferous tubule is pictured. The developement from the 
Type B spermatogonium to the mature spermatozoon in between the Sertolicells is schematically displayed.
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Figure 4  Schematised depiction of Golgiphase and mature spermatozoon.
Proacrosomic vesciles are produced by the Golgiapparatus, to land on the acroplaxome. There the vesicles 
fuse to form the acrosome that stretches over the elongating nucleus. In the end an oval shaped spermatozoon 
with an organized midpiece with mitochondriae is developed.
Phase Step Events
Golgi- phase Sa •  Formation, accumulation and fusion of proacrosomic granules 
from Golgi apparatus.
• Association acrosomic vesicle to nucleus
Cap phase Sb1-2 •  Enlargement of acrosomic granule by glycoproteins from the 
Golgi apparatus.
• Acrosome grows and flattens, head cap is formed.
• Separation from the Golgi apparatus.
Acrosome 
phase
Sc •  Application to inner acrosomal membrane, the acrosome 
 becomes hemispherical
•  Nucleus elongates, condenses and shifts towards the cell surface.
• Formation cytoplasmic lobe
Maturation 
phase
Sd1-2 • Condensation of the acrosome
• Mitochondria bind to middle piece of the tail
• Discarding cytoplasmic droplet
Table 1  Spermiogenesis.
In this table the different phases, the coherent steps and the most important events during the phases 
are displayed.
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AIM OF THE STUDY
In our search for a uniform phenotype to identify genetic factors underlying 
male subfertility, we encountered a new sperm morphology disorder. We named 
it ‘partial ’globozoospermia. After completing the study of the family described 
in Box 1, we identified more patients with apparently the same sperm 
morphological characteristics. The aim of the work described in this thesis is to 
identify the genetic defects underlying this specific morphological abnormality 
of sperm cells associated with subfertility and to characterize and describe 
(partial) globozoospermia in a cellular, molecular, and clinical way. 
OUTLINE OF THE THESIS
Chapter 1 Gives a broad introduction including a description of a consanguineous 
family with partial globozoospermia.
Part I: Globozoospermia
Chapter 2 In this chapter I collected all available literature on globozoospermia 
in a review article to provide a base for the further research. In this chapter all 
reported morphology characteristics, epidemiology, clinical features, etiology, 
sperm integrity, and genetic backgrounds are described. 
Part 2: Partial globozoospermia
Chapter 3 Describes the morphology studies of partial globozoospermia in 10 
patients in comparison to three total globozoospermic patients and nine normo-
zoospermic controls. We performed this study in order to determine whether 
partial globozospermia is a seperate kind of teratozoospermia next to total glo-
bozoospermia. 
Chapter 4 Describes the study on sperm DNA integrity in which partial globozo-
ospermia was compared to nine normozoospermic controls. This study was 
performed in order to evaluate the status of DNA damage in partial globozo-
ospermia.
Chapter 5 Describes the reproductive outcome in 42 couples with male partners 
with partial globozoospermia (spontaneous pregnancy/IUI/IVF/ICSI). In this 
study the clinical performance in partial globozoospermia was established 
based on a case control study on ICSI of 27 partial globozoospermia cases in 
comparison to 263 ICSI controls. 
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Part 3: Genetics
Chapter 6 Describes the search for a responsible gene and the mutation in SPATA16 
in a family suffering from total globozoospermia.
General discussion, Summary and appendices
Chapter 7 In the general discussion sperm morphology disorders, partial globozoo-
spermia and the current status and future of genetic research in spermatogenesis 
are discussed.
Chapter 8 Summarizes chapter 2 to 7 in English.
Chapter 9 contains the Dutch summary; the NCEBP list of theses since 2000, 
the acknowlegements and Curriculum vitae
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ABSTRACT
Globozoospermia is a rare (incidence <0.1%) but severe disorder in male 
infertility. Total globozoospermia is diagnosed by the presence of 100% round- 
headed spermatozoa lacking an acrosome. It is still unclear whether patients 
whose ejaculate contains both normal and globozoospermic cells (partial 
 globozoospermia) suffer from a variation of the same syndrome. Apart from 
the fact that affected males suffer from reduced fertility or even infertility, no 
other physical characteristics can be associated with the syndrome. ICSI is a 
treatment option for these patients, although low fertilization rates after ICSI 
show a reduced ability to activate the oocyte. In globozoospermic cells, the use 
of acrosome markers has demonstrated an absent or severely malformed 
acrosome. Chromatin compaction appears to be disturbed but is not consistently 
over- or undercondensed. In some cases, an increased number of cells with DNA 
fragmentation have been observed. The analysis of the cytogenetic composition 
revealed an increased aneuploidy rate in some cases. Nonetheless, no increased 
number of spontaneous abortions or congenital defects has been reported in 
pregnancies conceived after ICSI. The pathogenesis of globozoospermia most 
probably originates in spermiogenesis, more specifically in acrosome formation 
and sperm head elongation. In several knockout mouse models, a phenotype 
similar to that in humans was found. Together with the occurrence of affected 
siblings, these findings indicate a genetic origin, which makes globozoospermia 
a good candidate for genetic analysis. More research is needed to elucidate the 
pathogenesis of human globozoospermia to further understand globozoospermia 
as well as (abnormalities in) spermiogenesis and spermatogenesis in general.
Key words: acrosome/genetics/globozoospermia/male infertility/round-headed 
sperm cells
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INTRODUCTION
Globozoospermia is a rare but severe disorder causing male infertility. Schirren 
et al. (1971) were the first to properly describe this syndrome of round-headed 
spermatozoa that lacked an acrosome. In the following three decades, a limited 
number of additional case reports were published. In these case reports, the 
morphological and aetiological aspects of globozoospermia were emphasized. 
However, the underlying causes of the syndrome still remain to be elucidated. 
A genetic contribution was postulated by Kullander and Rausing, which was 
supported by additional case reports of affected brothers (Kullander and 
Rausing, 1975; Florke-Gerloff et al., 1984; Dale et al., 1994; Carrell et al., 1999, 
2001; Kilani et al.,2004). The gene(s) responsible or the mode(s) of inheritance 
remains obscure.
 It is clear that male infertility in general is based on a multifactorial aetiology 
and tends to cluster in families. Diverse inheritance patterns have been described 
(Gianotten et al., 2004; van Golde et al., 2004). Genetic analysis has been 
complicated by the lack of a distinct correlation between genotype and (a highly 
variable) phenotype. The first description of globozoospermia, presenting as a 
disorder that affected all spermatozoa of a patient in a very specific way (Schirren 
et al., 1971), suggested that globozoospermia was an exception. The apparently 
very distinct phenotype suggested a monogenetic trait, thereby rendering this 
syndrome into an attractive target for genetic studies. Subsequent reports, 
however, presented a more diverse phenotype, obscuring the initial clear-cut 
phenotype (Holstein et al., 1973; Anton- Lamprecht et al., 1976; Florke-Gerloff  
et al., 1984). 
 Morphological defects in human sperm cells raise suspicion for further 
anomalies within the sperm cell and could have implications in clinical practice. 
Therefore, in this review we have attempted to summarize the phenotypic 
manifestations, and possible causes of the condition as well as implications for 
clinical practice of globozoospermia, as a prerequisite for genetic analysis.
MATERIALS AND METHODS
For this systematic review, we collected all papers published on globozoo spermia 
from 1965 to January 2006, using the following keywords [globozoosperm* OR 
(round AND headed AND sperma*) OR (round AND headed AND sperm) 
OR acrosomeless].
 The initial literature search was performed using PubMed, Scirus and Medline. 
English was used as a limit, except for the Scirus database, because language 
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selection is not possible in this database. Regular updates were performed using 
the same keywords in PubMed up until January 2006. The initial search resulted 
in 88 hits in PubMed, 72 hits in Medline and 148 journal hits in Scirus. Subsequent 
searches in PubMed revealed another 11 papers. Papers dealing with megalohead 
sperm cells, round spermatids, macronuclear spermatozoa or acrosome 
malformation were excluded. In addition, we excluded papers in which cases of 
globozoospermia were used or proposed for research purposes, without 
specifically focusing on globozoospermia, nor providing additional information 
on globozoospermia (Kaufmann et al., 1987; von Bulow et al., 1995; Dimitrova- 
Dikanarova et al., 1998; Lefievre et al., 2003). Scirus appeared to be less accurate 
and produced a lot of hits that did not deal with globozoospermia or formed 
duplicates; these papers were excluded as well. After this selection, 80 PubMed, 
60 Medline and 69 Scirus papers remained. The hits generated by PubMed 
included the 60 Medline papers. Scirus found seven papers that were not found 
by PubMed, resulting in 87 papers selected for review. From the reference list 
of the selected papers, four German papers were selected to be included in our 
review, because they either mentioned the occurrence (Meyhöfer, 1965), features 
and pathogenesis of round-headed sperm cells (Schirren et al., 1971; Holstein 
et al., 1973) or suggested the term globozoospermia for the first time (Wolff  
et al., 1976). For background information see the Handbook of Andrology 
(http://www.andrologysociety.com/ resources/handbook.aspx).
RESULTS
Morphological description
The first to mention ‘Rundkopfspermatozoen’ (round-headed spermatozoa in 
German) after light microscopic analysis was Meyhöfer (1965). In 1971, Schirren et al. 
described the fine structure of these round-headed sperm cells as determined by 
electron microscopy (Figure 1) and discovered that their round shape was 
caused by a round nucleus lacking an acrosome. Other groups reported similar 
findings (Pedersen and Rebbe, 1974; Kullander and Rausing, 1975; Wolff et al., 
1976; Baccetti et al., 1977, 1981), of whom Wolff et al. first suggested the term 
 ‘globozoospermia’. Table I summarizes the reported morphological characteristics 
of globozoospermia.
 Globozoospermia is normally diagnosed by the detection of round-headed 
sperm heads during routine light microscopic examination of a semen sample. 
The absence of an acrosome is another major feature, which is best visualized 
by transmission electron microscopy. Furthermore, sperm cells tend to have 
multiple defects involving the cytoskeleton such as a round nucleus, absence of 
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the post-acrosomal sheath, separation of the nuclear membranes and frequently 
coiled tails. Also maturation defects such as a persisting residual cytoplasmic 
body or droplet surrounding the nucleus or the midpiece have frequently been 
reported.
 Most of the papers based on describing this morphology deal with patients 
who produced ejaculates showing 100% round sperm heads lacking an acrosome. 
Holstein et al. (1973), however, reported a number of patients who only had 
20–60% round-headed spermatozoa in their ejaculate. Whether this ‘partial’ glo-
bozoospermia was a different aspect of the same syndrome or a separate 
disorder could not be determined. The matter was further complicated by a case 
report by Anton-Lamprecht et al. (1976), who reported two types of patients with 
round-headed sperm cells. The first patient was of the classic ‘Schirren–Holstein 
type’, with exclusively round-headed acrosomeless sperm cells as determined 
by light and electron microscopy. The ejaculate of the second patient showed 
80% of round-headed sperm cells, as determined by light microscopy, but 
Figure 1   Globozoospermia.
Overview imaged by Transmission Electron microscopy (TEM).
In detail a globozoospermic sperm cell is shown. This cell clearly shows the main characteristics of globo-
zoospermia, such as round headed nucleus and the lack of an acrosome. Also the cytoplasmic droplet is 
evident.
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electron microscopy showed that the round-headed phenotype was due to a 
residual cytoplasmic body that surrounded the nucleus and acrosome. They 
suggested the terms ‘globozoospermia type I’ for the classic Schirren–Holstein 
phenotype, and ‘globozoospermia type II’ for the phenotype observed in the 
second patient. Although their first suggestion was adopted in literature, only 
two globozoospermia type II patients have been reported since (Christensen et 
al., 2006). However, patients with <100% round-headed sperm cells in their 
ejaculate have frequently been described (Pedersen and Rebbe, 1974; Weissenberg 
et al., 1983; Florke-Gerloff et al., 1984; Syms et al., 1984; Tyler et al., 1985; Singer et 
al., 1986; Lanzendorf et al., 1988; Rybouchkin et al., 1996, 1997; Carrell et al., 1999, 
2001; Coetzee et al., 2001; Larson et al., 2001).
 To complicate matters even further, a number of cases were described in 
which electron microscopic examination showed that the sperm cells in these 
patients that did not appear to be round- headed by light microscopy could 
nonetheless lack an acrosome (Pedersen and Rebbe, 1974; Tyler et al., 1985; 
Lanzendorf et al., 1988; Coetzee et al., 2001). In other cases, only the round-headed 
sperm cells were found to be acrosomeless (Syms et al., 1984; Singer et al., 1986; 
Carrell et al., 1999). This was confirmed by immunofluorescent techniques using 
antibodies against (pro-) acrosin (Florke-Gerloff et al., 1984). Even if sperm cells 
were of normal or otherwise abnormal shape, an acrosome often appeared to be 
missing or anomalous (Florke-Gerloff et al., 1984; Rybouchkin et al., 1996; Carrell 
et al., 2001; Larson et al., 2001). According to these findings, it is clear that these 
cases do not belong to type II as described by Anton-Lamprecht et al. (1976). 
100% round headed (50) Disturbed midpiece (4)
Acrosomeless (42) Abnormally arranged mitochondria (4)
<100% round headed (19) Acrosome separated from nucleus (2)
Round nucleus (14) Post-nuclear ring absent (2)
No postacrosomal sheath (12) Chromatin treads (2)
Coiled tails (partially) (11) Atypical implantation of the sperm tail (1)
Abnormally condensed nucleus (9) Double heads (1)
Vacuoles in nucleus (6) Tail abnormalities (1)
Separated nuclear envelope (6) Invagination (1)
Cytoplasmic droplet (6)
Table I  Overview of reported morphological characteristics of globozoospermia.
The order is established by the frequency of description; the quantity of references in which the 
characteristic was mentioned is indicated as acrosomeless (42).
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Hence, this nomenclature could be misleading. We therefore suggest the term 
‘partial globozoospermia’ for patients in which <100% of the sperm cells show a 
round-headed form without an acrosome. Whether classic/total globozoosper-
mia and partial globozoospermia are part of the same syndrome remains to be 
elucidated, today as urgently as >30 years ago.
Epidemiology
The first case of globozoospermia, described by Schirren et al. (1971), was found 
after the examination of 2200 patients undergoing routine andrological 
screening, indicating an incidence of <0.05%. Later, the same group corrected 
the incidence to 0.1% among andrological patients (Holstein et al., 1973). 
Subsequent reports adopted this estimated incidence (Schill, 1991; Coetzee et al., 
2001; Kim et al., 2001; Kalahanis et al., 2002). The documentation of globozo-
ospermia, however, did not go beyond the level of case reports, so this incidence 
might be overestimated.
 Round-headed cells also occur in otherwise normal semen samples (Florke-
Gerloff et al., 1984). In the ejaculate of a proven fertile man, Florke-Gerloff et al. 
(1984) observed up to 6% of round-headed sperm cells. These cells lacked acrosin 
and the outer acrosomal membrane. Andrade-Rocha examined 233 suspected 
infertile men. The percentage of round-headed sperm cells in their ejaculates 
varied from 0.1 to 0.8%. This percentage was, in contrast to the percentage of 
abnormal sperm cells in general, not significantly related to the sperm count 
(Andrade-Rocha, 2001). Finally, Kalahanis et al. (2002) examined semen from 114 
subfertile (≥2 years unvoluntary childlessness without a female cause) and 60 
proven fertile men. The percentage of round-headed sperm cells was slightly, 
but significantly higher in subfertile men (2.3 ± 0.5%) compared to fertile men 
(0.5 ± 0.1%) (Kalahanis et al., 2002). In relation to environmental factors, Rubes et 
al. (1998) concluded that smokers show a significantly increased amount of 
round-headed sperm cells in their ejaculate, in comparison with non-smokers. 
Although this was a relatively small study (20 smokers versus 15 non-smokers), 
these results might form an indication for an environmental factor in partial 
globozoospermia.
Clinical parameters
According to our search, 99 cases of globozoospermia have been reported since 
the first Schirren case. In this review, we summarize the clinical parameters of 
the patients involved. The mean age of the patients, as reported in 70 of 99 cases, 
was 34.7 years, and 68% of the men were between 30 and 40 years old when 
examined. Semen parameters were described in detail in 72 cases and showed 
great variation. Figure 2 shows the reported values in volume, concentration 
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and motility, respectively. Besides a general observation of slight asthenozoo-
spermia and the typical morphological characteristics, no abnormalities in semen 
parameters could be characterized as a typical feature of globozoo spermia. 
Closer investigations by a computerized digital image analysis system revealed 
no abnormalities in sperm movement characteristics in globozoospermia 
(Aitken et al., 1990). 
 In 16 of 99 cases, a somatic karyotype of the affected patient was determined. 
A normal male somatic karyotype was found in 15 cases, one case displayed 
a mosaic trisomy 21 in 17.5% of the somatic cells (Kim et al., 2001). On the level 
of DNA, a microdeletion of the Y-chromosome was found in another patient 
(Zeyneloglu et al., 2002). Gunalp et al. (2001), however, did not find any 
Y-chromosome microdeletions in 12 cases of globozoospermia. 
 In summary, these data indicate that patients with globozoospermia in general 
carry a normal karyotype. The incidence of Y-chromosome microdeletions in 
globozoospermia does not appear to exceed the incidence in male subfertility in 
general.
 The results of andrological history or examination were reported in 31 cases. 
In 22 cases, a normal health, normal masculine development and/or a normal 
aspect of the genitalia were reported (Pedersen and Rebbe, 1974; Kullander and 
Rausing, 1975; Anton-Lamprecht et al., 1976; Weissenberg et al., 1983; Jeyendran 
et al., 1985; Santi de et al., 1985; Lalonde et al., 1988; von Bernhardi et al., 1990; 
Figure 2   Semen parameters in 72 men with globozoospermia.
Semen volume (n = 43) mean = 3.7 ml. Sperm concentration (n = 67) mean = 67 × 106/ml. Sperm motility 
(n = 64) mean = 39%.
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Dale et al., 1994; Bourne et al., 1995; Kilani et al., 1998, 2004; Viville et al., 2000; 
Nardo et al., 2002; Vicari et al., 2002; Pirrello et al., 2005). The remaining nine 
cases included four (treated) varicoceles (Florke-Gerloff et al., 1985; Jeyendran et al., 
1985; Pirrello et al., 2005), two orchidectomies (Jeyendran et al., 1985; Pirrello et al., 
2005), two (gonorrhoeal) infectious epidydimitis (Kullander and Rausing, 1975; 
Singer et al., 1986) and one unspecified penile ulcer in the past (Pedersen and 
Rebbe, 1974).
 Aberrant details were sporadic, including a globozoospermic patient with 
bronchiectasis (Santi de et al., 1985), two cases of toxic exposition (Jeyendran et 
al., 1985; Carrell et al., 1999), two cases of consanguinity (Kilani et al., 2004; 
Pirrello et al., 2005) and two cases of opiate addiction in the past (Florke-Gerloff 
et al., 1985; Singer et al., 1986). Parotitis was mentioned in three cases, although 
orchitis did not occur in any case (Schirren et al., 1971; Kullander and Rausing, 
1975), thereby excluding parotitis as a causing factor. The inconsistent occurrence 
of these physical characteristics leads to the conclusion that next to reduced 
fertility, there are no other characteristics correlated with the globozoospermia 
phenotype.
(In)Fertility
In 64 cases, the patient was reported to be infertile. When Schirren et al. (1971) 
discovered that in case of globozoospermia all spermatozoa were acrosomeless, 
this was considered to be the cause of the infertility. Remarkably, proven fertility 
was noted in two separate cases. In the first case, a pregnancy was reported 
from a couple of whom the male partner presented with ‘type II’ globozoo-
spermia (Anton-Lamprecht et al., 1976). The second case suffered from a 3-year 
involuntary childlessness, but this episode was preceded by two subsequent 
spontaneous abortions. No cause, explanation or evidence for acquired total 
 globozoospermia was formulated (Arrighi et al., 1980). It should be noted that 
in neither case a paternity test was performed. Therefore, the involvement of a 
third party cannot be excluded.
 The introduction of ICSI (Palermo et al., 1992) provided a solution in fertility 
treatment for patients suffering from globozoospermia (Hamberger et al., 1998). 
In 1994, Lundin et al. reported the first pregnancy and delivery using globozoo-
spermic, acrosomeless spermatozoa in a second ICSI cycle. Since then, numerous 
reports have described successful attempts to achieve either fertilization or 
pregnancy following ICSI with globozoospermic sperm cells (Bourne et al., 
1995a,b; Liu et al., 1995; Trokoudes et al., 1995; Battaglia et al., 1997; Rybouchkin 
et al., 1997; Kilani et al., 1998, 2004; Stone et al., 2000; Coetzee et al., 2001; Kim et al., 
2001; Nardo et al., 2002; Tesarik et al., 2002; Zeyneloglu et al., 2002; Heindryckx et 
al., 2005). All reports are summarized in Table II. In general, ICSI with globozoo-
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spermic cells is less successful compared with ICSI in general. Several authors 
reported a low to absent fertilization (Liu et al., 1995; Battaglia et al., 1997; 
Rybouchkin et al., 1997; Stone et al., 2000; Kilani et al., 2004). Rybouchkin et al. 
(1996) discovered that fertilization was improved by the addition of a calcium 
ionophore subsequently confirmed by several studies (Rybouchkin et al.,1996; 
Gomez et al., 2000; Schmiady et al., 2005).
 As for the pregnancy outcome, Nagy et al. (1998) reported that although the 
fertilization rate was decreased in cases in which morphologically abnormal 
spermatozoa were used, no increase in the number of spontaneous abortions or 
congenital defects occurred. In accordance with these findings, no increase in 
such outcome failures has been reported in globozoospermia. Nevertheless, 
abnormal sperm morphology might be associated with genetic alterations in the 
sperm cells, which theoretically could have consequences on the long term for 
the offspring from artificial reproduction techniques. Sperm constitution in case 
of globozoospermia will be evaluated in the chapter ‘molecular description’.
Pathogenesis
In globozoospermia, one or more of the sperm-remodelling mechanisms in spermio-
 genesis appear to be impaired. Especially, acrosome formation and nucleus 
elongation were studied in detail in globozoospermia patients. Four possible 
mechanisms have been postulated to explain the absence of the acrosome.
 First, the acrosome may develop separately from the nucleus to be lost in the 
Sertoli cell.
 Electron microscopic studies by Schirren et al. (1971) showed that the acrosome 
is present in early spermatids but develops in the cytoplasm, independently from 
the nucleus. In addition, the nucleus remained round, but no condensation 
abnormalities were reported (Schirren et al., 1971). Several authors confirmed these 
findings (Baccetti et al., 1977; Castellani et al., 1978; Nistal and Paniagua, 1978). The 
same group (Holstein et al., 1973) observed that the abnormally developed acrosome 
was removed with the residual body and left in the Sertoli cell, where it degenerated. 
This has been confirmed by the identification of remnants of abnormal acrosomal 
vesicles in the Sertoli cell cytoplasm (Castellani et al., 1978).
 Second, the acrosomal vesicles do not fuse and even detach from the nuclear 
membrane. Results obtained with immunohistochemical techniques (Florke-
Gerloff et al., 1985) are in accordance with the electron microscopic findings 
described above. These authors demonstrated the presence of three acrosomal 
markers (acrosin, intra-acrosin inhibitor and purified outer acrosomal membrane) 
in early globozoospermic spermatids. These markers were located adjacent to, 
but separated from, the nuclear membrane. Instead, they appeared to move into 
the cytoplasm and to be discarded together with the residual body.R
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 Third, the acrosomal granules may be formed but degenerate subsequently. 
Baccetti et al. (1977) postulated this theory after the observation that the 
acrosomic vesicle does attach to the nuclear membrane but degenerates in the 
late spermatid stage, leaving a pouch of membranes and small vesicles located 
on top of the nucleus. Moreover, hypoplasia of the Golgi apparatus was found in 
most spermatids in case of globozoospermia. A malfunctioning Golgi apparatus 
was therefore postulated as a possible cause of this malformation of the acrosome 
(Baccetti et al., 1977; Castellani et al., 1978; Nistal and Paniagua, 1978).
 Finally, the caudal manchette may be absent or malfunctioning (Baccetti et al., 
1977; Castellani et al., 1978; Nistal and Paniagua, 1978). Naturally, a combination of 
these cytoskeleton impairments is possible as well (Lalonde et al., 1988; Escalier, 
1990).
 With regard to the round shape of the nucleus, Schirren et al. (1971) suggested 
that the nuclear shape was only determined by the acrosome, leaving the nucleus 
round-shaped in its absence. Subsequent studies, however, showed that the 
caudal manchette was often missing in developing spermatids of a globozo-
ospermic male, indicating that the shape of the nucleus might be influenced by 
aplasia or hypoplasia of the caudal manchette as well (Baccetti et al., 1977; 
Castellani et al., 1978; Nistal and Paniagua, 1978). Longo et al. (1987) showed that 
calicin, a basic protein that is almost exclusively located to the posterior part or 
calyx of the sperm nuclear theca, appeared to be absent in globozoospermic 
cells. This finding indicates an impaired development of the sperm-specific 
skeleton (Escalier, 1990; Courtot, 1991), which may influence both the formation 
of the acrosome and the shape of the nucleus. Research in genetically altered 
mice has succeeded in elucidating some aspects of spermiogenesis in globozo-
ospermia together with other kinds of teratozoospermia. This will be discussed 
in the last section of this article.
Functional aspects
Acrosomal markers
The apparent absence of the acrosome in globozoospermia initiated several 
studies to demonstrate a disturbance of the functional properties of the acrosome 
and its membranes. First, the location of acrosin, its precursor proacrosin and 
the outer acrosomal membrane at the acrosomal region was investigated in 
normal spermatozoa using an indirect immunofluorescent staining technique 
with antibodies specific to these acrosomal components. In normal spermatids, 
the acrosomal developmental pattern was in accordance with data obtained 
using the electron microscope. In contrast, both acrosin and the outer acrosomal 
membrane were absent in mature globozoospermic spermatozoa, and the 
developmental pattern of globozoospermic spermatids was disturbed compared 
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with normal spermatids. These findings were confirmed by testing acrosome 
function with the gelatinolysis test, which showed no proteolytic activity of the 
mature sperm-head of globozoospermic cells (Florke-Gerloff et al., 1983). Spec-
trophotometrically evaluated acrosin activity showed severely diminished to 
absent activity in globozoospermia (Florke-Gerloff et al., 1984, 1985; Lalonde et 
al., 1988). Jeyendran et al. (1985) found an eight times decreased amount of 
proacrosin, but the level of active acrosin after induced conversion appeared to 
be normal (Jeyendran et al., 1985). This suggests that the level of proacrosin was 
diminished, but yet capable of conversion.
 Phospholipase A2, which is believed to play a role in the acrosome reaction 
by hydrolysing fatty acids, which are linked to membrane phospholipids over - 
lying the acrosome. Its activity in globozoospermic cells was significantly lower 
compared with that of spermatozoa from donors of proven fertility (Lalonde 
et al.,1988).
 Fluorescein-labelled lectins were used as acrosome-membrane markers in 
developing spermatids. The binding of peanut agglutinin (PNA), a marker for 
acrosome differentiation, to the developing acrosome was absent. Ricinus communis 
agglutinin II (RCA II), which displays a cap-like fluorescence pattern in normal 
spermatids, presented a dot-like pattern in globozoospermic spermatids. The authors 
concluded that the adhesion and penetration failure observed in globozoo-
spermia might be caused by membrane defects (Wollina et al., 1989). In accordance 
with these findings, vesicle-associated membrane protein (VAMP) or synaptobrevin 
was only found in rudiment form on globozoospermic cells when used as an 
acrosome marker, again pointing at a defect acrosome formation (Ramalho-
Santos et al., 2002).
 In summary, these studies show a present, but disturbed acrosome genesis, 
resulting in either a severely malformed or an absent acrosome in globozoospermia.
Fertilization capacity
Literature indicates that no spontaneous fertilization occurs in case of total glo-
bozoospermia. Several authors tested the fertilization capacity of human 
round-headed spermatozoa in animal models. In summary, these spermatozoa 
were capable of penetrating the cervical mucus (Jeyendran et al., 1985) but did 
not succeed in fertilizing (zona-free) hamster oocytes, unlike spermatozoa of 
men of proven fertility (Weissenberg et al., 1983; Syms et al., 1984; Jeyendran et 
al., 1985; Sutherland et al., 1985; Lalonde et al., 1988; von Bernhardi et al., 1990). 
This was most probably because of the incapacity to bind to the zona pellucida, 
as well as to problems during the fusion process of the spermatozoon with the 
oocyte membrane. Globozoospermic spermatozoa also failed to adhere to 
human zona pellucida. As elevated intracellular Ca2+ levels were supposed to be 
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required for binding of the spermatozoon to the oocyte, binding capacity was 
also studied in the presence of the calcium ionophore A23187. Even then, 
however, the spermatozoa failed to adhere (Aitken et al., 1990; von Bernhardi et 
al., 1990; Carrell et al., 1999), which led to the conclusion that sperm fusion 
capacity cannot be triggered by increasing intracellular calcium (Dale et al., 
1994).
 Interestingly, the nuclei of round-headed spermatozoa do decondense to a 
similar degree as do normal spermatozoa when incubated with crushed hamster 
ova, indicating a normal fertilization capacity once the barrier of the oocyte 
membrane is overcome (Syms et al., 1984). Lanzendorf et al. (1988) elaborated on 
these findings by injecting human globozoospermic sperm cells into zona-intact 
hamster oocytes. They showed that the abnormal sperm was capable of 
apparently normal chromatin decondensation and pronucleus formation after 
injection (Lanzendorf et al., 1988). After the introduction of ICSI in humans 
(Palermo et al.,1992), fertilization and even pregnancy was achieved in several 
cases of globozoospermia (Lundin et al., 1994; Sathananthan,1994; Trokoudes et 
al., 1995). The success of ICSI as a treatment option for globozoospermia, 
however, was not universal, as successive case reports reported low to absent 
fertilization in cases of ICSI. A down-regulation of an oocyte-activating factor 
was suspected (Liu et al., 1995; Battaglia et al., 1997; Rybouchkin et al.,1997; Nagy 
et al., 1998; Gomez et al., 2000; Stone et al., 2000; Coetzee et al., 2001). Poor oocyte 
activation capability was confirmed by the observation of premature 
chromosome condensation of globozoospermic sperm cells (Edirisinghe et al., 
1998; Schmiady et al., 2005). Interestingly, performing ICSI in the presence of the 
calcium ionophore A23187 appeared to be able to overcome the failure in oocyte 
activation (Liu et al., 1995; Battaglia et al.,
1997; Rybouchkin et al., 1997; Nagy et al., 1998; Gomez et al.,2000; Stone et al., 
2000; Coetzee et al., 2001).
 Several heterologous ICSI models have been developed to test the oocyte-ac-
tivating capacity of spermatozoa after injection. In a mouse model, the human 
globozoospermic cells indeed failed to activate and fertilize the oocytes. When 
the oocytes were artificially activated with ethanol 8%, fertilization did increase 
to normal levels (Rybouchkin et al., 1996; Battaglia et al., 1997; Kim et al., 2001; 
Tesarik et al., 2002). A similar mouse oocyte activation test has been used in a 
clinical setting to predict the necessity of oocyte activation with a CaCl2/Ca2+ 
ionophore, and showed again poor fertilization of globozoospermic cells, 
overcome by the CaCl2/Ca2+ ionophore oocyte activation (Heindryckx et al., 
2005).
 Poor oocyte-activation capacity is thought to originate from the sperm 
centro some as well, in its function as a microtubule-organizing centre. The function 
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of the centrosome was examined in bovine oocytes and showed low sperm aster 
formation rates in globozoospermia after ICSI, supposedly because of a dysfunctional 
centrosome. Surprisingly, ethanol-induced oocyte activation increased fertilization 
rates, suggesting a centrosome-independent sperm ability to activate the oocyte 
(Terada et al., 2001, 2004; Nakamura et al., 2002; Terada, 2004).
Viability
Sperm viability is normally tested by eosin staining, as recommended by the 
World Health Organization (WHO). Jeyendran et al. (1984), however, developed 
the hypo-osmotic swelling test, based on the observation that exposing living 
sperm with intact membranes to hypo-osmotic conditions (150 mOsm/l) results 
in fluid flux into the cell, thereby increasing the sperm volume and resulting in 
a visible swelling of the tail membrane. This hypo- osmotic swelling test (HST) 
was used in combination with eosin staining to test the viability of round-headed 
sperm cells. In two globozoospermia patients, no decreased percentage of viable 
sperm cells were encountered (Jeyendran et al., 1985; Check et al., 1993).
Molecular aspects
Morphological deformities are indicative of structural chromatin and DNA 
abnormalities and cytogenetic defects in spermatozoa. Chromatin condensation 
and stability, DNA fragmentation and aneuploidy rates have been investigated 
and evaluated in round-headed sperm cells, although it should be noted that in 
general the number of patients investigated in each study was low, resulting in 
rather anecdotal data sets.
Nuclear chromatin
Sperm chromatin is condensed during spermiogenesis, in which process, 
amongst others, histones are replaced by protamines (for a review, see Dadoune, 
2003). Abnormal chromatin condensation is a strong indication of a maturation 
defect. The morphological aspects of chromatin condensation in globozoosper-
mia have been described repeatedly in various (electron microscopic) studies. 
These reports, however, differ in their findings. Chromatin condensation was 
classified as normal, granular or fine treaded in early reports (Pedersen and 
Rebbe, 1974; Anton-Lamprecht et al.,1976; Castellani et al., 1978). Later 
descriptions report abnormally condensed chromatin, without further 
specification (Kullander and Rausing, 1975; Wolff et al., 1976; Tyler et al., 1985; 
Lalonde et al.,1988; Escalier, 1990; Singh, 1992; Battaglia et al., 1997; Carrell et al., 
1999; Vicari et al., 2002). In addition, the evaluation of several factors involved in 
chromatin condensation was performed. Again, various results have been 
published. Arrighi et al. (1980) observed high heterogeneity in Feulgen DNA 
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contents within one patient, with low mean Feulgen stainability in globozoo-
spermia, indicating overmaturity (Arrighi et al., 1980). Baccetti et al. (1977) based 
their conclusions on their previous findings that chromatin immaturity is 
characterized by high zinc, low phosphorus and variable lysine levels (Baccetti 
et al., 1977). Varying results were obtained within one patient. Although most 
cells showed immature chromatin by their definition, several cells were compact 
and mature as defined by low zinc and high phosphorus levels and by severely 
reduced lysine levels.
 The presence of lysine was believed to indicate poor substitution of histones 
by protamines. Later reports indeed showed a disrupted replacement of histones 
by protamines (Blanchard et al., 1990). In one of two globozoospermia patients, 
a high histone rate in combination with a low protamine 1 (P1) percentage was 
found. The Protamine 2 (P2) percentage was low but not related to the histone 
content. In both patients, a decreased P1/P2 ratio (0.51 and 0.52, respectively in 
comparison with 0.59 in fertile controls) was found. By contrast, Contradictorily, 
an increased P1/P2 ratio (2.15) was found in one of two siblings suffering from 
globozoospermia (Carrell et al., 1999). In the other sibling, a normal ratio (0.79) 
in comparison with fertile controls was found. Chromatin structure measured 
by the flow cytometric sperm chromatin structure assay (SCSA), which is based 
on the susceptibility of sperm nuclear DNA to acid-induced denaturation, 
showed no differences in the chromatin stability of globozoospermic cells in 
comparison with highly fertile patients (Larson et al., 2001). Chromatin 
maturation can also be measured by propidium iodide staining, as immature 
chromatin is more accessible to this compound and is therefore more strongly 
stained. Vicari et al. (2002) reported an elevated number of globozoospermic 
sperm cells with immature chromatin in a case report, as determined by fluores-
cence-activated cell sorter (FACS) analysis of propidium iodide-stained semen 
samples (Vicari et al., 2002). Lalonde et al. (1988) investigated whether the 
absence of acrosomal components influenced nuclear chromatin decondensation. 
Globozoospermic sperm cells were therefore exposed to either dithiothreitol 
(DTT) or EDTA, which are known to induce nuclear chromatin decondensation. 
No difference was found between globozoospermic and normal spermatozoa 
(Lalonde et al., 1988). In contrast, Carrell et al. (1999) showed an increased 
decondensation rate in two affected siblings when exposed to heparin, from 
which they concluded that chromatin is less stable in globozoospermia (Carrell 
et al., 1999).
 Taken together, these findings indicate that chromatin condensation is 
disturbed in globozoospermia, with a high heterogeneity in the degree of 
maturity. The aetiology of these findings remains to be revealed.
Gl
ob
oz
oo
sp
er
m
ia
 re
vi
sit
ed
2
45
DNA fragmentation
DNA strand breaks can be visualized by labelling the 3′-OH ends using the TdT 
(terminal deoxynucleotidyl transferase)-mediated dUTP-biotin nick-end labelling 
(TUNEL) assay, which is indicative of DNA fragmentation. Both Baccetti et al. 
(1996) and Vicari et al. (2002) found an increased percentage of DNA fragmentation 
in globozoospermic sperm cells compared with fertile controls (10 versus 0.1% 
and 37 versus 22.5%, respectively). The neutral single-cell gel electrophoresis or 
COMET assay also quantifies double- stranded DNA breaks. Larson et al. (2001) 
found no elevation of DNA fragmentation in round-headed sperm cells compared 
with fertile controls, which was in accordance with their SCSA results, described 
in the previous section.
 The sperm-ubiquitin tag immunoassay (SUTI), which detects DNA damage 
as well, was developed to identify abnormal sperm cells (Sutovsky et al., 2001). 
Round-headed sperm cells were highly ubiquinated, indicating defective DNA.
Cytogenetics of sperm cells
Whether morphological sperm deformities are linked to sperm cell chromosomal 
abnormalities has been investigated extensively but is still controversial. Carrell et 
al. (1999) published two case reports in which siblings with globozoospermia 
were evaluated by fluorescence in-situ hybridization (FISH). After the evaluation 
of >5000 cells, they found increased aneuploidy rates for chromosomes 13, 21 and 
XY in one of two affected siblings and a mildly increased aneuploidy rate for 
chromosome 21 in the other sibling (Carrell et al., 1999). In a similar study, three 
siblings, of whom two brothers were affected, were tested. These authors found no 
significant increase in aneuploidy rates for chromosomes 18, X and Y in either 
sibling but did detect a significant increase in chromosome 15 aneuploidy in one 
of the affected siblings (4.03 versus <0.4% in fertile controls) and his fertile brother 
(1.18%). The other affected brother, however, did not show a significant increase in 
aneuploidy rates (Carrell et al., 2001). Martin et al. (2003) also tested chromosomes 
15, X and Y in over 10,000 cells. They did not detect an elevated rate of chromosome 
15 aneuploidy but did report an increase in XY disomy (Martin et al., 2003). 
Recently, these findings were supplemented with the observation of increased 
aneuploidy rates of chromosomes 13, 16 and 21 in a globozoospermic man 
compared to a normozoospermic man (Ditzel et al., 2005). Other studies could not 
confirm a higher aneuploidy rate in globozoospermic cells compared with 
aneuploidy rates in sperm cells of fertile controls (Rybouchkin et al., 1996; Viville 
et al., 2000; Vicari et al., 2002; Morel et al., 2004), although Morel et al. did observe 
a significantly higher disomy rate of chromosomes 13 and 21 in one patient 
compared with another globozoospermic man. Machev et al. (2005) have reviewed 
these papers, who concluded that increased aneuploidy rates occurred mostly in 
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the acrocentric (13, 14, 15, 18 and 21) and sex chromosomes and that these findings 
do not differ from other types of infertility.
Genetic etiology?
A genetic basis for globozoospermia was suspected and is supported by several 
case reports of families with two or more affected siblings (Kullander and 
Rausing, 1975; Florke-Gerloff et al., 1984; Dale et al., 1994; Carrell et al., 1999, 
2001; Kilani et al.,2004). The mode of inheritance remains obscure. By 
investigating the occurrence of sperm defects in consanguinity, no additive 
evidence was found for an autosomal recessive condition in case of globozo-
ospermia (Baccetti et al., 2001). Also, evidence for the participation of Y 
chromosome microdeletions in globozoospermia could not be established 
(Gunalp et al., 2001). As early as 1975, Moutschen and Colizzi designated acro-
somelessness as an interesting and efficient tool in mammalian mutation 
research. Up to now, four mouse genes have been associated with globozoosper-
mia. The first gene, the so-called blind-sterile (bs) mutation, was identified in 1986. 
This was an autosomal recessive mutation on chromosome 2 that was shown to 
result in a failure to assemble an acrosome, a severely impaired spermatogenesis 
leading to a strongly reduced sperm count, and absence of motility and 
bilenticular cataract (Sotomayor and Handel, 1986).
 In a more recent publication, globozoospermia was reported in mice with a 
homozygous deletion of the Csnk2a2 gene1* (Xu et al., 1999; Rocha and Affara, 
2000; Truong et al., 2003). This gene encodes a substrate of protein kinase casein 
kinase II, which is preferentially expressed in the late stages of spermatogenesis 
and is associated with the nuclear matrix. In these mice, the nucleus of 
spermatozoa was deformed. In spermatids, the acrosome often detached from 
the nucleus and disappeared during the next stages of spermatogenesis. Also, 
oligozoospermia due to Sertoli cell phagocytosis and apoptosis was observed 
(Xu et al., 1999). Recently, the CSNK2A2* gene has been examined for mutations 
in human globozoospermia patients. Despite expectations, no mutations were 
detected in any of six investigated patients (Pirrello et al., 2005).
*  Literature searches in another context revealed an article (Escalier, Silvius et al., 2003), in which the 
authors of the same group that discovered the relation between Csnk2A2 and globozoospermia 
(Xu, Toselli et al., 1999) concluded in this paper that their former conclusions on Cnsk2A2-/- mouse 
sperm cells were incorrect regarding the morphology characteristics. Although these sperm cells 
appeared round-headed by scanning electron microscopy, closer examinations revealed poorly 
elongated nuclei and anomalies, but not absence of the acrosome. They explain these misconceptions 
by the presence of a coiled flagellum around the nucleus and a cytoplasmic droplet looking like a 
round nucleus. They clearly state that this phenotype is different from (total) human globozoo-
spermia. This could contribute to the fact that no mutations were found in human globozoo-
spermia patients.
Gl
ob
oz
oo
sp
er
m
ia
 re
vi
sit
ed
2
47
 Globozoospermia has also been described in Hrb–/– mice. Besides the 
characteristic round-headed and acrosomeless sperm cells, also sperm cells with 
a midpiece lacking a mitochondrial sheath in combination with reduced sperm 
motility were observed (Kang-Decker et al., 2001). Additional characteristics 
included loss in cell polarity, intracellular flagellar coiling, multinucleation, 
supernumerary centrioles and multiflagellation and nuclear vacuolization 
(Juneja and Van Deursen, 2005). The Hrb gene encodes for the HIV-1 Rev binding 
protein, an important factor in proacrosomic vesicle fusion, which is abundantly 
transcribed during spermiogenesis. As a consequence, proacrosomic vesicles 
are formed in the medulla of the Golgi apparatus in  Hrb–/–  mice spermatids but 
fail to fuse and transform into an acrosome (Kang-Decker et al., 2001). 
Kierszenbaum et al. (2004) investigated the factors involved in sperm nuclear 
morphogenesis and identified a structure they previously designated the 
acroplaxome. This cytoskeletal scaffold, which, amongst others, contains F-actin 
and keratin 5, develops in the subacrosomal space and anchors the developing 
acrosome to the nuclear envelope and is involved in acrosome formation. When 
they studied the acroplaxome in Hrb–/– mice, they observed a deficiency in 
keratin 5 and the formation of a pseudo- acrosome (Kierszenbaum et al., 2004). 
The latter result was definitely reminiscent of the observations described by 
Baccetti et al. (1977), which would make Hrb an interesting candidate gene for 
human globozoospermia. Unfortunately, the first results on human globozoo-
spermia patients are yet less promising (Christensen et al., 2006).
 The most recently described mouse gene that is known to result in globozo-
ospermia when knocked out is called the Golgi-associated PDZ and coiled-coil 
motif containing protein (Gopc) gene2#. In spermatids, this protein is localized in 
the trans-Golgi cisternae and the trans-Golgi network. It plays a role in Gol-
gi-to-membrane vesicle transport. In early spermatids, the fragmentation of the 
acrosomal cap was observed, as well as abnormal proacrosomic vesicles that 
failed to fuse (Yao et al., 2002).
 Characteristics that remind of the observations made in human globozo-
ospermia patients in early reports (Baccetti et al., 1977; Castellani et al., 1978; 
Nistal and Paniagua, 1978; Florke-Gerloff et al., 1985) were observed in later 
studies. These concluded that in Gopc–/– mice larger proacrosomic vesicles are 
formed and do attach to the poorly developed acroplaxome but that the vesicles 
detach and are lost when the spermatozoon is released into the lumen. Multiple 
#  PDZ domains were originally identified in the post-synaptic density protein PSD-95 as three 
 repeats of about 90 residues containing the conserved motif Gly-Leu-Gly-Phe (GLGF) 3. The name 
PDZ domain is derived from the names of three proteins containing such domains [PSD-95, the 
 Drosophila discs-large tumor suppressor protein DlgA and the tight junction protein ZO-1];  alternative 
designations are GLGF-repeat and DIgA homology region, DHR (Saras and Heldin, 1996).
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failures regarding the nucleus, caudal manchette, post-acrosomal sheath and 
posterior ring were noted, resulting in impaired spermatid nuclear elongation 
(Ito et al., 2004). In detail, the defective posterior ring did not influence tail 
formation, but during epididymal passage, the tail was coiled around the 
nucleus, with the dislocation of the implantation fossa and a disorganized 
mitochondrial sheath (Suzuki-Toyota et al., 2004).
  The last three candidate genes (Table III) have recently been screened in two 
men with (partial) globozoospermia. This study led to the identification of 
polymorphisms, but no mutation with a clear link to partial globozoospermia 
was found (Christensen et al., 2006). These results have yet to be confirmed in a 
larger group of patients with partial or total globozoospermia, before conclusions 
on these candidate genes can be drawn. Undoubtedly, the identification of proteins 
and protein complexes that are involved in spermiogenesis will substantially 
facilitate the search for additional candidate genes (Luo et al., 2003).
CONCLUSIONS AND DISCUSSION
Globozoospermia can be diagnosed by an extended semen analysis, which is 
likely to show the typical feature of round-headed, acrosomeless spermatozoa. 
A slight asthenozoospermia might also be found. No peculiarities in case history 
or physical examination of affected males have been associated with globozoo-
spermia. The pathogenesis occurs during spermiogenesis and probably originates 
in acrosomic vesicle fusion and cytoskeleton disorders, which remains to be 
elucidated. Genetically manipulated mice show that the knockout of different 
genes can lead to approximately the same phenotype. Moreover, these observations 
show similarities with the results reported several decades ago (Baccetti et al., 
1977; Castellani et al., 1978; Nistal and Paniagua, 1978; Florke-Gerloff et al., 1985), 
which indicates that there might indeed be different genetic pathways of 
pathogenesis that lead to this sperm morphology disorder (Sotomayor and 
Handel, 1986; Xu et al., 1999; Kang-Decker et al., 2001; Yao et al., 2002; 
Kierszenbaum et al., 2004).
 This could also explain the variable results in the cases of globozoospermia as 
described above. It is clear that a Schirren-Holstein or type I globozoospermia is a 
common term for 100% of round-headed and acrosomeless spermatozoa per 
ejaculate. The term type II globozoospermia for round-headed spermatozoa 
with an acrosome but with maturation defects was not broadly adopted in 
literature (Anton-Lamprecht et al., 1976; Singh, 1992; Christensen et al., 2006). 
Also, the use of the current nomenclature, namely type I and II, is not consistent 
and therefore misleading, as well in literature as in daily practice. We therefore 
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suggest replacing these terms by total globozoospermia in case of 100% round- 
headed, acrosomeless spermatozoa and of partial globozoospermia if <100% of 
the spermatozoa are affected. Because globozoospermia is a rare disorder, only 
a relatively small number of patients have been described in literature. Moreover, 
various methods have been used to study these patients. These factors make an 
overall analysis very difficult. In our opinion, systematic collection and citation 
of all the facts found was the best solution, severe selection on quality would 
have excluded too much information. This implicates that no firm conclusions 
can be drawn. Instead, an overview of what has been written on globozoo-
spermia in the past three decades has been provided to outline the syndrome 
globozoospermia.
 Next to these academical considerations, physicians in their daily practice 
are in need of treatment options for these patients. No treatment was available 
until ICSI was introduced, which seemed to be a promising solution. Unfortunately, 
fertilization rates after ICSI often appear to be severely diminished in globozoo-
spermia (Table II). A solution to this problem could be to use diagnostic 
heterologous ICSI to evaluate the fertilization capacity for each case, in order 
to predict the need of oocyte activation with a calcium ionophore (Heindryckx 
et al., 2005).
 An important factor to consider is the possible effect on offspring of the 
abnormalities in chromatin structure and DNA integrity that, although 
inconsistently, have been described in globozoospermic cells. Whenever 
possible, these factors should be evaluated for each case in specialized centres. 
Obviously, preferably normally shaped sperm cells should be used in case of 
partial globozoospermia.
 A lot of questions on globozoospermia remain to be answered. Additional 
studies are needed to elucidate whether cases of partial globozoospermia and 
total globozoospermia are variations of the same syndrome. Genetic analysis 
could be of great distinctive value in this matter, although environmental factors 
involved in globozoospermia etiology cannot be ruled out completely. 
Nevertheless, genetic analysis in globozoospermia could be easier than in male 
subfertility in general, because of its distinct morphological characteristics, 
which places its origin in spermiogenesis.
 Therefore, studies should be focused on genes that are involved in the Golgi 
apparatus and cytoskeleton structures during spermiogenesis, like the candidate 
genes found in mice. Although mouse models may not be directly applicable to 
the human situation, these models may nevertheless help us better understand 
mammal spermatogenesis, giving us a perspective on the cause(s) of human 
globozoospermia. The fact that similar pathophysiologies are found in both 
mice and men does not necessarily mean that the homologous genes are involved 
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in both species but surely gives an indication on what kind of genes we are 
looking for. In addition, the rarity of the syndrome is suggestive for a homozygous 
inheritance pattern, although Baccetti et al. (2001) did not find correlation between 
consanguinity and globozoospermia. Candidate genes could be identified by 
linkage analysis in consanguineous families, or families with more than one 
affected member, as the syndrome is too rare to occur in first-degree family 
members by chance. Also, the identification of proteins that are involved in 
spermiogenesis and the etiology of globozoospermia by testing testis mRNA on 
expression microarrays could provide candidate genes that could subsequently 
be screened in patients and their families.
 In conclusion, genetic research on globozoospermia is still in its initial 
stages but will undoubtedly prove to be invaluable in elucidating the processes 
of spermiogenesis and spermatogenesis in general and of the etiology of globo-
zoospermia in particular.
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ABSTRACT 
Total globozoospermia is a rare sperm morphology disorder that consists of 
100% round-headed, acrosomeless spermatozoa. There is also a larger group of 
patients whose sperm cells are partially acrosomeless. The aim of this investigation 
was to describe partial globozoospermia compared to total globozoospermia 
and normozoospermia. Ejaculates from 10 patients with more than 50% 
acrosomeless spermatozoa (partial globozoospermia), 3 patients with total 
 globozoospermia, and 9 normozoospermic controls were analyzed with light 
microscopy, transmission electron microscopy, and flow cytometry. Qualitative 
and quantitative examination of spermatozoa from the 3 groups shows differences 
in the percentage of round-headed sperm cells and acrosome malformation. 
Total globozoospermia presents as a homogenous kind of teratozoospermia. 
Partial globozoospermia is a distinctive sperm malformation with an increased 
proportion of round-headed sperm cells and acrosome malformations compared 
to normozoospermia, which exists separately from total globozoospermia. It thereby 
contains oval sperm cells that may have distinctive malformations of the sperm 
head matrix, but also morphologically normal sperm cells that may be used in 
a clinical setting.
Key words: Sperm morphology disorder, male subfertility.
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INTRODUCTION
Total globozoospermia is a well-described sperm morphology disorder that 
consists of round-headed, acrosomeless spermatozoa (Schirren et al, 1971). Men 
suffering from this syndrome are considered infertile, although the introduction 
of intracytoplasmic sperm injection (ICSI) has made some pregnancies possible 
in this patient group (Larson et al, 2001). Given its morphological features, 
 globozoospermia likely originates during spermiogenesis. This theory has been 
confirmed in several mouse knockout models (Kang-Decker et al, 2001; Yao et al, 
2002; Xiao et al, 2009). A candidate gene has been identified in humans. The 
mutation in SPATA16 indicates a genetic origin in human spermiogenesis as 
well, but we found no mutations in other patients with globozoospermia except 
the one in the affected family (Dam et al, 2007b). These findings reinforce the 
idea of a multigenetic disorder in which several etiologies may cause the same 
morphologic phenotype.
 There is a group of patients whose semen samples show only a fraction with 
this typical head shape. The research group that first described globozoospermia 
noted this ‘‘partial’’ condition only two years after their initial publication 
(Holstein et al, 1973). In the first description of partial globozoospermia, the 
round-headedness was attributed to a cytoplasmic droplet surrounding the 
sperm head and acrosome. The authors named it type II globozoospermia 
 (Anton-Lamprecht et al, 1976). This nomenclature was rarely used in the 
literature, and when it was, it referred to partially affected individuals who did 
not have the other characteristics that Anton-Lamprecht and colleagues (1976) 
described earlier. Because of this confusion in nomenclature, we suggest the 
terms ‘‘total’’ and ‘‘partial’’ globozoospermia (Dam et al, 2007a).
 Cases with a large proportion of acrosomeless spermatozoa are more 
common in daily clinical practice than total globozoospermia. Although there is 
no defined threshold for the normal proportion of round- headed spermatozoa 
in an ejaculate, it is well known that even fertile men have up to 3% sperm cells 
in the ejaculate (Kalahanis et al, 2002). Unfortunately, many reports describe 
cases of partial globo- zoospermia without detailed morphology studies using, 
for example, transmission electron microscopy (TEM) providing validation of 
this condition, which leads to confusing results (Holstein et al, 1973; Pedersen 
and Rebbe, 1974; Weissenberg et al, 1983; Florke-Gerloff et al, 1984; Syms et al, 
1984; Tyler et al, 1985; Singer et al, 1986; Lanzendorf et al, 1988; Rybouchkin et al, 
1996; Carrell et al, 1999, 2001; Coetzee et al, 2001; Larson et al, 2001; Christensen 
et al, 2006). No detailed morphological description has yet been provided for 
cases of partial globozoospermia. The main purpose of this study was to 
investigate whether partial globozoospermia and total globozoospermia are 
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two different morphology disorders and to describe sperm characteristics in 
partial globozoospermia.
MATERIALS AND METHODS
Design
We included 10 patients who had more than 50% acrosomeless spermatozoa as 
the main morphologic head characteristic (partial globozoospermia) and 
compared their spermatozoa with the spermatozoa of three patients with total 
globozoospermia and nine normozoospermic controls. We used qualitative 
techniques such as Diff-Quik staining, TEM, and quantitative flow cytometry to 
determine proacrosin and acrosin levels for this purpose.
Patients
Patients were recruited at the Centre for Reproductive Medicine in Nijmegen, 
The Netherlands. Infertile men (as evidenced by ≥ 1 year of unprotected 
intercourse) are routinely subjected to a semen analysis, including sperm count 
and motility assessment in accordance with World Health Organization (WHO) 
guidelines. In our center, the morphology is routinely assessed with aniline blue 
and eosin-Y staining (Ebisch et al, 2006), and we used this staining method for 
patient inclusion. Briefly, several drops of the semen sample are incubated for 10 
minutes at room temperature with trypsin, mixed with 2% eosin and 25% 
aniline blue stain on a glass slide, smeared out, and air dried. The slides show a 
blue background, vital sperm cells stain white, and nonvital sperm cells stain 
red. We used strict criteria for the morphology evaluation of the vital cells 
(Menkveld et al, 2001). Sperm head morphology is considered normal if there is 
an oval head, a smooth surface, and an acrosome that covers 40%–70% of the 
head. Two trained technicians evaluated at least 200 sperm cells per sample. 
Patients whose ejaculate had more than 50% acrosomeless sperm cells were 
invited to participate in the study. Controls were selected from among normozoo-
spermic men who were enrolled in an in vitro fertilization (IVF) program 
because of a female factor. Total globozoospermia is rare, so that the three 
patients who are included in this study received treatment at the Egyptian 
IVF-ET Center in Cairo. This study was approved by the regional Ethics 
Committee in Nijmegen. All patients gave informed consent for the study.
 Each of the participants provided a second fresh sample for the study. These 
fresh samples were processed for standard semen analysis (WHO, 1999), 
including a Diff-Quik stain and TEM for morphology evaluation. The remnants 
of the samples were then frozen for future use in flow cytometry analysis.
M
or
ph
ol
og
y 
of
 p
ar
tia
l g
lo
bo
zo
os
pe
rm
ia
3
65
Diff-Quik Stain
We evaluated the morphology with Diff-Quik stain only for the second fresh 
sample as an alternative to Papanicolaou stain (WHO, 1999). In short, a drop of 
semen was smeared on a slide and air dried. We stained the slides automatically 
with the Wescor 7120 Aerospray Hematology Slide Stainer (Elitech Group, 
Puteaux, France) for staining with the reagents eosin and thiazin (azure B and 
methylene blue). Two technicians evaluated at least 200 cells per patient sample 
at 61000x magnification. The main outcome terms used to describe the sperm 
head morphology were normal (or oval), dysmorphic, and round. The acrosome 
was scored as present or absent.
Transmission Electron Microscopy
For electron microscopy, each sample was diluted or concentrated to a final 
sperm concentration of 10–25 x 106 sperm/mL (10 x 106 sperm/pellet). Sperm 
cells were washed and concentrated by centrifugation in human tubal fluid 
medium, supernatant was discarded, and the pellet was fixed in 2.5% 
glutaraldehyde left to dissolve in 0.1 M sodium cacodylate buffer, pH 7.4, at 4oC 
overnight. Subsequently, samples were washed in the same buffer, postfixed in 
Palade buffered 2% OsO4 for 2 h, pelleted in 15% gelatin, dehydrated, and 
embedded in Epon 812 (Merck, Darmstadt, Germany). Ultrathin sections were 
sliced on an ultratome (Leica, Reichert Ultracuts, Vienna, Austria), contrasted 
with 4% uranyl acetate for 45 minutes and then with lead citrate for 5 minutes 
at room temperature. Sections were examined in a Jeol 1200 EX2 electron 
microscope (JEOL, Tokyo, Japan). Only cells with a complete sperm head and at 
least one-third of the tail (including midpiece) were included for evaluation. 
Thirteen to 30 cells per field were found for each patient. In total, 189 cells were 
evaluated in normozoospermia, 213 in partial globozoospermia, and 54 in total 
globozoospermia. Morpho- logic outcomes evaluated are based on previous 
literature descriptive features (normal or aberrant), sperm head morphology 
(oval or round), acrosome presence (yes, partially, or absent), chromatin condensation 
(highly or poorly condensed), invagination (no or yes), mitochondria in the 
sperm head (no or yes), and space between the nuclear membranes (no or yes; for 
review see Dam, 2007a).
Flow Cytometry for Acrosin and Proacrosin
Immunofluorescent Staining frozen-thawed sperm samples were washed twice 
in phosphate-buffered saline (PBS), fixed in 1% paraformaldehyde (15 minutes), 
and preincubated in 10% normal goat serum (NGS, 10 minutes). An aliquot of 
each sample was held aside for the base (background) measurement. The rest of 
the sample was then incubated for 1 h at room temperature in either mouse 
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proacrosin monoclonal antibody (mAb) 4D4 (Escalier et al, 1991), 1% (dilution 
1:100 PBS:10% NGS) or mouse acrosin mAb Acr-C5F10 (Biosonda, Santiago, 
Chile) 2.5% (dilution 1:40 PBS:10% NGS). Samples were then washed in PBS 
before the second incubation with 0.2% Alexa 488 goat anti-mouse (dilution 
1:500 PBS:10% NGS; Molecular Probes, Eugene, Oregon) for 1 hour at room 
temperature in the dark. Then the samples were washed in PBS and brought to 
a final volume of 500 uL for the flow cytometry. After flow cytometry 
measurements, the samples were counterstained with 100 mL of 4,6-diamino- 
2-phenylindole (0.0025 mg/mL; Sigma, St Louis, Missouri) and incubated for 
10 minutes. A droplet of this sperm suspension was dried on a glass slide to check 
the staining pattern. The slides were mounted in 20 mL Vectashield (Vectra 
Laboratories, Burlingame, Califormia) to preserve staining; the sperm samples 
were photographed under a fluorescence microscope at magnification 6400–6630.
 Flow Cytometry—At least 2000 cells per sample were analyzed on a Coulter 
Epics Elite flow cytometer (Beckman Coulter, Miami, Florida) equipped with a 
488-nm excitation laser (for the presence and intensity measurements of 
proacrosin and acrosin). After background correction, using an unstained 
sample, proacrosin or acrosin intensity was measured on photomultiplier tube 2 
log (525 bp 615 nm) and gated on forward scatter vs side scatter to discriminate 
cells from debris. The main outcomes were the percentages of gated cells positive 
for acrosin and proacrosin staining and the mean staining intensity (x¯) on a 
logarithmic scale.
Statistical Analysis
Results of aniline blue and eosin-Y staining were compared with Diff-Quik staining 
in a separate paired samples t-test for each patient group. The percentages of 
normal patterns in TEM in normozoospermia and partial globozoospermia and 
acrosome presence per morphology category were compared with the X2 test. 
All other results were analyzed with 1-way analysis of variance (ANOVA) along 
with the Welch and Brown-Forsythe tests of robustness, and the Tukey, Tukey-B, 
and Games-Howell tests as post hoc tests. P < .05 was considered significant. 
We used the SPPS 15.0 software pack for statistical analysis.
RESULTS
Table 1 shows the results of the routine semen analyses and the summarized 
results for the Diff-Quik staining of the second samples of all patients and 
controls. Although the inclusion criterion for the partial globozoospermia group 
was the presence of more than 50% acrosomeless sperm, the acrosomeless sperm 
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in the second sample varied from 30% to 82% with aniline blue and eosin-Y 
staining and between 25% and 83% in the Diff-Quik staining. The semen 
volumes of the three groups were comparable. The sperm concentrations of 
patients with partial globozoospermia were significantly lower than those of the 
controls and the patients with total globozoospermia (P = .002 and P < .001, 
respectively), whereas motility was only significantly different between controls 
and patients with partial globozoospermia (P = .002). On the basis of the 
inclusion criteria used in this study, the proportions of acrosomeless sperm 
obviously differ in the three groups. Aniline blue and eosin-Y staining and 
Diff-Quik staining correlated well with respect to morphology and acrosome 
absence in partial and total globozoospermia, but differed significantly with 
respect to the percentage of normal morphology (19% vs 13%, P = .031) and 
acrosome absence of the controls (0% vs 5%, P = .022).
 Table 2 displays the detailed morphologic evaluations of the Diff-Quik 
staining. Oval head forms (normal sperm cells) are rarely found in partial globo-
zoospermia (mean 1%), and never in total globozoospermia. The absence of the 
acrosome is rarely seen in normozoospermia (mean 5%; see Table 1), but is the 
predominant morphologic characteristic in total globozoospermia. In partial 
globozoospermia, we found a mean of 53% acrosomeless cells (see Table 1). 
Acrosomeless cells were present in the dysmorphic sperm cells (mean 40%), but 
mostly in round-headed cells (mean 93%; see Table 2). We found a significant 
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Controls 3.4 (1.9-6.3) 56 (25-85)   55 (25-85)  81 (70-95) 0
Partial  
globozoospermia
2.9 (0.8-5.0) 21 (4-50) 22 (10-35) 98 (95-100) 58 (30-82)
Total  
globozoospermia
2.0 (1.0-3.0) 70 (70) 38 (25-50) 100 (100) 100 (100)
Table 1  Semen analysis.
The mean values and percentages of the different parameters in semen analysis are displayed. Volume 
is expressed in ml; concentration is expressed in million spermcells/ ml; motility represents progressive 
motility (A+B), morphology represents abnormal head morphology and acrosomeless is the percentage 
of acrosomeless spermatozoa. Morphology analysis was performed by aniline/ eosin Y staining and 
may show somewhat different results than the Diff-Quik staining.
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difference between these morphological head characteristics and the presence 
of acrosomeless cells in all groups (P < .001).
 Figure 1 displays a TEM picture of a representative cell for each of the 3 
groups. The results for TEM were analyzed with 1-way ANOVA, which showed 
a significant difference (P < .001) between groups for all features. In detail, no 
significant difference for chromatin condensation was found between normozoo-
spermia and partial globozoospermia. Invagination, mitochondria in the sperm 
head, and space between membranes differed nonsignificantly between total 
and partial globozoospermia.
 Table 3 displays all TEM characteristics related to the 2 main types of sperm 
head morphology (round and oval). The amounts of oval and round sperm cells 
were significantly different between normozoospermia, partial globozoospermia, 
and total globozoospermia. When sperm head characteristics were analyzed 
Figure 1a-c   TEM pictures.
a normozoospermia - all organelles are present and organized as a normal sperm cell; b partial globozoo-
spermia – a more or less oval head shape with less condensed chromatin (<<), a partially present 
acrosome. and a disorganized midpiece. Mitochondriae ( ) are present not only in the midpiece, but also 
in the sperm head. Invagination of the acrosome (*) is an often observed abnormality, and the acrosome 
is also incorrectly attached; c the round-headed, acrosomeless form, which is characteristic for total 
 globozoospermia
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within the oval sperm cells, considered normal in this setting, partial globozoo-
spermia differed significantly from normozoospermia for partially formed 
acrosomes (P < .001), mitochondria in the sperm head (P < .001), and space 
between the sperm head membranes (P < .001). In the outer right column of 
Table 3 are the percentages sperm cells with normal characteristics (presence 
of acrosomes, highly condensed chromatin, no invagination or mitochondria 
in the sperm head, and no space between sperm head membranes). These 
percentages differed significantly for controls and patients with partial globozoo-
Sperm head 
morphology 
group
Sample type Nr. of 
sperm 
analyzed
sperm head 
morphology type 
(%)
%  
Acrosomea
%  
poor chromatinb
%  
Mitochondriac
%  
Invaginationd
%  
Membrane spacee
%  
Total normal 
patternsf
absent partial
(range) p (range) p (range) p (range) p (range) p (range) p (range) p (range) p
Oval
headed
Normozoosp.
176
93
(71–100)
13
(0–24)
1
(0–8)
33
(8–52)
1
(0–8)
2
(0–11)
27
(16–50)
40
(22–58)
Partial 
globozoosp. 146
68
(8–89)
0.04* 7
(0–17)
0.95 31
(9–100)
<0.001* 39
(0–73)
0.50 12
(0–50)
<0.001* 7
(0–100)
0.07 50
(44–100)
<0.001* 17
(0–32)
0.004*
Total 
globozoosp.
2 4
(0–7)
<0.001# 50
(0–100)
- 0
.
- 50
(0–100)
- 0
.
- 0
.
- 50
(0–100)
- 0
.
Round
headed
Normozoosp.
13
7
 (0–29)
36
(0–100)
0
.
69
(40–100)
0
.
0
.
31
(0–67)
No normal patterns 
present
Partial 
globozoosp.
67 32
(11–92)
0.04* 18
(0–29)
0.98 46
(0–80)
0.002* 63
(0–86)
0.89 18
(0–60)
0.01* 8
(0–73)
0.01* 57
(0–86)
0.21
Total 
globozoosp.
52 96
(96–100)
<0.001# 32
(15–46)
0.46 27
(9–46)
0.12 81
(73–94)
0.71 13
(4–23)
0.79 8
(6–10)
0.20 52
(32–71)
0.86
Table 3  Sperm head morphology and structures observed by TEM a.
Abbreviation: TEM, transmission electron microscopy.
a   This table displays the mean percentages (with ranges in parentheses) for the sperm head  morphology 
and specific structures found in sperm as observed with TEM. P values are displayed for partial 
 globozoospermia with respect to normozoospermia and for total globozoospermia in respect to 
partial globozoospermia. Significantly different values for partial globozoospermia are in bold.
b   Mean percentage of cells per patient either acrosomeless or with a partially present acrosome  according 
to sperm head morphology.
c   Mean percentage of cells per patient with poorly condensed chromatin according to sperm head 
 morphology.
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spermia (P = 0 .004) in the results of the X2 test. Invagination was not significantly 
different (P = 0.07). Chromatin condensation did not differ significantly in the 
3 sperm sample types. In the total globozoospermia group only two oval sperm 
heads were found; therefore, no conclusions about the oval forms of this group 
can be reached.
Round-headed sperm cells in partial globozoospermia differed significantly 
from those in normozoospermia for partially formed acrosomes (P = .002), 
Sperm head 
morphology 
group
Sample type Nr. of 
sperm 
analyzed
sperm head 
morphology type 
(%)
%  
Acrosomea
%  
poor chromatinb
%  
Mitochondriac
%  
Invaginationd
%  
Membrane spacee
%  
Total normal 
patternsf
absent partial
(range) p (range) p (range) p (range) p (range) p (range) p (range) p (range) p
Oval
headed
Normozoosp.
176
93
(71–100)
13
(0–24)
1
(0–8)
33
(8–52)
1
(0–8)
2
(0–11)
27
(16–50)
40
(22–58)
Partial 
globozoosp. 146
68
(8–89)
0.04* 7
(0–17)
0.95 31
(9–100)
<0.001* 39
(0–73)
0.50 12
(0–50)
<0.001* 7
(0–100)
0.07 50
(44–100)
<0.001* 17
(0–32)
0.004*
Total 
globozoosp.
2 4
(0–7)
<0.001# 50
(0–100)
- 0
.
- 50
(0–100)
- 0
.
- 0
.
- 50
(0–100)
- 0
.
Round
headed
Normozoosp.
13
7
 (0–29)
36
(0–100)
0
.
69
(40–100)
0
.
0
.
31
(0–67)
No normal patterns 
present
Partial 
globozoosp.
67 32
(11–92)
0.04* 18
(0–29)
0.98 46
(0–80)
0.002* 63
(0–86)
0.89 18
(0–60)
0.01* 8
(0–73)
0.01* 57
(0–86)
0.21
Total 
globozoosp.
52 96
(96–100)
<0.001# 32
(15–46)
0.46 27
(9–46)
0.12 81
(73–94)
0.71 13
(4–23)
0.79 8
(6–10)
0.20 52
(32–71)
0.86
Table 3  Sperm head morphology and structures observed by TEM a.
Abbreviation: TEM, transmission electron microscopy.
a   This table displays the mean percentages (with ranges in parentheses) for the sperm head  morphology 
and specific structures found in sperm as observed with TEM. P values are displayed for partial 
 globozoospermia with respect to normozoospermia and for total globozoospermia in respect to 
partial globozoospermia. Significantly different values for partial globozoospermia are in bold.
b   Mean percentage of cells per patient either acrosomeless or with a partially present acrosome  according 
to sperm head morphology.
c   Mean percentage of cells per patient with poorly condensed chromatin according to sperm head 
 morphology.
d   Mean percentage of cells per patient with mitochondria in the sperm head according to sperm head 
morphology.
e   Mean percentage of cells per patient with invagination of the acrosome in the sperm head according 
to sperm head morphology.
f   Mean percentage of cells per patient with a space between the sperm head membranes according to 
sperm head morphology.
g   Mean percentage of cells presenting normal head morphology features in TEM.
h   Significantly different with respect to normozoospermia.
i Significantly different with respect to partial globozoospermia.
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mitochondria in the sperm head (P = .01), and invagination (P = .01). There were 
no significant differences for acrosome absence, chromatin condensation, or the 
space between head membranes. There was a significant difference in 
mitochondria in the sperm head between controls and total globozoospermia (P 
= .019; not shown in Table 3). It is noteworthy that in this setting all the observed 
features in the round-headed cells were comparable between partial and total 
globozoospermia.
 Figure 2 shows the flow cytometry measurements of the acrosin and proacrosin; 
the mean intensities of all samples for the proacrosin and acrosin staining 
are given on the X-axis and the percentage of positive cells on the Y-axis. 
Unfortunately, control 9 was lost for analysis. The mean cell positivity and 
staining intensity show a differential pattern for each group: in total globozoo-
spermia a small percentage of the sperm samples stained with low intensity 
for proacrosin and acrosin. The percentage of positive cells in partial globozoo-
Figure 2   Flow cytometry results after proacrosin and acrosin staining.
Percentages of gated cells that are positive for acrosin and proacrosin are displayed on the x-axis. The results 
of the intensity measurements (arbitrary units) using a monoclonal antibody for acrosin or proacrosin 
are presented on the y-axis. The 3 groups present different staining patterns (content) for both acrosin 
and proacrosin. In partial globozoospermia, the acrosomes are present, but show a low intensity, 
which indicates little activity.
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spermia samples was about equal to that in control samples in acrosin staining. 
The acrosin staining intensity in partial globozoospermia was intermediate 
between the staining intensities of total globozoospermia samples and control 
samples, suggesting a partially present or malformed acrosome. 
 In proacrosin staining, a lower percentage of positive cells and a far lower 
intensity were found for partial globozoospermia in comparison to controls. 
Statistical analysis showed significant differences between the groups in both 
the mean intensity of staining (P = .001) and numbers of positive cells (P = .002).
DISCUSSION
As a result of this study, we would describe partial globozoospermia as an oligo-
asthenoteratozoospermia that contains an increased amount of round-headed 
sperm cells (>25% in this study) as well as an increased occurrence of acrosomes 
defects (>25% in this study). Detailed observation by TEM shows an occurrence 
of differentiation defects in oval sperm heads that is significantly different from 
that of normozoospermia, next to a limited number of normal sperm cells that 
might be used in ART (assisted reproductive techniques).
 Both partial and total globozoospermia are rare conditions and therefore 
difficult to investigate. However, such investigations of these conditions will 
improve the further knowledge of this specific type of sperm morphology; 
 characteristics of these types of sperm morphology aberrations facilitate the 
classification of patients’ conditions, reveal information about their prognoses 
in fertility care, and unravel the details of a potential abnormal mechanism 
during spermatogenesis. As for the robustness of our results, we were hampered 
by the small number of patients available for participation, which makes analysis 
and interpretation more difficult. Thereby, we used techniques that are common 
in our laboratory, such as aniline blue and eosin-Y staining, to select our patients. 
We added the Diff-Quik stain to adhere to WHO (1999) standards. The results of 
aniline blue and eosin-Y staining and Diff-Quik staining did correlate well for 
morphology and acrosome presence in partial and total globozoospermia, but 
differed significantly for morphology and acrosome absence in the control 
samples. This finding might be due to the fact that in the aniline blue and eosin-Y 
staining only vital cells are assessed. As for the staining of the acrosome, in spite 
of the fact that only acrosin antibodies are commercially available, but we were 
able to obtain a proacrosin antibody (kind gift of Dr. D. Escalier, Paris). Although 
it is assumed that in nonactivated sperm only proacrosin is present and that it 
converts to acrosin after capacitation and acrosome reaction, both proacrosin 
and acrosin are present in human ejaculated sperm (Florke-Gerloff et al, 1984; 
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Jeyendran et al, 1985; Lalonde et al, 1988). Our results support these findings.
 In this experimental setting, we selected partial globozoospermia patients 
with the criterion of more than 50% acrosomeless sperm cells. We found a 
variation of the numbers of acrosomeless sperm cells between the first and 
second samples, which indicates that this criterion is yet not strictly applicable. 
As observed with light microscopy, partial globozoospermia consists of a 
limited number of normal (oval) sperm cells next to aberrant forms (round-headed 
and dysmorphic sperm heads). The proportions differ from those found for both 
controls and patients with total globozoospermia.  In TEM, we found that oval 
sperm cells in partial globozoospermia compared to normozoospermia often 
show sperm head construction defaults, such as space between the sperm head 
membranes and disarrangement of mitochondria next to partially formed 
acrosomes. The existence of partially formed acrosomes was confirmed by flow 
cytometry, which shows that some of the sperm cells of patients with partial 
globozoospermia contain acrosomal enzymes (proacrosin and acrosin), but 
lesser amounts than in the sperm cells of controls. The round-headed cells in 
partial globozoospermia were comparable to those in total globozoospermia for 
the examined features in TEM.
 It is noteworthy that the significant differences between partial and total 
globozoospermia for all characteristics evaluated with TEM rather disappear in 
the analysis done according to head shape (oval or round). Although the unequal 
distribution of cells between the morphology groups is partly the cause, round 
sperm head morphology appears to be the most important discriminating factor. 
Round-headed sperm cells are accompanied by acrosome malformations and 
aberrant chromatin condensation. This implies that partial and total globozo-
ospermia may have similar etiologic pathways leading to aberrant sperm head 
formation during spermiogenesis. The exact spermiogenetic defects in partial 
and total globozoospermia probably differ, but these entities may represent a 
variant phenotype of the same genetic factor(s). The phenotype of the mouse 
model Csnk2A22/2, at first wrongly classified as total globozoospermia, seems to 
share certain traits with partial globozoospermia (Xu et al,1999; Escalier et al, 
2003). This gene is expressed in the brain and in the human testis, and it may 
play a role in globozoospermia, although additional physical features would 
then be expected. The combination of increased apoptosis in the early stages of 
spermatogenesis and the hampered maturation of the spermatids, as described 
by Escalier et al (2003), could form a starting point for speculation about the 
etiological pathways of partial globozoospermia. The Csnk2A2 protein appears 
to promote cell survival and opposes cell death in the apoptotic pathways by 
phosphorylating several proteins that induce caspase-mediated degradation 
during apoptosis (Escalier et al, 2003). We may speculate that partial globozo-
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ospermia exists because the labeled defective spermatids do not follow apoptotic 
degradation as suggested by Sakkas et al (1999). Surprisingly, this effect 
described in oligozoospermia is not always observed in total globozoospermia 
(Dam et al, 2007a).
 In other studies, total globozoospermia is always described as 100% 
round-headed and acrosomeless sperm round-headed sperm cells and acrosome 
malformations that exists separately from total globozoospermia. Partial globo-
zoospermia contains oval sperm cells with distinctive malformations to the 
sperm head matrix compared to normozoospermia, but still normal sperm cells 
are found, which may be used in a clinical setting.
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Chapter 4
Sperm Integrity in partial 
globozoospermia
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ABSTRACT
Partial globozoospermia is recently described as a teratozoospermia wherein at 
least 25 % of the sperm cells is round-headed and acrosomeless. Previously, we 
found indications for an aberrant spermiogenesis in partial globozoospermia. In 
this study we evaluated 10 partial globozoospermic patients and nine normozo-
ospermic controls using computerised karyometric image analysis (CKIA) and 
DNA integrity by the immunofluorescence tests with TUNEL, CMA3 and KM-2 
(tri-acetylated histone H4, indicative for early apoptosis or abnormalities in 
the spermiogenesis) and TH2B. All tests indicate that not only the total sperm 
population differs from normospermic controls as expected, but also the normal 
morphological sperm in PG differs in terms of DNA integrity. The significant 
difference in KM-2 staining intensity, observed in normal shaped cells, disappears 
when analyzed in morphologically abnormal cells in normozoospermia and 
partial globozoospermia.  The testis-specific anti-histon 2B (TH2B) staining is 
more prominent in partial globozoospermia, although not significant different 
at sample level. 
 We conclude that early spermiogenesis is disturbed and that DNA damage is 
increased, although there is no significant difference in DNA damage compared 
to normozoospermia. 
Key words: Sperm; partial globozoospermia; chromatin, DNA damage, CKIA
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INTRODUCTION
Partial globozoospermia has been recently morphologically characterized as a 
subtype of teratozoospermia wherein at least 25 % of the ejaculated sperm cells 
is round-headed and a mean of 93% of the cells is acrosomeless, as determined 
by light microscopy [1]. Evaluation of partial globozoospermia by transmission 
electron microscopy (TEM) shows that round-headed cells present a rudimentary 
or a partial acrosome, which cannot be distinguished by conventional methods. 
Round-headed sperm cells in partial globozoospermia appear to be associated 
with poorly condensed chromatin, which implies an increased susceptibility to 
DNA damage. Previous studies in total globozoospermia show a variable 
chromatin structure and an increased DNA damage (see review[2]). Round- 
headed cells in partial globozoospermia and total globozoospermia also share 
an augmented percentage of other abnormal structural characteristics, such as 
space between nuclear membranes and displaced mitochondria [1]. In partial 
globozoospermia patients, similar structural abnormalities can be demonstrated 
in oval-headed (‘normal-alike’) sperm cells [1].
  During spermiogenesis, sperm head elongation, acrosome formation and 
chromatin condensation take place, thereby transforming the spermatid into a 
mature spermatozoon [3, 4]. When acrosome formation is disturbed, the final 
steps in sperm maturation and morphology shaping are unbalanced and 
sperm cells develop as round-headed, usually acrosomeless or with partial/
rudimentary acrosome-like structure next to a poorly condensed chromatin, 
which suggests an association between these processes [1, 5, 6]. Interestingly, 
in partial globozoospermia the morphological ‘normal’ oval-headed as well as 
the round-headed shaped sperm show an increased percentage of structural 
abnormalities compared to normal or oval shaped sperm in normozoospermic 
controls, suggesting an aberrant maturation during spermiogenesis besides 
head shaping [1]. This finding has led us to further characterize sperm integrity 
and chromatin characteristics in partial globozoospermia in order to get a better 
insight of the probable risks for fertility treatment when using sperm from these 
patients. 
 The purpose of this study is to investigate sperm morphometric patterns 
using colorimetric techniques and computer evaluation (CKIA), and further 
evaluate sperm integrity using molecular techniques (immunofluorescence, IF) 
with TUNEL, CMA3, KM-2 and TH2B staining in order to obtain a more complete 
description of spermatozoa in partial globozoospermia.
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MATERIALS AND METHODS 
Patients
Patients were recruited at the Centre for Reproductive Medicine at Radboudumc, 
Nijmegen, the Netherlands. A total of 10 partial globozoospermia patients and 
nine normozoospermic controls were enrolled in this study. These partial globo-
zoospermia and controls samples were also used in our previous study [1]. 
Patients’ semen analyses are summarized in Table 1. Fresh sperm samples were 
analyzed following WHO criteria (motility and concentration) or strict criteria 
(morphology), and also stained for CKIA-analysis. The remnant of the sample 
was cryopreserved for further integrity analyses.
 Because of the limited amount of material available, we could not perform all 
tests for all patients. For CMA3 and TUNEL, all samples were analyzed. For CKIA 
we used nine partial globozoospermia and all nine control samples. Immuno-
fluorescence staining with anti-triacetylated H4 (KM-2) and anti-TH2B antibodies 
was possible in only seven partial globozoospermia and eight control samples. 
CKIA
Feulgen stain and Computerized karyometric image analysis (CKIA)
Sperm head morphometric values were evaluated in detail using the computerized 
karyometric image analysis (CKIA). We previously adapted this technique, originally 
developed for urological cancer cells [7], to analyze human spermatozoa [8, 9]. 
The measurement specifications of the CKIA method have been extensively 
described previously [10, 11].
 For the Feulgen stain, all chemicals were provided by Merck (Darmstadt, 
Germany). Air dried sperm samples were pre-fixed in a freshly prepared 100% 
Carbowax (2% polyethylenglycol, molecular weight 1500 in 50%)/ NaCl 0.9% 
solution (1/1) at 4ºC during 3 days. Subsequently the slides were fixed with 100% 
Carbowax at 4ºC for one day. The slides were immersed before staining in Böhm 
solution (10% formaldehyde [37%], 5% glacial acetic acid, 85% absolute ethanol). 
Staining was performed with Feulgen-Schiff stain (hydrolysis at room 
temperature in 5N HCl for 60 minutes and Schiff-reagent for 30 minutes). Cells 
were mounted in Permount (Fischer Scientific, Fairlawn, NJ, USA). 
 Feulgen stained sperm samples were evaluated digitally (CKIA), thereby 
yielding information on the 1) morphometry (size and shape of sperm cell), 2) 
densitometry (stain intensity of chromatin) and 3) chromatin texture (stain 
pattern distribution) of the cells analyzed. Only intact sperm cells were used. 
1)  Morphometric parameters: describes size and shape of the nucleus. Measures 
consist of area (number of pixels/µm2), fellicity (minor axis/major axis, a 
measurement for head roundness), ben (nuclear roundness, arbitrary units, 
Sp
er
m
 In
te
gr
ity
 in
 p
ar
tia
l g
lo
bo
zo
os
pe
rm
ia
4
83
au), and nominal mean curvature (nmac: combines the head contour with 
smooth Freeman difference chain code of the cell perimeter, (au).
2)  Densitometric parameters: related to DNA staining intensity. These parameters 
are the OD (optical density, au), IOD (integrated OD= area x OD (au)), and 
varOD (mean variation of the OD (au)).
3)  Chromatin texture parameters: quantify stain distribution patterns. The mean-his 
(average OD along the maximal diameter (au)), the SD-his (standard deviation of 
the meanhis (au)), and the CV-his (coefficient of variation of the SD-his(au)). 
Morphometric measurements with CKIA can evaluate each sperm in a complete 
and integral manner without observers’ interpretation bias. In principle, at least 
100 cells were evaluated per patient. 
CMA3
Defective chromatin packaging was analyzed using the binding properties of 
chromomycine A3 (CMA3) (Sigma-Aldrich, Steinheim, Germany). CMA3 specifically 
binds to GC-rich sequences in the DNA in competition with protamines and it is 
associated with changes in protein composition, suggesting an incomplete 
protamination and condensation. Incomplete chromatin condensation is more 
susceptible for oxidative stress and can lead to increased DNA damage[12-15]. 
For CMA3 staining, the procedure described by Bianchi and colleagues [12] was 
used. A droplet of 5 µl of cell suspension was air-dried on a glass slide. Cells 
were fixed during 3 minutes in cold methanol/ acetic acid 3:1 and washed twice 
with phosphate buffered saline (PBS, Sigma, St Louis, MO, USA), pH 7.4. Each 
n Vol. mL Conc. 
x106/mL
% Motil. 
(A+B)
%  
Morphology
%  
Acrosomeless 
(range) (range) (range) (range) (range)
   A/E D-Q A/E D-Q
Ctrl 9 3.4
(1.9–6.3)
56
(25–85)
55
(25–85)
19
(5–30)
13
(9–17)
0
.
5
(0–16)
PG 10 2.9
(0.8–5.0)
21
(4–50)
22
(10–35)
2
(0–5)
1
(0–4)
58
(30–82)
53
(25–83)
Table 1  Semen characteristics of the patients and controls included in the study.
Ctrl= controls; PG= partial globozoospermia; Conc. = concentration; Motil. = motility (A+B) =  progressive 
motility; ; % morphology = percentage of normal morphology according to strict criteria; A/E = 
aniline blue and eosin-Y staining; D-Q = Diff-Quik staining, % acrosomeless = percentage of sperm 
without acrosomes.
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slide was treated with 100 µl CMA3 solution (0.25 mg/ml in McIlvaine buffer, 
pH 7.0 containing 10 mmol MgCl2) in the dark for 20 minutes at room temperature. 
Slides were washed three times (5 minutes) in PBS and mounted in mounting 
medium for fluorescence (Vectashield, Vector laboratories, Inc, Burlingame, CA, 
USA). Chromatin condensation was assessed by scoring CMA3 stained sperma- 
tozoa as positive or negative (positive cells are poorly condensed, therefore, 
stain intensity is high). Scoring was carried out using a Leitz DM RBE fluorescence 
microscope provided with a band pass filter (13, excitation BP 450-490 nm, emission 
LP 515). At least 200 cells were scored per sample by 2 trained technicians.
TUNEL
DNA damage was evaluated by TdT-UTP nick end-labelling (TUNEL) assay. 
This is a direct marker for DNA fragmentation, as it binds to the free 3′-OH ends 
in DNA strand breaks (DSB). The presence of DNA strand breaks is characteristic 
for late apoptosis [16].
 The TUNEL assay (Cell Death Detection kit, Roche Biochemicals) was 
executed following the manufacturer’s specifications with minor modifications 
[17]. Briefly, air-dried spermatozoa were fixated in 1% PFA in PBS for 10 min at 
room temperature and rinsed twice with PBS followed by permeabilization 
with 0.2% Triton X-100 in PBS, for 10 min. Nuclei were exposed to the TdT-labelled 
nucleotide mix for 60 min at 37ºC. Slides were rinsed twice (5 min) in PBS and 
the sperm nuclei were counterstained with 4’,6-diamidino-2-fenylindool (DAPI) 
(0.01 mg/l in PBS). Nuclei were mounted in 25 µl Vectashield. The total number 
of DAPI blue staining sperm nuclei per field was counted first. A minimum of 
200, but mostly between 300 and 400, nuclei per fraction were scored by two 
independent observers.
Immunofluorescence staining with KM-2 (anti-H4) and  
anti-TH2B antibodies 
KM-2 has been used as an early marker for somatic cell apoptosis, to differentiate 
DNA damage caused by oxidative stress post maturation from DNA damage by 
aberrant/incomplete chromatin remodeling [18, 19]. KM-2 is specific for H4 
acetylated at K8, K12, and/or K16 [20].
 Testicular histone 2B (TH2B), one of the testicular histone variants, is 
involved in the remodeling processes during spermatogenesis, capacitation and 
fertilization [21]. 
 Cryopreserved samples from controls (n=8) and partial globozoospermic 
patients (n=7) were used. Because of a shortage of material we could not perform 
these test on all patients. From all samples, five slides were prepared following 
a decondensation protocol adapted from Ramos et al. [18]: cryopreserved sperm 
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was thawed for 5 min; washed once with Human Tubal fluid (HTF) (3000 rpm, 5 
min) and resuspended in 50 μl HTF to be diluted in water 1:4. A 5 μl sperm 
suspension droplet was dried on a glass slide for about 10 min. 100 μl 
Dithiothreitol (DTT) solution was added and incubated in a humid incubation 
box for 10min. After removal of excess fluid, 100 μl decondensation mix 
(decondensation mix: 2.5 mM DTT/0.2% Triton X100/100 IU heparin/ml ) was 
added and incubated in a humidified incubation box for 2- 3.5 min. The slides 
were fixed in a coplin jar with 4% PFA for 15 min, washed in PBS for 3x 5 min, 
rinsed in milliQ, air-dried and kept on 4 °C before use.
 Immunofluorescence staining was performed for both controls and partial 
globozoospermic samples using the mouse monoclonal antibody KM-2 (1:4000) 
and rabbit polyclonal TH2B (Abcam (ab23913); dilution 1:5000. Alexa fluor 488 
goat anti-mouse (1:500) and Alexa fluor 594 goat anti-rabbit (1:500) were used as 
secondary antibodies. The slides were washed 2 x 10min in PBS-0.1% Triton X100 
at room temperature, then blocked for 1 hour at 37 °C with 200 μl blocking buffer 
per slide. After removal of excess fluid, 100μl of blocking buffer with 0.1%-Triton 
containing the first antibody was incubated at 37 °C for 20 min, and then 
incubated overnight at 4 °C. After continuous incubation at 37 °C for 20 min the 
next day, the slides were washed in PBS-Triton for 15 min. After removal of 
excess fluid, 200 μl blocking buffer was applied and incubated at 37 °C for 30 
min. 100 μl per slide of the second antibody in blocking buffer was applied and 
incubated at 37 °C for 2 hours, then washed in PBS for 10 min. 200 μl DAPI 
(dilution 1:3000) was applied and incubated at room temperature for 10 min. The 
slides were then rinsed in PBS and covered with a coverslip after applying 
Vectashield and stored in the dark at 4 °C until further assessment.
 Cells were localized and photographed with a Zeiss Axiophot2 Fluorescence 
microscope with Axiocam MRm CCD camera and Axiovision software. The 
DAPI, FITC and Texas red filters were used. The extent of decondensation and 
the fluorescence intensity were determined. Only well decondensed cells (+) 
were used for analysis. In order to semi-quantify the light and signal intensity, 
an ordinal representation was used (no signal (-); weak intensity (+-); strong 
intensity (+) and highly fluorescent nucleus (++). Representation of the score 
procedure in Figure 1. At least 50 cells were evaluated per sample.
Statistics
One way ANOVA was used for comparing the groups in CKIA, CMA3, TUNEL, 
KM-2 and anti-TH2B. The SPSS software pack 19.0 for Windows was used.
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RESULTS
 
CKIA analysis
A total of 1032 and 1107 spermatozoa was analyzed in controls (range 89-153 
cells/ sample) and partial globozoospermia patients (range 86-156 cells/ sample), 
respectively. The outcomes of the CKIA measurements are shown in Table 2A 
and 2B and Fig 2 and 3. 
 Figure 2 and Table 2A show a decreased percentage of normal cells (mean 
4.3% vs.1.4%, p= 0.04) and a increased but not significant percentage of 
round-headed spermatozoa (mean 18.7% vs. 34.2%, p=0.08) in partial globozoo-
spermia, as expected from the inclusion criteria used. Although this difference 
is not significant, it is in line with the former description of partial globozoo-
spermia, wherein it is set as ≥25 % round headed cells [1].
 The percentage of spermatozoa within the normal reference range for 
morphometry and densitometry parameters was significantly lower for partial 
globozoospermia samples compared to controls (ANOVA, p < 0.001) (Table 2A). 
Although individual parameters differ, the integrated normal chromatin texture 
measurements were comparable to controls. These data indicate normal sperm 
can be found in the ejaculates of partial globozoospermia males, however  in 
low percentages compared to normospermic samples. 
Figure 1   Representation of the score procedure.
In order to semi-quantify the light and signal intensity, an ordinal representation was used (no signal (-); 
weak intensity (+-); strong intensity (+) and highly fluorescent nucleus (++).
Sp
er
m
 In
te
gr
ity
 in
 p
ar
tia
l g
lo
bo
zo
os
pe
rm
ia
4
87
Figure 2   Morphometric parameters measured by CKIA in PG and controls.
Data for this figure are presented in Table 2A. (*) indicates significant difference.
-  Percentages normal sperm cells: all integrated normal CKIA– values for sperm head normalcy 
-  Percentage round headed sperm is related to the shape of the head: fellicity values > 0.7 indicates a round 
headed sperm
-  Percentage of cells in the categories morphometry, densitometry and chromatin texture: values within the 
normal ranges for each category.
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Ctrl 1032 4.3 18.7 37.6 24.3 41.2
0.9-12.10 0.9-46.2 19.3-54.3 10.9-34.3 16.3-65.1
PG 1107 1.4 34.2 10.6 9.8 35.6
0-4.5 12.8-59.8 3.4-27.6 0-18.9 0.9-48.5
p 0.04 0.06 <0.001 <0.001 0.37
Table 2A  Integrated morphometric evaluation.
In table 2A, the percentage of normal cells as evaluated by CKIA based on the normal reference values 
according to Ramos et al. (2004). The percentage integral normal CKIA-morphology is the percentage of 
cells considered normal per evaluated sample. This integral evaluation is based on 3 main parameters: 
morphometry, densitometry and chromatin texture. Specifically, the round headed sperm are given, 
which are those cases with a fellicity >0.7 um2. P values ≤ 0.05 are considered statitstical different.
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 In table 2B, the individual morphometric parameters are given. The mean 
values of the control samples are displayed, which are comparable to earlier 
defined normal reference ranges [10]. Although all individual CKIA variables 
were significantly different between controls and partial globozoospermia, for 
the total sample, the mean values for roundness (fell); BEN; nmac; IOD; varOD; 
meanhis, sdhis and cvhis remained within the defined reference ranges for both 
groups, again indicating that sperm still do meet the values defined for 
normality. We should take into account that the mean values reflect the average 
of a population and are therefore not representative for single cells. The smaller 
area and higher OD (staining) is indicative for sperm with a small nucleus and 
poorly condensed chromatin, which allows a better binding of the Feulgen 
stain to DNA, increasing the OD. Figure 3 (left side) displays the differences in 
parameters (felicity, area, OD en varOD) between partial globozoospermia and 
controls. In the right side of figure 3 the differences in these paramenters has 
been given for the ‘normal/oval shaped sperm’ vs. the ‘round headed sperm’ 
found in partial globozoospermia and controls samples. Interestingly, normal 
shaped sperm differs between partial globozoospermia and control samples. 
Molecular evaluation of sperm integrity using immunofluorescence
The results for CMA3, TUNEL, anti-Th2B and KM-2 are summarized in Fig 4. 
 For CMA3 a total of 2347 sperm (range 179-343 in nine controls) and 2596 
sperm (range 230-309 in 10 partial globozoospermia patients) were scored. No 
statistical difference was found for CMA3 positive sperm in partial globozoo-
spermia (mean 18.6%) and controls (mean 14.5%), respectively. For TUNEL, we 
scored 5786 (range 452-831 in nine controls) and 6210 spermatozoa (range 423-812 
in 10 partial globozoospermia patients) respectively. A tendency for a higher 
percentage of TUNEL positive cells was observed in partial globozoospermia 
(mean 29.7 % vs. 19.8 % in controls), but this difference was not statistical 
significant (p= 0.077). Although a disturbed protamination and abnormal 
compactation (CKIA, CMA3 +) and higher levels of DNA damage (TUNEL) are 
observed in partial globozoospermia, at sample level these values do not 
statistically differ from controls samples For immunofluorescence staining, 
decondensation of the sperm head is crucial in order to be sure that the antibodies 
can reach the whole nucleus and assure the binding to all histones present. Still 
after decondensation, morphology can be evaluated as the shape is retained but 
the volume is increased. Only proper decondensed sperm was scored for KM-2 
and TH2B staining (Table 3). TH2B staining is more prominent in partial globo-
zoospermia, indicating a higher retention of histones, but did not reach significant 
difference. For H4 acetylated at K8, K12, and/or K16 (stained with KM-2) 444 
sperm (eight controls) and 385 sperm (seven globozoospermia patients) were 
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Figure 3   Representation of individual CKIA measurements of PG and controls 
for all sample (left) or round/normal shaped sperm (right).
PG (partial globozoospermia). *= significantly different form controls
Left, from top to bottom: mean values for fellicity, area, OD and var-OD for the total group of controls and 
PG respectively. Middle: mean values for area, OD and var-OD for the round-headed sperm cells (fellicity 
≥0.7um2) in controls and PG, respectively. Right: mean values for area, OD and var-OD for the normal 
headed sperm cells (fellicity ≥0.52 and ≤0.7 um2). The reference  lines indicate the normal ranges.
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scored. KM-2 was found to be increased in partial globozoospermia (p= 0.014). 
When all sperm independently of the morphology were included, KM-2 staining 
was significantly different between partial globozoospermia and controls. 
However, when sperm morphology (‘normal or abnormal’) was taken into 
account, differences for KM-2 staining emerged for the ‘normal-shaped’ group: 
KM-2 (-) 18 % vs. controls 9%; and KM-2 (+) 40 % vs. 27% respectively (p=0.007). 
In the ‘abnormal-shaped’ group the statistical difference disappeared and 
similar amount of high positivity KM-2 (+/++) was observed (67% vs. controls 
62%) respectively. In summary, chromatin integrity in spermatozoa from partial 
 globozoospermia shows signs of a disturbed deacetylation at the start of spermio -
genesis. 
Figure 4   Chromatin integrity in PG.
Boxplot representation of the spermatozoa stained with CMA3, TUNEL, KM-2 and TH2B, indicating the 
population of damaged cells per studied group (control or partial globozoospermia). The percentage of KM-2 
(+) cells is significantly different between controls and PG.
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DISCUSSION
Partial globozoospermia is an aberrant kind of teratozoospermia, with structural 
abnormalities that occur during spermiogenesis. One of the main changes in 
this maturation phase is chromatin condensation, protamin eviction, formation 
of the acrosome and final sperm shaping. 
 As expected from the inclusion criteria, the evaluation by CKIA corroborates 
the presence of more round-headed cells (p=0.06) and significantly less normally 
shaped sperm cells (p=0.04) in partial globozoospermia patients. Mainly the 
sperm head area and optical density (OD) differed. When analysed in round- 
headed cells, also the median value of varOD fell outside the reference values. 
Combined chromatin densitometry indicated a significantly less well condensed 
chromatin in partial globozoospermia (p<0.001). On the other hand, still normal 
cells within partial globozoospermia samples (1.4% ). Integral normal CKIA 
morphology vs. controls 4.3% p= 0.04) can be found, which can explain the 
successful clinical outcome when treating these patients with ICSI [22]. KM-2 
staining shows signs of a disturbed deacetylation at the start of spermiogenesis 
(p= 0.014), also in normal shaped cells (p= 0.007). However, markers of disturbed 
chromatin condensation (CMA3), disturbed protamination (TH2B) or DNA damage 
(TUNEL) did not reach significance, although a tendency to an augmented level 
of (potential) damage was demonstrated. 
 The study population used here is the same as in our previous study [1], 
which confirms the presence of other molecular/structural anomalies which 
cannot be found using conventional techniques. 
 In this study, using the morphometrical data obtained by CKIA, we found 
clearly less condensed chromatin in partial globozoospermia, a difference that 
increases after analyzing the samples separately for OD and varOD in normal 
and round-headed cells respectively (Figure 2). The latter can be explained by 
the acrosome malformation and high stainability of the round-headed sperm. 
Notably, the smaller area of the spermatozoa in partial globozoospermia 
compared to controls is a distinct, inexplicable feature that was not observed 
before and  seems to be in contradiction to the poor condensation of the 
chromatin in these samples. 
 It is unclear why in this typical type of teratozoospermia the CMA3 levels 
were lower than in the OAT samples described before by others [13, 18, 23]. 
Interestingly, this observation is also valid for the measurement of DNA 
fragmentation by TUNEL: a higher TUNEL staining intensity was observed in 
partial globozoospermia, but not significantly different from controls at sample 
level. To back up these observations by other chromatin markers, we applied IF 
with monoclonal antibodies for a testicular histone variant (TH2B, as a marker 
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of incomplete protamination and remodeling) and a specific histone modification 
that is a tri-acetylation pattern on H4, recognized by the antibody KM-2. 
 TH2B is a histone variant that is present in early spermatogenesis when it 
replaces the somatic H2B in the spermatogonia, but is most expressed in round 
spermatids after meiosis [24]. In contradiction to TH2A, which is not expressed 
beyond meiosis, TH2B remains throughout spermiogenesis and is not entirely 
replaced after protamination. Observations of this process show that replacement 
of histone by protamines follows a specific pattern starting from acrosome to the 
caudal pole of the spermatid [24]. In normal ejaculated sperm samples, TH2B is 
present in a subfraction of the sperm samples, approximately in about 20-40% of 
the sperm cells [18, 19, 25]. It is remarkable that in normal sperm samples this 
histone variant is almost always present in low levels, suggesting a role in 
regulating genes that take part in spermiogenesis itself  [26], but when present 
in high levels (observed with IF; + and ++ fractions), incomplete spermiogenesis 
should be suspected. Therefore, low levels of anti-TH2B staining (+/-) in sperm 
can be considered to be a positive marker for sperm maturation as suggested 
[18]. In our current study we found higher percentage of anti-TH2B staining (++) 
in abnormal cells for both controls and in partial globozoospermia (41% vs. 31%) 
compared with the normal (oval) sperms (26% vs. 26% respectively, see table 3). 
This is however different from literature in which percentages of 1% [18] or up to 
23% in normozoospermia and 46 % in case of OAT [19] has been described. One 
explanation for such variation in results may relay in the type of antibody used: 
we used rabbit polyclonal TH2B antibody instead of tyrosine hydroxylase 
antibody [19, 24, 27]. The rabbit polyclonal antibody used in this study recognizes 
the amino acids ATISKKGFKK instead of peptide KGF in case of the anti-tyrosine 
hydroxylase antibody, making the first one more specific for this testicular 
histone variant. We do observe the same trend in partial globozoospermia 
samples as in the OAT population that was described previously[19]. This might 
indicate that the presence of TH2B at low levels could be a positive predictor for 
normal condensation, however, too high levels of TH2B may indicate an 
incomplete protamination, therefore, abnormal chromatin condensation 
inducing poor fertilization. In our study the anti-TH2B stain intensity in poor 
decondensed sperm is stronger in partial globozoospermia, indicating that the 
accessibility to the antibody is not impaired but an abnormal high TH2B content 
is related to less well-organized chromatin.  
 The histone modification that recognizes H4 acetylated at lysine 8, 12 and 16 
(H4acK8,12,16) is called KM-2 in this and other studies of our group. Histone 4 
acetylation takes place before meiosis, is deacetylated during meiosis, but is 
reacetylated, probably just like H3, in the elongating spermatid and it is known 
as a prerequisite for the histone-to-protamine exchange [28]. Hyperacetylated 
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H4 is normally detected in all spermatids at the start of elongation in normal 
spermatogenesis, but in only 75-90 % of the spermatids in case of OAT, probably 
due to premature or decreased acetylation of H4 leading to a disturbed 
protamination or even a maturation arrest [29]. Its presence in ejaculated sperm 
cells may indicate an early sign of apoptosis or abnormal chromatin maturation 
[18, 19]. In this study we see a significantly increased percentage of KM-2 (+) cells 
in partial globozoospermia compared to controls. This difference is even more 
present in normally shaped sperm cells, indicating that chromatin condensation 
may also be disturbed in apparently normal cells in partial globozoospermia. 
This finding is a precautionary conclusion because of the low numbers analysed. 
The difference disappears when the abnormal cells in both study groups are 
compared (both are elevated), which seems proof of the theory that KM-2 
positive cells implicate a disturbed spermiogenesis at the level of sperm head 
shaping. Here, the percentage of KM-2 positive cells is higher than in previous 
studies from our group [18, 19]. 
 From a biologic point of view, partial globozoospermia emerges to be a 
remarkable sperm phenotype in order to better understand spermiogenesis. In 
1971 Schirren et al. [30] described the etiology of (total) globozoospermia as the 
formation of the acrosome in the cytoplasm, seperated of the sperm head. The 
acrosome was then supposed to be lost in the cytoplasmic droplet, resulting in a 
round-headed sperm head. Nowadays, it appears that the elongation of the 
sperm head, the formation of the acrosome and chromatin condensation are 
processes that are not causally related but occur simultaneously, communicating 
amongst each other during the process [4]. This latter study shows that all three 
processes: sperm head elongation, protamination and acrosome formation start 
at the top of the sperm head and go down to the tail at a strict coordinated 
sequential process. In our earlier study on partial globozoospermia, we noted 
that chromatin condensation was equally disturbed in round-headed cells of 
controls, partial globozoospermia or total globozoospermia, indicating a 
common pathway disturbance. Also, we observed that even oval shaped sperm 
cells in partial globozoospermia displayed structural anomalies regarding the 
head matrix [1], suggesting that the maturation processes during spermiogenesis 
of these men are affected independently of the final shape of the sperm. One can 
speculate that the chromatin aberrations might arise from a mild or more severe 
communication disorder during spermiogenesis, or a shortcoming in repair 
mechanisms. Unclear is whether this “miscommunication” is due to a genetic 
origin or to a temporal effect such as disease, drugs, medication or another 
environmental effect. Total globozoospermia is observed at all sperm cells of 
one individual; however, the percentage of round-headed sperm in partial 
 globozoospermia can vary between semen analyses in one individual in time. 
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Notably, in this study we observed that also normal sperm cells are produced 
that can be used in case of ICSI [22]. 
 In conclusion, there are several indications that early processes during 
spermiogenesis are disturbed and that DNA damage may be increased in partial 
globozoospermia, although these defects do not affect all sperm in the sample. 
From the clinical point of view, it is reassuring that these patients performed so 
well in ART (assisted reproductive technology) programs, with good fertilisation 
and pregnancy rates and without increased miscarriage rates [22]. 
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ABSTRACT
Objective: To compare the outcome of intracytoplasmic sperm injection (ICSI) in 
patient couples where the male partner has partial globozoospermia with the 
outcome in a general ICSI population.
Design: Case-control study.
Setting: Center for Reproductive Medicine, Radboud University Nijmegen Medical 
Center, the Netherlands, a tertiary referral center.
Patient(s): Between 1997 and 2005, 42 couples were identified in which the male 
presented with partial globozoospermia; 27 couples treated with ICSI were matched 
with 263 control couples from a general ICSI population regarding female age 
and year of first ICSI cycle.
Intervention(s): One ICSI treatment (1–10 ICSI cycles).
Main Outcome Measure(s): Live birth rate after one ICSI treatment (1–10 ICSI 
cycles).
Result(s): In the partial globozoospermia group, the live birth rate was 66.7% 
compared with 50.0% in the control group. In partial globozoospermia, three 
out of 21 pregnancies ended in a miscarriage, one major birth defect occurred, 
and one pregnancy ended in a neonatal death due to sepsis in a premature child, 
compared with four stillborn in the control group.
Conclusion(s): ICSI is an effective treatment in couples that failed to conceive 
spontaneously within 1 year combined with male infertility due to partial 
globo zoospermia. The fertilization rates and the live birth rates in this specific 
group did not differ from those of the general ICSI population. 
Key Words: Partial globozoospermia, sperm morphology disorder, ICSI
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INTRODUCTION
Partial globozoospermia is a recently described type of teratozoospermia that is 
characterized by an increased amount of round-headed sperm cells and typical 
acrosome defects. Remarkably, the oval spermatozoa derived from PG patients 
display an increased incidence of differentiation defects as well. Although the 
round-headed cells that are present in partial and total globozoospermia appear 
alike regarding additional structural defects, partial and complete globozoo-
spermia may represent different disorders (1).
 The first pregnancy using round- headed spermatozoa derived from a 
patient suffering from total globozoospermia was achieved in 1994 with the use 
of intracytoplasmic sperm injection (ICSI) (2). In subsequent cases, fertilization 
rates were poor in 50% (3). The poor fertilization rates with ICSI may be due to 
deficient oocyte activation by these spermatozoa (4). Oocyte activation with 
calcium ionophores or electric activation has been applied in some studies and 
resulted in better fertilization rates in most cases (3, 5–11). To our knowledge, no 
augmented risk on congenital abnormalities has been reported in such pregnancies.
 In partial globozoospermia, the ejaculate contains not only round- headed 
spermatozoa, but also a certain percentage of normal sperm cells (1). A spontaneous 
conception is therefore possible in theory, although we expect that these patients 
may have impaired fertility and a need for medical assistance in conceiving a child.
 To date, there are no studies on the need and the efficacy of assisted reproductive 
techniques (ART) in this specific group of patients. Because we found defects in 
spermatozoa that appeared normally shaped in an earlier study (1), this disorder 
may lead to an unknown cause for poor fertilization, as in total globozoospermia. 
The aim of the present study was therefore to assess the success rate as well 
as the possible adverse risks of ART for patients suffering from this rare kind of 
teratozoospermia.
MATERIALS AND METHODS
Fertility Treatment
In our center, patients are offered fertility treatment according to the guidelines 
of the Dutch Society of Obstetrics and Gynecology. This means that couples are 
evaluated by the family doctor after a 1-year existence of a fertility disorder. 
If necessary, they are referred to a hospital. In case of male subfertility, the VCM 
(volume concentration motility count, without processing) is calculated to determine 
the severity of the male infertility to provide the best treatment. A VCM of >3 106 
sperm cells/ mL is considered to be mild male subfertility, for which expectant 
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management is pursued. A VCM of 1–3 106/mL, is considered to be moderate, 
for which treatment is indicated in the form of intrauterine insemination (IUI, 
homologous) or in vitro fertilization (IVF). In case of a severe male subfertility 
(VCM <1 106/mL), IVF or ICSI is offered; in case of VCM <0.5 106, ICSI is offered 
as the only solution. In daily practice, ICSI is offered when total fertilization 
failure occurs in IVF. Patients are counseled and treated according to this 
guideline (17).
Partial Globozoospermia Group
PG patients were collected at the Radboud University Nijmegen Medical Center 
of Reproduction between 1997 and 2005. In total, 42 couples were identified with 
the male partner presenting with partial globozoospermia (>25% round-headed 
or acrosomeless sperm cells in the ejaculate) (1). All of the couples suffered from 
a primary fertility disorder. These couples were enrolled in our assisted fertility 
program (Fig. 1). Ten couples eventually did not receive any treatment. Three 
of these couples (patients 3, 5, and 6) conceived spontaneously with a time to 
pregnancy between 1 and 3 years. Two patients (patients 1 and 8) decided not to 
make use of assisted reproductive technologies (ART), and finally, five couples 
were referred elsewhere for treatment (patients 2, 4, 7, 9, and 10). The remaining 
32 couples received ART IUI, IVF, or ICSI at our center. A flowchart of the patient 
treatment and outcomes is shown in Figure 1. Two out of the three couples 
undergoing IUI (patients 11 and 12) conceived after six and four cycles, 
respectively. The third couple ceased treatment after two cycles (patient 13). IVF 
was performed in eight couples: Total fertilization failure occurred in five 
couples (patients 15, 17–19, and 21), and poor fertilization (27% and 8%, 
respectively) in two couples (patients 16 and 20). These seven couples were 
referred for ICSI. The last couple ceased treatment after two cycles of IVF (patient 
14). From the 28 couples that started ICSI treatment (patients 22–42), one couple 
was excluded for further analysis because no ovum pick-up (OPU) could be 
performed (patient 22).
 We compared the outcome of the 27 PG patient couples who underwent ICSI 
with the outcome in a general ICSI population with no known partial globozoo-
spermia.
Control Subjects
Each PG patient couple that was treated with ICSI was intended to be matched with 
ten control couples. For seven control couples, sufficient data were not available, and 
they were therefore excluded from further analysis, resulting in a total of 263 control 
couples and 27 PG couples for comparative analysis. Matching was performed 
in a random fashion from the cohort of couples receiving ICSI in our center.
In
tra
cy
to
pl
as
m
ic 
sp
er
m
 in
jec
tio
n 
in
 p
ar
tia
l g
lo
bo
zo
os
pe
rm
ia
5
105
Matching criteria were female age at the time of the first OPU and year of the 
first ICSI cycle. These matching criteria were chosen for the well-known influence 
of female age on ART outcome and to compensate for slight changes in protocols 
that may have occurred over the years, respectively. All control couples suffered 
from a primary fertility disorder, they were selected for treatment according 
to the guideline, and none of the male partners suffered from (partial) globozo-
ospermia.
ICSI Treatment
Only the first ICSI treatment was included for analysis. Note that a single 
treatment may contain several ICSI cycles (1–10 cycles in this study).
 Ovarian stimulation was performed by administration of GnRH agonist 
starting on day 21 of the previous cycle, followed by a stimulation phase with 
recombinant FSH. OPU was planned when R13 follicles with a diameter of >18 
mm were observed by ultrasound examination, and OPU was performed 36 
hours after hCG injection. ICSI was performed basically as described previously 
by Palermo et al. (12). Fertilization rates were scored 18–22 hours after the ICSI 
procedure. On day 3 after OPU, the embryos were scored regarding number of 
Figure 1   Flow chart of number of patient couples and treatment offered  
in partial globozoospermia.
ART = assisted reproductive technologies; ICSI = intracytoplasmic sperm injection; IUI = intrauterine 
insemination; IVF = in vitro fertilization.
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blastomeres and percentage of fragmentation. Embryos were classified as A, B 
or C, with A embryos having the highest chance of implantation and C embryos 
the lowest.
 The best embryos were selected for single-embryo transfer (SET) or double- 
embryo transfer (DET). Embryo cryopreservation was performed on surplus 
class A embryos. A pregnancy test was performed on day 18 after OPU, and an 
ultrasound was made 3–5 weeks after the embryo transfer. One or more 
intrauterine gestational sacs and fetal heartbeat were considered to indicate a 
pregnancy. A miscarriage was considered as such before 16 weeks of gestation. 
Pregnancy and neonatal outcome were collected by patient questionnaires (13).
DATA COLLECTION
The live birth rate was set as the primary outcome measure, and clinical 
pregnancies, miscarriages, stillborns, and twins were secondary outcome 
measures. Medical records of all patient and control couples were reviewed and 
the following data collected: female date of birth, date of the first and last OPU, 
start date of fertility disorder, number of ICSI cycles (including cryo-embryo 
tranfer), total number of obtained oocytes, fertilization rate, total number of 
transferred embryos (cryo-embryos included), embryo quality (A [excellent], 
B [good-regular], and C [poor]); the presence of cryo-embryo transfer as a 
secondary marker for embryo quality, and outcome of the treatment: live birth, 
miscarriages, twins, and stillborns. Detailed information on the newborns in 
the PG group was also collected. The following figures were calculated per 
treatment: percentage of live births, percentage of miscarriages, number of ICSI 
cycles, presence of cryocycles, and percentages of quality A, B, or C embryos 
(Table 1). Female age and duration of fertility disorder (years) were calculated by 
female date of birth and start date of fertility disorder compared with the date 
of the first OPU. Duration of treatment (years) was calculated by the date of the 
first OPU compared with the date of the last OPU. The following figures were 
calculated per cycle: number of obtained oocytes, fertilization rate, and number 
of transferred embryos.
Statistical Methods
This study was designed to study differences between PG patient couples and 
matched control couples. Each patient couple was intended to be matched with 
ten control couples. A linear mixed model was used to test the difference 
between the patient group and the control group that accounts for the matched 
design (multilevel model). The dependent variable was duration of the fertility 
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disorder, duration of treatment, fertilization rate, quality of transferred embryos, 
and number of obtained oocytes, respectively. The independent variable was 
group (PG patient, control), and the match number was treated as a random 
effect.
 A conditional logistic regression model was used in case of dichotomous 
outcomes. The dependent variable was number of cycles (dichotomized as <2 
or >2), number of transferred embryos (dichotomized as <2 or >2), presence of 
cryopreservation, pregnancy, and live birth, respectively. Again, the independent 
class variable was group (PG patient, control), and the match number was the 
identifier of the strata (levels).
 The Fisher exact test was used to test the difference between groups of 
percentage of miscarriages, singletons, twins, and stillborns as a proportion of 
the pregnancies for statistical significance. A t-test was performed to compare 
means of the semen parameters in the pregnant and nonpregnant couples. Note 
that a matched analysis is not applicable in these cases. A P value of < .05 was 
considered to be statistically significant. The statistical analysis was performed 
using SAS 9.2 for Windows and SPSS 16.0 for Windows. 
RESULTS
Between 1997 and 2005, 42 subfertile couples in which the male suffered from 
partial globozoospermia were identified (Fig. 1). Of these 42 couples, 27 underwent 
ICSI. The first ICSI treatments of PG patient couples were included for analysis 
and were matched with 263 first ICSI treatments in the control group.
 Table 2 presents the patient semen parameters with the fertility treatment 
and outcome. In the patient couples that conceived spontaneously or by IUI, no 
more than a mild oligozoospermia or asthenozoospermia was found in the 
semen analysis, rather than an obvious teratozoospermia. Although these 
values are not that different from the semen analysis of the couples that initially 
underwent IVF and were found to have a poor fertilization rate, they are 
different from the values of the patients that underwent ICSI as initial treatment 
(concentration: P < .001; motility: P = .012). The mean semen parameters, including 
the percentage of acrosomeless sperm cells, were not significantly different 
between the pregnant and non-pregnant ICSI couples.
 Table 1 presents the characteristics of the patient and control groups. The 
patient and control groups were similar regarding female age because this was 
a matching criterion. Also, duration of the fertility disorder, duration of the 
treatment, and number of ICSI cycles were similar in the two groups. No 
significant differences were found for number of oocytes obtained per cycle, 
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fertilization rate, percentage of transferred A, B, or C embryos, or ability to freeze 
spare embryos.
 Primary and secondary outcomes measures are presented in Table 3. The 
live birth rate in the patient group was higher compared with the control group 
(66.7% versus 50.0%, respectively), but this difference did not reach statistical 
significance (Fisher exact test: P = .09). The secondary outcome measures were 
not significantly different, either: pregnancy rate 74.1% versus 57.6% (Fisher 
exact test: P = .10); miscarriage 14.3% versus 18.5% (Fisher exact test: P = .77); 
and twin pregnancy 14.3% versus 21.6% (Fisher exact test: P = .58). No stillborns 
occurred in the patient group, compared with one stillborn in a singleton pregnancy 
and three stillborns as part of a twin pregnancy in the control group.
Patients Controls p
n 27 263
median range median range
Age women at first cycle 30.7 (20.9- 37.3) 30.7 (21.3-37.5) 0.94a (match)
Duration of fertility disorder 
(years) 
3.7 (1.0-8.9) 3.5 (0.7-14.4) 0.54a
Duration of treatment (years)* 0.5 (0.0-3.4) 0.5 (0.0-6.5) 0.95a
ICSI cycles (n) 2 (1-5) 2 (1-10) 0.32b
Obtained oocytes per cycle (n) 9 (1-21) 11 (1-30) 0.27a
Fertilization rate per cycle (%) 75 (20-100) 75 (14-100) 0.86a
Transferred embryos  
per cycle(n)
1.8 (0-2) 1.8 (0-2) 0.78b
%  A- embryo/  
total transferred embryo’s 
67  (0-100) 47 (0-100) 0.13a
%  B- embryo/  
total transferred embryo’s
21 (0-100) 32 (0-100) 0.16a
%  C- embryo/  
total transferred embryo’s
12 (0-100) 21 (0-100) 0.66a
Cryopreservation (%) 14.8 9.5 0.35b
Table 2  Treatment characteristics of PG patient and control groups.
a  A linear mixed model was used to test the difference between the PG group and the control group that 
accounts for the matched design (multilevel model). 
b  A conditional logistic regression model was used in case of dichotomous outcomes. 
The p-value represents the statistical difference between the PG group and controls, using the multilevel 
model (a) or the conditional logistic regression. Note that the dependent variables; number of cycles (≤ 2 
or  >2) the number  of transferred embryo’s (≤2 or >2) were dichotomized to facilitate calculation. 
*   Duration of treatment was calculated by the date of the first and the last ovum pick up. In case of 1 
ICSI-cycle this may be 0.
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 Information on the sex, gestational age, birth weight, and congenital 
abnormalities of the newborns in the PG group were obtained for 17 out of 18 
cases. In this group, 6 boys and 11 girls were born. Mean gestational age was 38 
weeks 1 day. Mean birth weight was 2,993.6 grams (within 20th-50th percentiles). 
One case of mild aortic coarctation was reported. One child died in the neonatal 
period (day 10) because of sepsis in prematurity (28 weeks 1day).
DISCUSSION
In this study, we report on the efficacy and safety of ICSI as a treatment for 
infertility due to partial globozoospermia, of which disorder little is known to 
date. We show that this group of couples performed at least equally to a general 
ICSI population regarding the live birth rate. This is a reassuring finding for 
patients with partial globozoospermia.
 We chose to describe all 42 PG patients that were identified in an 8-year 
period at our center, and subsequently we chose to perform a per-treatment 
analysis (possibly including several ICSI cycles) rather than an analysis per ICSI 
cycle. We did so because we believe that the combination of description and 
case-control analysis provides us with the ingredients for proper counseling of 
Patients Controls p
n 27 263
n % n %
Pregnant couples 20 74.1 152 57.6 0.10b
Pregnancies 21 162
•  Miscarriages 3 14.3 30 18.5 0.77c
•  Singleton live births 15 71.4 96 59.3 0.24c
•  Singleton stillborn 0 0 1 0.6 0.20 c
•  Twin live births 3 14.3 35 21.6 0.58c
•  One of twin stillborn 0 0 3 8.6 1.00c
Total live born 21 164
Total live births 18 66.7 132 50.2 0.09b
Table 3   Outcome of the episode characteristics for partial globozoospermia  
and controls.
b  p-value using conditional logistic regression
c  p-value the Fisher’s exact test.
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patients suffering from partial globozoospermia about their chances of conceiving 
a child at the start of an ART treatment.
 From these data, we can conclude that spontaneous pregnancies can occur 
in cases with normal to mild oligospermia in combination with a mild astheno-
zoospermia and teratozoospermia (according to World Health Organization 
criteria [14]). Whenever spermatozoa with acrosomes are present, spontaneous 
conception can occur but possibly with a longer time to pregnancy, as was 
observed in three patient couples. This suggests that PG may occur more often 
than expected in a proven fertile population. When, however, patients do not 
conceive spontaneously within a reasonable period of 1 year, or even via IUI 
when the semen parameters are acceptable to do so, ICSI seems to be the optimal 
treatment, because poor fertilization or even total fertilization failure appears to 
be a common result after IVF.
 We could not find a significant difference in any of the investigated parameters 
(including fertilization rate, percentage of quality A embryos, percentage of 
cryo preserved embryos of good quality, pregnancy rate, percentage of mis- 
carriages, and live birth rate) between the PG and control groups. In fact, these 
couples performed somewhat better on the last three items, though not 
significantly. In addition, the follow-up of 17 out of the 18 children born in the 
patient group was also reassuring. No aberrations regarding gestational age at 
time of birth or birth weight (which was within the 20th–50th percentile) were 
found. In one child out of the 18, a congenital disorder was observed, namely, an 
aortic coarctation, representing a prevalence of 5.6%. Compared with the odds 
ratio for birth defects after ICSI (between1.4% to 2.0% (15), this is a high figure. 
We should, however, take the small sample size of our group into consideration 
before drawing any conclusions. Obviously, future research should focus on the 
occurrence of birth defects in a larger group of partial globozoospermia patients. 
The data should then be linked to studies on the molecular aspects of partial 
globozoospermia regarding DNA damage and/or possible genomic anomalies 
in the sperm head.
 In one case a neonatal death was observed. This death occurred because of 
sepsis in a premature infant on the tenth day after birth. It is not probable that 
this neonatal death was causally linked to ICSI in general or ICSI with semen 
derived from partial globozoospermia patient in particular.
 The round-headed spermatozoa in partial globozoospermia share a lot of 
characteristics with those found in total globozoospermia (1). In total globozoo-
spermia, a reduced ability to fertilize is described in about one-half of the cases 
reported, for which oocyte activation is applied in various reports (5–11, 16). 
Because a previous study from our group (1) demonstrated an increased 
occurrence of structural abnormalities in ‘‘normal’’ oval spermatozoa derived 
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from PG men, we anticipated that these ‘‘normal cells’’ that are picked for ICSI 
could have the impaired ability to fertilize similar as in total globozoospermia. 
Interestingly, fertilization via ICSI does not appear to be negatively affected by 
these abnormalities, but they may still play a role in spontaneous fertilization or 
fertilization via IVF, so further research on partial globozoospermia is still 
warranted regarding this aspect.
 In reviewing our data, we can conclude that we are now better equipped to 
counsel subfertile couples with partial globozoospermia. First, their chance to 
conceive spontaneously is lower compared with the normal population, but this 
chance is by no means absent, provided that the other semen parameters are 
favorable. When enrolled in a fertility program, however, ICSI is the treatment 
of choice. Second, their chance of conceiving a child via ICSI seems to be at least 
similar to the general ICSI population. Finally, there appears to be no increased 
risk for a miscarriage. Unfortunately, we cannot yet counsel on the risk of 
congenital anomalies in this population, because our study group is too small to 
draw definite conclusions on this aspect of the treatment.
 This study shows that that in compromised male fertility due to partial 
 globozoospermia, ICSI is an adequate treatment to get pregnant, although 
spontaneous pregnancies cannot be excluded. Pending future research on the 
ICSI results in a larger study, including the prevalence of birth defects and the 
molecular aspects of the sperm heads in this population, these patients should 
be reassured that they have a good chance to father a healthy child.
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Chapter 6
Homozygous mutation in 
SPATA16 is associated with 
male infertility in human 
globozoospermia
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ABSTRACT
Globozoospermia is a rare (incidence 0.1% in male infertile patients) form of 
teratozoospermia, mainly characterized by round-headed spermatozoa that 
lack an acrosome. It originates from a disturbed spermiogenesis, which is 
expected to be induced by a genetic factor. Several family cases and recessive 
mouse models with the same phenotype support this expectation. In this study, 
we present a consanguineous family with three affected brothers, in whom we 
have identified a homozygous mutation in the spermatogenesis-specific gene 
SPATA16. This is the first example of a nonsyndromic male infertility condition 
in humans caused by an autosomal gene defect, and it could also mean that 
the identification of other partners like SPATA16 could elucidate acrosome 
formation.
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Approximately 15% of couples are confronted with the inability to conceive after 
2 years of unprotected intercourse (1). In about half of these cases, infertility is 
due to the inability of the male partner to produce spermatozoa of sufficient 
number (oligozoospermia), adequate motility (asthenozoospermia), or normal 
morphology (teratozoo- spermia) or to combinations of these defects. Globozoo-
spermia (MIM 102530) is a rare but severe teratozoospermia, characterized by 
ejaculates consisting completely of round-headed spermatozoa that lack an 
acrosome or, in partial globozoospermia, containing a variable proportion 
(20%-90%) of acrosomeless spermatozoa (2–4). Men that are affected with total 
globozoospermia are infertile, and even the application of intracytoplasmic 
sperm injection (ICSI) has met with disappointingly low success rates (2). Globo-
zoospermia originates from a disturbed spermiogenesis, and, although the 
underlying cause is still unknown, a genetic contribution appears to be 
supported by several familial case reports (5–7) and by three recessive mouse 
models involving CSNK2A2 (MIM 115442), HRB (MIM 600862), and GOPC (MIM 
606845) (8–10). However, no causative gene mutations have been identified in 
these orthologues or any other human genes to date (11,12). We describe a family 
with three affected brothers, in whom we have identified a homozygous 
mutation in the spermatogenesis-specific gene SPATA16 (MIM 609856). To our 
knowledge, this is the first example of a nonsyndromic male infertility condition 
in humans caused by a single gene defect. We investigated an Ashkenazi Jewish 
family with six brothers (three affected and three healthy) and four sisters (fig. 1D) 
that was identified at the Centre for Reproductive Medicine of the Dutch-Speaking 
Brussels Free University. The three unaffected brothers fathered seven, six, and 
five children, respectively, but the three affected brothers were childless and 
presented with a fertility disorder due to oligoasthenoteratozoospermia, showing 
the characteristics of total globozoospermia, such as roundheadedness and 
 acrosomelessness, as shown by acrosin (MIM 102480) staining in figure 1A. No 
known consanguinity was reported, although the family belonged to an isolated 
Jewish population. A normal karyotype and no Y-chromosome microdeletion 
were found. In two brothers, ICSI was performed, but fertilization was poor, and 
no pregnancy occurred.
 We performed a genomewide scan analysis of all six brothers, using a 10K 
SNP array (Affymetrix GeneChip). Regions of homozygosity were defined by the 
presence of 125 consecutive homozygous SNPs. Large regions of homozygosity 
were observed in all six individuals (tables 1 and 2), indicating consanguinity in 
the second or third degree in the family. Therefore, we considered this family to 
be consanguineous and expected the pathology to be autosomal recessive. We 
identified a unique region of haplotypic identical homozygosity shared by all 
affected brothers, in which the healthy brothers were heterozygous. The smallest 
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region of overlap spanned 17 Mb of chromosome 3q26 (167054711–184087390). 
This region contains 50 known genes in the UCSC Genome Browser. We selected 
the SPATA16 gene (spermatogenesis-associated 16, also known as “NYD-SP12”) 
as the most plausible candidate gene, because recent studies showed that 
SPATA16 is specifically expressed in human testis and that the mouse ortholog 
is primarily expressed in the spermatocyte and spermatids (13). Localization in 
the Golgi apparatus and the shift with Golgi vesicles to the acrosome was 
observed in round and elongated spermatids by use of a SPATA19-GTP (green 
Figure 1   Family with globozoospermia and a mutation in the SPATA16 gene.
A, Sperm morphology. Fluorescent acrosin (green) staining (with fluorescein) of acrosomes and 
4,6- diamidino-2-phenylindole (blue) staining of nuclei. On the left is a sample from a fertile control, in 
which the most important content of the acrosome (acrosin) is clearly and abundantly present; on the 
right is a sample from a patient. Sperm morphology and acrosome structures are severely disrupted in 
patient cells. Remnants of acrosin staining were observed for some deformed sperm cells, but most 
signals represent nonspecific acrosin staining in the leukocytes. B, Chromatograms of the mutation. 
Shown are the sequences from a control sample, the heterozygous father, and one of the patients. 
C, The NciI recognition site (5-CCCGG-3) is lost because of the GrA mutation at the last nucleotide of 
exon 4. (The HpaII recognition site is not shown but overlaps at 5-CCGG-3). This mutation predicts a 
R283Q amino acid substitution, as well as the disruption of the 5 splice site of intron 4. D, Pedigree of 
the Ashkenazi Jewish family in this study. The order of the 10 siblings is arbitrary. The segregation of 
the mutation was studied by NciI digestion of a PCR amplification of exon 4 and its flanking sequences. 
The first lane is the marker lane. As asterisk (*) indicates tested individuals. The two parents and two 
siblings are heterozygous for the mutation. The three affected males are homozygous, and one 
unaffected male and a control (C) are not carriers of the mutation.
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Chr Physical Position SNP ID S0389 S0390 S0391
3 165727121 SNP_A-1508753 AA AA AA
3 167054711 SNP_A-1512676 AB AB AB
3 167631594 SNP_A-1508627 AA AA AA
3 167801377 SNP_A-1519252 AA AA AA
3 169050879 SNP_A-1511126 BB BB BB
3 169140975 SNP_A-1509483 AA AA AA
3 169748882 SNP_A-1518417 BB BB BB
3 170222552 SNP_A-1518965 BB BB BB
3 170229669 SNP_A-1509719 BB BB BB
3 170266790 SNP_A-1519387 BB BB BB
3 170341708 SNP_A-1513150 BB BB BB
3 170440150 SNP_A-1513458 AA AA AA
3 170815817 SNP_A-1516975 AA AA AA
3 171062673 SNP_A-1514614 NoCall NoCall AA
3 171141972 SNP_A-1508020 BB BB BB
3 172368188 SNP_A-1510308 AA AA AA
3 172643136 SNP_A-1517656 BB BB BB
3 172771949 SNP_A-1509479 AA AA AA
3 172933454 SNP_A-1509435 AA AA AA
3 172933529 SNP_A-1509382 BB BB BB
3 173575998 SNP_A-1516388 BB BB BB
3 173580444 SNP_A-1514288 BB BB BB
3 173580729 SNP_A-1514241 AA AA AA
3 174671975 SNP_A-1507368 AA AA AA
3 175782878 SNP_A-1508795 BB BB BB
3 176537318 SNP_A-1511779 AA AA AA
3 176610712 SNP_A-1509801 BB BB BB
3 176827123 SNP_A-1511813 AA AA AA
3 177333023 SNP_A-1517824 AA AA AA
3 177621541 SNP_A-1518682 BB BB BB
3 177708137 SNP_A-1510834 AA AA AA
3 177723240 SNP_A-1516780 BB BB BB
Table 1   SNPdata of chromosome 3.
In this table, a part of the results of the SNP-array regarding the three affected brothers is presented. 
Several large area’s of shared haplotype were identified, indicating consanguinity. The area of shared 
haplotype on which we concentrated is shown here. The homozygous region is hatched in grey.
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fluorescent protein) fusion protein, strongly suggesting a role for the SPATA16 
protein in acrosome formation during spermiogenesis (14). SPATA16 is composed 
of 11 exons encoding a highly conserved protein of 65 kDa (569 aa), which 
contains a tetratricopeptide repeat (TPR [MIM 602259]) domain. Sequence 
alignment (by use of ClustalW 1.81 [SDSC Biology Work-bench]) (fig. 2) shows 
that SPATA16 is highly conserved across mammals, exhibiting an identity rate 
varying from 77% (mouse) to 96% (chimpanzee) (NCBI Blast) (table 3). The conservation 
is even higher (92% and 98% in mouse and chimpanzee, respectively) for the 
TPR domain, a protein-protein interaction domain commonly but exclusively 
found in cochaperone proteins (15). Sequence analysis of one of the affected sons 
revealed a homozygous sequence variation in exon 4 (c.848G>A), which disrupts 
a NciI or an HpaII recognition site (fig. 1C). Restriction-enzyme analysis revealed 
that the three affected brothers are homozygous and that the two parents and 
two healthy brothers are heterozygous for the mutation. The third unaffected 
brother appeared to be homozygous for the wild-type sequence (fig. 1D). The 
c.848G>A nucleotide variation is not known in any SNP database and was not 
identified in 231 controls, including 151 random controls of both sexes and 80 
fertile males. The mutation predicts an amino acid change of a highly conserved 
Chr Physical Position SNP ID S0389 S0390 S0391
3 178105620 SNP_A-1516425 AA AA AA
3 178105781 SNP_A-1515959 NoCall NoCall BB
3 179324469 SNP_A-1517000 NoCall NoCall AA
3 179597123 SNP_A-1516215 AA AA AA
3 179597352 SNP_A-1516746 AA AA AA
3 179636158 SNP_A-1512810 BB BB BB
3 179706441 SNP_A-1510950 BB BB BB
3 179839122 SNP_A-1514173 BB BB BB
3 180413909 SNP_A-1511671 AA AA AA
3 180729255 SNP_A-1508156 BB BB BB
3 181028753 SNP_A-1512457 BB BB BB
3 181180943 SNP_A-1507868 BB BB BB
3 181251555 SNP_A-1512336 AA AA AA
3 181298402 SNP_A-1513747 AA AA AA
3 181506449 SNP_A-1517808 BB BB BB
3 181552274 SNP_A-1509494 BB BB BB
Table 1   Continued.
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Figure 2   Sequence alignment SPATA16.
Consensus key (see documentation for details) 
* - single, fully conserved residue 
: - conservation of strong groups 
. - conservation of weak groups 
  - no consensus 
    TPR domain  
    altered amino acid 
    expected to be affected 
 
CLUSTAL W (1.81) multiple sequence alignment 
 
 
Bos_taurus                  -------------------------------------------------- 
Canis_familiaris            MDSGSDKNLENTVNRIYPDQLVPKINTSKKMSTLANQPNILEMSQEVKKS 
Mus_musculus_isoform_1      MDSGKSRSLETTVKRVYRDLLLPKINTSKKMSTLTNSPSSLEGTPGIKKN 
Mus_musculus_isoform_2      MDSGKSRSLETTVKRVYRDLLLPKINTSKKMSTLTNSPSSLEGTPGIKKN 
Rattus_norvegicus           MDSGKSRSLETTVKRVYRDLLLPKINTSKKMSTLTNSPNSLEGPPEIKKS 
Macaca_fascicularis         MDAGSSRSLENAVNKIYHDQLVPKINTSKKMSTLAHPPNILEMPQEIKKN 
Homo_sapiens                MDAGSSRSLENAVNRIYHDQLVPKINTSKKMSTLAHPPNILEMSQEIKKN 
Pan_troglodytes             -------------------------------------------------- 
 
 
Bos_taurus                  -------------------------------------------------- 
Canis_familiaris            CGDKQVEITSERIKMAKSIKEKQSNDSEKVAFKRKAENEEKPAGKKEAKI 
Mus_musculus_isoform_1      SGEMQAEASAERVKLTKSIKEKQNNELEKVALKRKADSEEKLVGKKEAKI 
Mus_musculus_isoform_2      SGEMQAEASAERVKLTKSIKEKQNNELEKVALKRKADSEEKLVGKKEAKI 
Rattus_norvegicus           CGEKQAETSAERVKLTKSIKEKQSNELEKVALKRKVDSEEKLVGKKEAKV 
Macaca_fascicularis         CGGKQVEITLERIKMTKSIKEKQSNDLEKAAFKRKAEGEEKPTRKKEAKI 
Homo_sapiens                CGGKQVEITLERTKMTKGIKEKQSNDLEKAAFKRKAEGEEKPTRKKQAKI 
Pan_troglodytes             MGLVARDVSSPGVPASKQPDQASQWDVGKPVLADAVAGR----------- 
 
 
Bos_taurus                  ---------------------MDVEVKLVYVDEEKVSYEFVESYPSTGNR 
Canis_familiaris            TELDSMLIS-MPLPHIPLKNIMDVEAKLVYVDEEDVRYEFVESFMSTGIR 
Mus_musculus_isoform_1      MELDNQLVTTVPLPHIPLKNIMDVEMKLVYVDEEDVSYEFAQPNMCLGLQ 
Mus_musculus_isoform_2      MELDNQLVTTVPLPHIPLKNIMDVEMKLVYVDEEDVSYEFAQPNMCLGLQ 
Rattus_norvegicus           MELDSQVLTTIPLPHIPLKNIMDVEMKLVYVDEEDVSYEFAQSYMCPGLQ 
Macaca_fascicularis         IELDNQLIT-MPLPHIPLKNIMDVEMKLVYIDEVGVRYEFVESFMSTGSQ 
Homo_sapiens                TELDNQLIT-MPLPHIPLKNIMDVEMKLVYIDEMGVRYEFVESFMSTGSQ 
Pan_troglodytes             ----------------------SPELRPVPAG---------LSHNCLGSV 
                                                  . * : *  .          .  . *   
 
Bos_taurus                  PTC--RAAEIADPLHEPNFSVLPQIDKWLQVALKDASSCYRQKKYAVAAG 
Canis_familiaris            PTSNQRAAEIVDPLHVPNFNFPPQIDKWLQVALKDASSCYRQKKYAVAAG 
Mus_musculus_isoform_1      ATG--QTATTMPPASPRDLTTLPQIDKWLQVALKDASSCYRQKKYAVAAG 
Mus_musculus_isoform_2      ATG--QTATTMPPASPRDLTTLPQIDKWLQVALKDASSCYRQKKYAVAAG 
Rattus_norvegicus           TTG--QIATMMFPTSTRDHATLPQIDKWLQVALKDASSCYRQKKYAVAAG 
Macaca_fascicularis         PTC--RVAEIVDPLSVPNFSFLPQIDKWLQVALKDASSCYRQKKYALAAG 
Homo_sapiens                PTC--QAAEIVDPLSVHNFSFLPQIDKWLQVALKDASSCYRQKKYALAAG 
Pan_troglodytes             ISD--IQHCAVYPRANHMEKSQPTVSQVLKMSVYSAT-CKRKD------- 
                             :          *         * :.: *:::: .*: * *:.        
 
Bos_taurus                  QFRTALELCSKGAVLGKPFEASAEDIASVASFIETKLVACYLRMRKPDLA 
Canis_familiaris            QFRTALELCSKGAALGKPFEASAEDIASVASFIETKLVTCYLRMRKPDLA 
Mus_musculus_isoform_1      QFRTALELCSKGAALGKPFEAHAEDIASIASFIETKLVTCYLRMRKPDLA 
Mus_musculus_isoform_2      QFRTALELCSKGAALGKPFEAHAEDIASIASFIETKLVTCYLRMRKPDLA 
Rattus_norvegicus           QFRTALELCSKGAALGKPFEAHAEDIASVASFIETKLVTCYLRMRKPDLA 
Macaca_fascicularis         QFRTALELCSKGAVLEEPFDASAEDIASVASFIETKLVTCYLRMRKPDLA 
Homo_sapiens                QFRTALELCSKGAVLGEPFDAPAEDIASVASFIETKLVTCYLRMRKPDLA 
Pan_troglodytes             ------SLCSKGAVLAEPFDAPAEDIASVASFIETKLVTCYLRMRKPDLA 
                                  .******.* :**:* ******:*********:*********** 
 
Bos_taurus                  LNHAHRSIVLNPAYFRNHLRQATVFRCLERYSEAARSAMIADYMFWLCGG 
Canis_familiaris            LNHAHRSIVLNPAYFRNHLRQATVFRCLERYSEAARSAMIADYMFWLCGG 
Mus_musculus_isoform_1      LNHAHRSIVLNPAYFRNHLRQAAVFRCLERYSEAARSAMIADYMFWLCGG 
Mus_musculus_isoform_2      LNHAHRSIVLNPAYFRNHLRQAAVFRCLERYSEAARSAMIADYMFWLCGG 
Rattus_norvegicus           LNHAHRSIVLNPAYFRNHLRQAAVFRCLERYSEAARSAMIADYMFWLCGG 
Macaca_fascicularis         LNHAHRSIVLNPAYFRNHLRQATVFRCLERYSEAARSAMIADYMFWLGGG 
Homo_sapiens                LNHAHRSIVLNPAYFRNHLRQATVFRCLERYSEAARSAVIADYMFWLGGG 
Pan_troglodytes             LNHAHRSIVLNPAYFRNHLRQATVFRCLERYSEAARSAMIADYMFWLGGG 
                            **********************:***************:******** ** 
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Figure 2   Continued.
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residue (p.R283Q) located at the C-terminal end of the highly conserved TPR 
domain. In addition, the c.848G>A mutation affects the last nucleotide of exon 4 
(fig. 1C) and, therefore, may disrupt the 5 splice site of intron 4. Three different 
splice-site prediction models predicted that the mutation disrupts this splice 
site (table 4). Unfortunately, the SPATA16 protein presents a testis- restricted 
expression, and we were not allowed to use fresh sperm cells or to perform a 
biopsy in these religious patients to verify the predicted aberrant splicing in 
vivo. Therefore, minigene constructs were made that consisted of two 
constitutive b-globin exons surrounding a 420-bp fragment containing either 
the wild-type or the mutated form of exon 4 and the flanking intronic sequences 
of SPATA16. These minigene constructs were transfected into COS1 or HeLa 
cells, and transcripts were analyzed by RT- PCR 24 h after the transfection (fig. 
3A). As shown in figure 3B, wild-type exon 4 is invariably included in the final 
mRNA, as confirmed by the sequencing of the PCR product. In sharp contrast, 
the mutated exon gives rise to two aberrant splicing forms, as shown by cloning 
and sequencing of these PCR products. The most prominent, larger product is 
the result of the use of a splice site situated in the b-globin intron used for the 
minigene construct. The weaker, smaller product corresponds to the use of a 
cryptic splice site situated 18 bp upstream of the normal splice site. These 
aspecific products are likely the result of the very short intron sequences in the 
minigene construct. Such products are often seen in exon-trapping experiments 
in the absence of a bona fide splice site and are indicative of the occurrence of 
exon skipping due to the mutation (16,17) Importantly, we did not detect any 
transcript containing the correct junctions from the mutated exon 4, indicating 
that the mutation hinders normal splicing.
Figure 2   Continued.
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 The first and critical step of exon inclusion is the binding of the U1 small 
nuclear ribonucleoprotein (SnRNP) splicing factor to the 5 splice sites (18). To 
confirm that the mutated SPATA16 exon 4 is not recognized by the splicing 
machinery, we checked its binding to the U1 SnRNP by psoralen-mediated UV 
crosslinking. Whereas binding of U1 SnRNP to wild-type DNA was readily 
detected, this was not observed when DNA carrying the c.848G>A mutation 
was used as template (fig. 3C). The identity of the U1 SnRNP was confirmed by 
RNAse H treatment by use of an oligodeoxynucleotide complementary to 
 Identity
with Human (%)
Positivesa  
(%)
Gapsb  
(%)
 TPR  TPR TPR 
Species SPATA16 Domain SPATA16 Domain SPATA16 Domain
Homo sapiens 100 100 100 100 0 0
Bos taurus 87 94 92 97 0 0
Canis familiaris 83 97 89 97 0 0
Macaca fascicularis 95 97 97 97 0 0
Mus musculus isoform 1 77 92 86 96 0 0
M. musculus isoform 2 78 92 87 96 0 0
Pan troglodytes 96 98 98 98 0 0
Rattus norvegicus 80 93 87 96 0 0
Table 3   Identity Rates among Species for the SPATA16 Sequence and the TPR 
Domain of the Protein.
a  Amino acid positive-match score.
b   Space introduced into an alignment to compensate for insertions and deletions in one sequence relative 
to another. In our search, the gaps did not exceed 0.5%.
Odds Ratio for Sequence
Web Sitea Wild Type Mutant
NetGene2 Server .80  <.50
SpliceSiteFinder .805 .681
Splice Site Prediction by Neural Network .97 <.40
Table 4   Splice-Site Predictions from Three Web Sites.
a  See the Web Resources for URLs.
132
positions 1–15 of U1 SnRNA (19). Therefore, the results of the of the bioinformatic 
prediction, the minigene, and the U1 binding strongly suggest that the c.848G>A 
mutation leads to inappropriate splicing of exon 4 and, therefore, the disruption 
of the TPR domain.
Figure 3   Mutated donor splice site of SPATA16 intron 4 and U1 SnRNP 
binding to wild-type (WT) and mutant (MT) donor splice sites.
A. Overview of the used prediction sites. B. Minigene constructs used to test the splicing of exon 4. 
T- = construct without exon; T-RT = construct without exon in RT-PCR. C. Gel showing that wild-type 
exon 4 is invariably included in the final mRNA. In sharp contrast, the mutant exon gives rise to two 
aberrant splicing forms. M = marker lane. D. U1 SnRNP binding analyzed by psoralen- mediated 
UV-crosslinking experiments, revealing that mutant exon 4 is not recognized by the splicing machinery, 
whereas wild-type exon 4 is clearly recognized. The identity of the U1 SnRNP was confirmed by 
RNAse H treatment with use of an oligodeoxynucleotide complementary to nucleotide positions 1–15 
of U1 SnRNA.
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 SPATA16 was also analyzed in 29 patients with globozoospermia, including 
6 familial cases involving 14 patients. Of the 29 patients, 12 presented with total 
globozoospermia, and 17 with partial globozoospermia. None of them presented 
with any variation in the SPATA16 sequence, with the exception of three known 
polymorphisms and two point mutations that did not segregate with the disease 
(table 5).
 This is, to our knowledge, the first description of a gene involved in the 
pathogenesis of human globozoospermia. The data strongly suggest that the 
identified homozygous mutation in SPATA16 causes globozoospermia in three 
of six brothers in the family studied, which allows us to state that globozoo-
spermia can be a genetic trait with an autosomal recessive mode of transmission. 
The SPATA16 protein localizes to the Golgi apparatus and to the proacrosomic 
vesicles that are transported to the acrosome in round and elongated spermatids 
during spermiogenesis. Our observations support the hypothesis of a crucial 
role for SPATA16 in acrosome formation (14). The strongest protein conservation 
is seen in the TPR domain, which is disrupted in these cases of globozoo spermia. 
The TPR domain is known to mediate protein-protein interactions and assembly 
of multiprotein complexes. Study of the x- ray structure revealed that the TPR 
domain adopts a helix- turn-helix arrangement, with the ability to associate 
with other a-helical structures. A possible interacting protein may be from the 
gene GOPC, a Golgi-associated protein containing coiled-coil motif a-helices(10), 
or from the HIV-1 rev binding protein gene (HRB), which also localizes to the 
Golgi complex (9). Both these genes are involved in the pathogenesis of globozoo-
spermia in mouse models. Finally, it is worth noting that SPATA16 contains six 
casein kinase II phosphorylation sites and that the casein kinase IIa is the most 
abundant casein kinase in the testis (8), for which the knockout model shows 
acrosome and other morphological defects (20). Moreover, the existence of 
several candidate genes (8–10) suggests genetic heterogeneity in human globo-
zoospermia, which could be a reason why we did not find other patients with a 
gene alteration in SPATA16. Noteworthy as well is the fact that the heterozygous 
mouse models show no sperm abnormalities. This indicates that mutation 
carriers should have normal fertility. In this family, this seems to be the case, 
since the father and two heterozygous brothers have fathered 10, 7, and 6 
children, respectively. In two of the affected brothers, ICSI was performed to 
induce fertilization and pregnancy, but without success. This is in accordance 
with the literature, which shows that ICSI enables oocyte fertilization, but with 
low fertilization rates in about half of the cases.
 Since male infertility does not respect the canonical rule of genetics, the 
determination of inheritance patterns and the elucidation of genetic causes are 
complicated. Several genetic factors have been described that affect male fertility 
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(21), but these give rise to more complex phenotypes. However, the patients in 
this study did not show any mental or physical abnormalities -in particular, no 
andrological abnormalities- in addition to their aberrant semen analysis. Thus, 
the mutation in SPATA16 that we found in this study appears to present a human 
gene in which mutations give rise to male infertility without any associated 
other anomalies.
 Further studies of other patients may help to identify other participant 
genes involved of the formation of the acrosome, allowing the fine dissection of 
the mechanisms involved in the setup of such a specialized cellular organelle. 
SPATA16 defects influence spermiogenesis, whereas meiosis is not disturbed. 
Thus, modulation of SPATA16 function or that of other components in the same 
pathway could offer an innovative, reversible approach to male contraception 
that is not based on controlling the hormonal pathway of sperm production.
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GENERAL DISCUSSION
In this thesis I have reported an extensive study on partial globozoospermia, 
comprising an analysis of the typical morphological aspects, the molecular 
characteristics and the clinical implications of this syndrome. Although I could 
not succeed in finding a causative genetic factor in a family with partial globo-
zoospermia, I was successful in identifying the first human gene SPATA16, 
carrying causative mutations in complete globozoospermia.
The main findings of this thesis are:
	Partial globozoospermia is a heterogeneous sperm morphology disorder.
	Partial globozoospermia is best described as a heterogeneous sperm 
morphology disorder that consists of a high incidence of round-headed 
(>25%) and/ or acrosome-less sperm cells (>25%).
	The evaluation of sperm integrity in partial globozoospermia shows an early 
deacetylation defect, also in apparently normal shaped sperm cells. 
Although the integrity markers for protamination, chromatin condensation 
and DNA damage are augmented, still normal sperm can be found in PG.
	Spontaneous pregnancies are rare but possible in partial globozoospermia. 
	ICSI is the first treatment of choice for a couple of which the man has partial 
globozoospermia.
	Based on our observations, there is no indication for increased risk for 
congenital anomalies for the offspring in partial globozoospermia.
	Total globozoospermia is a rare sperm morphology disorder, with a clear 
genetic background different from partial globozoospermia.
Morphology and integrity of partial globozoospermia
In chapter 3, I have studied the morphological aspects of partial globozoosper-
mia. Our group established that the morphological features of partial globozo-
ospermia differ from the normal heterogeneity in normozoospermia, as well as 
from the homogeneous total globozoospermia. Partial globozoospermia can be 
classified as an oligoasthenoteratozoospermia (OAT) that contains an increased 
amount of round-headed sperm cells (>25%) without acrosomes, as well as an 
increased occurrence of acrosome defects (>25%) next to other types of deformed 
spermatozoa. 
 Also with respect to acrosomal contents, partial globozoospermia appears to be 
grouped between normozoospermia and total globozoospermia. The morphological 
phenotype of partial globozoospermia shows a higher variability than already 
seen in human sperm. The morphological features of round-headed, acrosomeless 
cells in partial globozoospermia were, however, comparable to those in total 
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globozoospermia as examined by transmission electron microscopy (TEM; chapter 3). 
Round-headed sperm cells are accompanied by acrosome malformations and 
aberrant chromatin condensation. This malformation can be also sparsely found 
in the ejaculate of normozoospermic men. 
 While the study of chapter 3 was performed to describe partial globozo-
ospermia, chapter 4 included the same samples to focus on molecular aspects of 
the sperm integrity, in order to investigate whether it is responsible to treat 
patients with this disorder to father their own genetic child. Apparently partial 
globozoospermia sperm cells tend to have a smaller head, the reason for the 
decreased surface area could not be explained as we would expect that poor 
condensed chromatin produce larger heads. The reassuring findings in chapter 
4 is that still ‘normal’ sperm can be found and that the right sperm selection of 
sperm during ICSI will probably not affect clinical outcome (chapter 5). 
Clinical features in partial and total globozoospermia 
Despite the immunohistochemical abnormalities described in chapter 3 and 4, 
the partial globozoospermia couples performed at least equally well to a 
unselected ICSI population regarding the live birth rate after ICSI. Fertilisation 
rates in ICSI are not negatively affected in partial globozoospermia, probably 
because only ‘normal (oval)’ sperm is selected for injection. Finally, no increased 
risk for a miscarriage has been observed. In this population I did not find major 
congenital anomalies, but it is still too early to draw definitive conclusions 
because of the small study size. Altogether, these results appear reassuring for 
patients with partial globozoospermia. Although partial globozoospermia 
males may be occasionally accountable for spontaneous pregnancies, there is 
typically a long time to a pregnancy to occur. When patients do not conceive 
spontaneously within a reasonable period of one year, ICSI seems to be the 
optimal treatment. Since our paper in 2012 [1], no further studies on assisted 
reproductive techniques or pregnancy in partial globozoospermia have been 
published. 
 Men suffering from total globozoospermia can only father a child by ICSI. 
As described in chapter 2, the sperm of these males have an impaired capacity 
to fertilize even by ICSI. Since the publication of chapter 2 (2007), a total of 11 
patients (case reports) have been presented that successfully achieved live births 
[2-9]. Again, in at least seven cases fertilisation needed to be induced with oocyte 
activation by either mechanical, electrical or calcium ionophore oocyte 
activation. Taylor (2010) describes that phospholipase C (PLC) expression, a 
recently established sperm factor involved in oocyte activation localised at the 
equatorial part of the sperm head, is absent in total globozoospermia as a cause 
for impaired oocyte activation [7, 10].
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Genetic aetiology
We speculate that the origin of partial globozoospermia is an autosomal 
recessive genetic defect, as we identified a consanguineous family in which 
several members were diagnosed with partial globozoospermia. Unfortunately, 
we did not manage to find the underlying gene defect in this family (chapter 1). 
As we cannot exclude that another mode of inheritance underlies the condition 
in this family, we suggest to apply whole exome/ or genome sequencing for 
further genetic studies to resolve the genetic defect.
 Our group and a French collaborating group succeeded to find a homozygous, 
autosomal recessive genetic mutation in the SPATA16 gene in another 
consanguineous family in which three brothers suffered from total globozo-
ospermia [11] (chapter 6). This was the first uncovered gene defect that caused 
total globozoospermia in humans. The SPATA16 protein localizes in the Golgi 
apparatus and in the proacrosomic vesicles that are transported to the acrosome 
in round and elongated spermatids during spermiogenesis, implying a crucial 
role for SPATA16 in acrosome formation [12]. The gene is disrupted in the highly 
conserved TPR domain that is known to mediate protein-protein interactions 
and assembly of multiprotein complexes.
 Since our discovery, other genetic genes or mechanisms causing human glo-
bozoospermia have been revealed (Figure 1). First, a homozygous missense 
mutation in the PICK1 (protein interacting with C kinase 1) gene was found in a 
member of a Chinese family with autosomal recessive globozoospermia [13]. 
This gene codes for a protein that is involved in protein trafficking and localized 
to Golgi-derived proacrosomal granules and was already described to cause 
globozoospermia in a knockout mouse model [14]. It is therefore the only gene 
to date reported to cause globozoospermia in both mice and men [13, 14].
 Homozygous or compound heterozygous mutations in DPY19L2, located at 
on chromosome 12, appear to be a major cause for total globozoospermia [8, 15-19]. 
Deletions encompassing the DPY19L2 gene arisen by non-allelic homologous 
recombination between the flanking low-copy repeats are most commonly seen 
in patients [17]. In total 93 out of 144 globozoospermia patients appeared to have 
a mutation within DPY19L2. The protein derived from DPY19L2 is strongly 
expressed in the testis. Koscinski et al. (2011), examined the immature germ cells 
in the semen of three globozoospermic patients and concluded that in humans, 
DPY19L2 is involved in the formation of the acrosome, but not directly on the 
acrosomic vesicles like SPATA16 and PICK1 [8]. Since then, the localisation of 
DPY19L2 in spermatids was found to be restricted to the inner nuclear membrane 
facing the acrosomal vesicle [20]. The nuclear dense lamina (NDL) and the 
junction between the acroplaxome and the nuclear envelope is destabilised and, 
consequently, the acrosome and the manchette fail to be linked to the nucleus. 
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This leads to the disruption of vesicular trafficking and probably failure of 
sperm nuclear shaping and the elimination of the unbound acrosomal vesicle by 
the discarding of the residual body. This is very reminiscent of the studies of 
Holstein et al. (1973), who showed that the acrosome is first formed in the free 
cytoplasm, and then discarded together with the residual body [21]. 
 Next to these “globozoospermia genes” identified in humans, several other 
genes have been shown to cause a similar phenotype in mice (displayed in table 1). 
In chapter 6 we speculate about a possible interaction between SPATA16 and 
other candidate genes that were identified as being expressed in the Golgi 
apparatus in mice, such as GOPC [22] or Hrb [23]. Subsequent research by other 
groups have provided support for this hypothesis. PICK1 for example, was 
proven to interact with GOPC and the primary catalytic subunit of protein 
kinase 2 (CK2α′). The sperm acrosome associated protein 1 (SPACA1) is absent in 
GOPC-/- and ZPBP1-/- mice, suggesting a cascade of processes is needed to form 
the acrosome [24]. This is emphasised by another study, in which flagellum 
defects were described as a part of the defects next to anomalous development 
of Golgi-derived pro-acrosomic vesicles and failure of perinuclear theca proteins 
to properly associate with the nuclear surface [25]. The apprehension that each 
of these little steps can cause a similar phenotype, makes it logical that several 
descriptions of the pathogenesis of globozoospermia exist, simply because there 
are several components in the pathway that lead to similar abnormalities [26-36]. 
Figure 1   All known involved genes in total globozoospermia and their 
location during spermiogenesis.
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Therefore, we can conclude that total globozoospermia as a phenotype has 
various origins, as speculated earlier in chapter 2, in which DPY19L2 plays a 
major role. 
FUTURE RESEARCH
Genetic background of partial globozoospermia
In chapter 4 we speculate that partial globozoospermia might originate from an 
epigenetic problem in spermiogenesis with a variable penetrance. Disruption of 
proper epigenetic signatures during the various phases in spermiogenesis will 
impact the tight transcriptional regulation of a plethora of genes [12]. It can be 
envisaged that already subtle deviations in expression of specific genes can 
cause a variable syndrome such as partial globozoospermia. The phenotype of 
the Csnk2A2 knockout mouse, which was initially wrongly classified as total 
globozoospermia, seems to share certain traits with partial globozoospermia 
and might form a candidate gene[37, 38]. This gene is expressed in the brain and 
in the human testis. The Csnk2A2 protein appears to promote cell survival and 
opposes cell death in the apoptotic pathways by phosphorylating several 
Name Full name Function Reference
PICK1 protein interacting with  
C kinase 1
protein trafficking [62]
Hsp90b1 heat shock protein  
90 chaparone member
- protein folding 
- targeting of malfolded 
 proteins to ER–associated 
degradation 
- calcium storage
[89]
SPACA1 sperm acrosome  
associated 1
component of the subacrosomal 
part of the perinuclear theca
[72]
SMAP2 small ArfGAP2 binds to the clathrin of the 
clathrin-coated  proacrosomic 
vesicles and the clathrin 
 assembly protein (CALM)
[91]
ZPBP1 Zona pellucida binding  
protein 1
in zona pellucida binding  [92]
Wobbler (WR) Missence mutation in  
vesicular protein-sorting 
(VPS) factor 54
vesicular protein-sorting  [93]
Table 1   Mouse knockout models with phenotype globozoospermia.
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proteins that induce caspase-mediated degradation during apoptosis [38]. We 
speculate that partial globozoospermia, as well other morphological defects, 
exists because the phosphor-labelled apoptotic spermatids escape degradation 
as suggested by Sakkas et al [39]. On the other hand, reduced protein levels or 
mutant proteins with residual activity could induce augmented levels of 
apoptosis during spermatogenesis, a possible reason why oligozoospermia is 
more common in partial than in total globozoospermia. Up till now no mutations 
in Csnk2A2 have been found in globozoospermia patients [40] [41], but future 
research could consist of screening partial globozoospermia patients. A very 
interesting development in genetics using exome or whole genome sequencing 
may in the future help to find more genes involved in this highly complex 
process. 
Can we restore fertility in globozoospermia?
As mentioned above, we can help partial or total globozoospermia patients by 
ICSI, with or without oocyte activation. Now that DPY19L2 mutations are known 
to be the major cause of globozoospermia possibilities towards gene therapy 
could be explored, although ethical concerns regarding germ-cell therapy 
should be taken seriously. Recently, the creation of a PICK1 transgenic mouse 
was published [42]. In this paper the authors infected PICK1 knock-out mice per 
testicular microinjection with a lentivirus that incorporated PICK1. They did 
manage to induce expression of PICK1 in knockout mice, which was still present 
after two semiferous cycles, suggesting that the new gene has been integrated 
into the genome. Unfortunately, they did not manage to restore fertility by 
directly microinjecting the knockout mice, probably due to the scarcity of 
infected spermatogonical stem cells (SSC) with a probable maximal overall ratio 
of infected SSCs of only 1.6%–6.4%. This could be tackled by increasing the viral 
titer and the combination of intratubular and intertubular injections. However, 
they did manage to create a transgenic line by infecting wild-type mice, who 
mated with the knockout mice. The male pups from this method appeared to be 
fertile due to the conserved PICK1-virus combination [42]. These genetic rescue 
experiments, which are still in its early developing stages, can provide proof-of-
concept that rescue of infertility in globozoospermia is feasible in adult males. If 
so, this would raise hope that in the future patients with globozoospermia (or 
even other morphological abnormalities) could be treated with other strategies 
that would not make use of DNA integrating transgenic approaches. Finding 
additional causative genes for partial and total globozoospermia and further 
research into their molecular and cellular modes of action will be mandatory to 
develop targeted strategies towards correcting the effects of gene mutations.
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Can globozoospermia play a role in the development of  
new contraception methods?
In chapter 6, we speculated on finding a way for male contraception that is not 
based on hormonal therapy [11], but by silencing SPATA16. We did not further 
investigate the opportunities to really do so. Another candidate gene in globo-
zoospermia: Hsp90b1 [43] could open other non-hormonal methods for male 
contraception. Hsp90b1 was known to be involved in cancer and bipolar disorder; 
all members of the Hsp90 family share an adenosine triphosphatase domain that 
can be blocked by anticancer drugs such as the derivatives of geldanamycin. The 
effect on the functions of the endoplasmic Hsp90b can affect spermatogenesis. 
Geldanamycin is however accompanied by a several severe other side effects, 
which make them unsuitable for contraception.
 The uncovering of genes underlying male infertility may reveal a different 
view on how to reach an alternative to male contraception. Each of the known 
globozoospermia genes pictured in Figure 1, comprises its own perspective in 
the development of a non-hormonal contraceptive pill for men. By studying 
their exact molecular function and pathway in spermiogenesis, a strategy could 
be designed to try and develop an isolated and reversible effect in spermiogenesis 
that causes temporary sterility like acrosomelessness is and is safe to the future 
male fertility and offspring. 
Final thoughts
So far, and probably due to the scarcity of cases presenting with this condition, 
it seems that after Holstein in 1973 we are one of the few worldwide that took the 
effort to collect data and investigate partial globozoospermia so far. We must 
consider that partial globozoospermia may have an important contribution to 
the frequency of failed fertilisation in IUI or IVF, but that it is not recognised as 
such during semen analysis and diagnosis. This condition has been named after 
his “big brother” total globozoospermia because of the augmented percentage 
of round-headed and acrosomeless sperm cells and we therefore speculated, 
like most others, that it originates from the same process that has been revealed 
in the recent years. However, this kind of teratozoospermia is not caused by the 
total absence of a protein but rather by the presence of a malfunctioning protein, as I 
have demonstrated in our studies presented in this thesis. Consequences as poor 
adhesion between the pro-acrosomic vesicles can occur. This might be tolerated in 
some cells, but other cells might be lacking an acrosome as a consequence. Also 
impaired repair can be a pathway considered. Multifactor processes should be 
expected and environmental factors cannot be ruled out [44]. 
 Future research should focus on finding families with multiple cases of 
partial globozoospermia and screening them genetically. Protein arrays on 
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testicular tissue could help to identify which proteins are down or up-regulated 
in partial globozoospermia in comparison to fertile controls. Total globozoo-
spermia has led to the revealing of several important steps in the spermiogenesis 
pathway, partial globozoospermia could be a suitable model to fill in the gaps. 
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SUMMARY
Chapter 1
This chapter comprises the general introduction of the thesis, with the back grounds 
and motives for the studies that are performed in this thesis. The focus of this 
thesis is on the genetic background of (total) globozoospermia and the cellular, 
molecular, and clinical features of partial globozoospermia. We encountered 
this new sperm morphology disorder, in the search for a uniform phenotype to 
identify genetic factors underlying male subfertility. We described a consanguineous 
family with partial globozoospermia in an autosomal recessive pattern. Unfortunately, 
we could not identify the responsible gene for this morphological abnormality. 
Lastly, spermatogenesis and spermiogenesis are described as background information 
for this thesis. 
    
Part 1
In part 1, all available literature on globozoospermia is assembled and summarised.
Chapter 2
This chapter consists of a review of all literature on globozoospermia until 2007. 
We conclude that globozoospermia is a rare (incidence <0.1%) disorder in male 
infertility. Total globozoospermia is diagnosed by the presence of 100% 
round-headed spermatozoa lacking an acrosome. Apart from the fact that 
affected males are infertile, no other physical characteristics can be associated 
with the syndrome. ICSI is a treatment option for these patients, although low 
fertilization rates after ICSI show a reduced ability to activate the oocyte. In glo-
bozoospermic cells, the use of acrosome markers has demonstrated an absent or 
severely malformed acrosome. Chromatin compaction appears to be disturbed 
but is not consistently over- or undercondensed. In some cases, an increased 
number of cells with DNA fragmentation have been observed. The analysis of 
the cytogenetic composition revealed an increased aneuploidy rate in some 
cases. Nonetheless, no increased number of spontaneous abortions or congenital 
defects has been reported in pregnancies conceived after ICSI. The pathogenesis 
of globozoospermia most probably originates during spermiogenesis, more 
specifically when the acrosome is formed and sperm head elongation starts. In 
several knockout mouse models, a phenotype similar to that in humans was 
found. These findings indicate a genetic origin, which is supported by the 
occurrence of affected siblings with globozoospermia in humans. We call for 
more research to elucidate the pathogenesis of human globozoospermia, but 
also to understand the steps in spermiogenesis and spermatogenesis in general. 
It is still unclear whether patients whose ejaculate contains both normal and 
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globozoospermic cells (partial globozoospermia) suffer from a variation of the 
same syndrome. For that reason, we conducted part 2 of this thesis.
Part 2
In part 2, partial globozoospermia is evaluated based on cellular, molecular, and clinical features. 
Chapter 3
Partial globozoospermia is more commonly found during semen diagnostics 
than total globozoospermia. However, only one description on partially 
round-headed ejaculates has been published, dating from 1973. The aim of the 
investigation in this chapter was to describe partial globozoospermia compared 
to total globozoospermia and normozoospermia. Ejaculates from ten patients 
exceeding 50% of acrosomeless spermatozoa (partial globozoospermia), three 
patients with total globozoospermia, and nine normozoospermic controls were 
analysed using light microscopy, transmission electronmicroscopy, and flow 
cytometry. Qualitative and quantitative examination of spermatozoa from the 
three groups shows differences in the percentage of round-headed sperm cells 
and acrosome malformation. Total globozoospermia presents as a homogenous 
kind of teratozoospermia. Partial globozoospermia is a distinctive sperm 
malformation with an increased proportion (>25%) of round-headed sperm cells 
and acrosome malformations, that is different from total globozoospermia. In 
addition, ejaculates of males with partial globozoospermia contain oval sperm 
cells that have distinctive malformations of the sperm head matrix, but also 
morphologically normal sperm cells can be found which, based on pregnancy 
rates described for this group, are suitable to be used in a clinical setting (see 
chapter 5).
Chapter 4
In partial globozoospermia both the morphological ‘normal’ oval-headed as 
well as the round-headed shaped sperm show an increased percentage of 
structural abnormalities suggestive of an aberrant spermiogenesis. Therefore 
ten partial globozoospermia patients were evaluated in comparison to nine 
controls using the computerized karyometric image analysis (CKIA) for sperm 
head structure; fluorochrome Chromomycin A3 (CMA3) as a marker for 
protamination; TdT-UTP nick end-labelling (TUNEL) assay for DNA damage; 
testicular histone 2B (TH2B) as a marker for proper chromatin remodeling 
and KM-2 as an marker for disturbed acetylation and therefore a disturbed 
spermiogenesis and possible DNA damage. The percentage of normal spermatozoa 
for morphometry and densitometry was significantly lower for partial globozoo-
spermia samples, an effect that persisted in oval sperm cells. No statistical 
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difference was found for CMA3 positive sperm, TUNEL positive cells or TH2B 
staining between controls an partial globozoospermia. KM-2 staining is 
significantly different in partial globozoospermia. When scored by morphology 
(‘normal or abnormal’ after decondensation), the differences for KM-2 are 
especially observed in the ‘normal’ group and disappear in the abnormal 
group. The conclusion from these data is that we still should be aware that in 
partial globozoospermia, spermatozoa might be abnormal, despite external 
morphological characteristics. In partial globozoospermia there are several 
indications that some processes during spermiogenesis are disturbed and that 
DNA damage is increased, although these aberrations do not differ from 
spermatozoa in normozoospermia. 
Chapter 5
Between 1997 and 2005, 42 couples were identified in which the male presented 
with partial globozoospermia. In this chapter we describe the clinical outcome 
in these couples. Three spontaneous pregnancies were achieved with a longer 
time to pregnancy; two more pregnancies were achieved by IUI. Of the eight 
couples treated by IVF, seven had poor fertilisation and were referred to ICSI in 
the second cycle. In total, 27 couples had ICSI treatment and were matched with 
263 control couples from a general ICSI population regarding female age and 
year of first ICSI cycle. One treatment, consisting of 1–10 ICSI cycles, was 
analysed. In the partial globozoospermia group, the live birth rate was 
comparable to the control group, as was the miscarriage rate. One major birth 
defect occurred, and one pregnancy ended in a neonatal death due to sepsis in a 
premature child, compared with four stillborn in the control group. We conclude 
that ICSI is an effective treatment in couples that failed to conceive spontaneously 
within one year combined with male infertility due to partial globozoospermia. 
Part 3
In part 3, the first unveiled gene in human globozoospermia is described.
Chapter 6
In this chapter, we present a consanguineous family with three affected brothers, 
in whom we have identified a homozygous mutation in the spermatogenesis- 
specific gene SPATA16. SPATA16 is specifically expressed in the testis and is 
known for its protein interaction. The SPATA16 protein localizes to the Golgi 
apparatus and to the pro acrosomic vesicles that are transported to the acrosome 
in round and elongated spermatids during spermiogenesis. Next to the fact that 
this is the first example of nonsyndromic male infertility condition in humans 
due to an autosomal gene defect, we speculate that the identification of other 
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“globozoospermia genes” like SPATA16 could elucidate acrosome formation 
and may therefore form an alternative path in male contraception. 
Chapter 7
In the general discussion, the major conclusions are summarized and related to 
current literature. Newly revealed genes that are involved in the pathogenesis of 
globozoospermia are discussed, just as all new mouse models. We speculate on 
future research topics regarding partial globozoospermia and the unravelling 
of spermatogenesis.
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SAMENVATTING 
Hoofdstuk 1
Dit hoofdstuk bevat de algemene inleiding, met daarin de achtergronden en de 
aanleiding voor het onderzoek dat is uitgevoerd in het kader van dit proefschrift. 
Dit proefschrift gaat over op de genetische achtergrond van (totale) globozoö-
spermie en de cellulaire, moleculaire en klinische aspecten van partiële globo-
zoöspermie.  Partiële globozoöspermie werd ontdekt terwijl er gezocht werd 
naar een uniforme morfologische zaadafwijking om het onderzoek naar de 
genetische achtergrond van mannelijke subfertiliteit te kunnen voortzetten. Een 
consanguine familie, waarbinnen partiële globozoöspermie voorkwam in een 
autosomaal recessief patroon, wordt beschreven. Helaas kon het verantwoordelijke 
gen binnen deze familie niet gevonden worden. Het hoofdstuk wordt afgesloten 
met een algemene beschrijving van spermatogenese en spermiogenese, welke dient 
als achtergrondinformatie voor dit proefschrift. 
    
Deel 1
In deel 1 is alle beschikbare literatuur over globozoöspermie verzameld en samengevat.
Hoofdstuk 2
Dit hoofdstuk bestaat uit een review van alle literatuur over globozoöspermie 
tot en met 2007. Hieruit concluderen we dat globozoöspermie een zeldzame 
aandoening is binnen mannelijke infertiliteit (incidentie <0.1%). Totale globo-
zoöspermie kan worden beschreven als 100 % rondkoppige zaadcellen, waarvan 
het acrosoom mist. Er zij geen andere lichamelijke kenmerken geassocieerd met 
het syndroom, naast dat de aangedane mannen onvruchtbaar zijn. ICSI is op 
zich een behandeloptie voor deze patiënten, alhoewel er waarschijnlijk sprake is 
van een verlaagd vermogen tot oöcyt activatie gezien de lage fertilisatie cijfers. 
Met acrosoom merkstoffen is aangetoond dat het acrosoom geheel ontbreekt of 
minimaal sterk afwijkend is. Daarnaast lijkt chromatine condensatie verstoord 
te zijn, maar is er geen sprake van een consequente over- of ondercondensatie. 
In sommige beschreven casus werd een verhoogd aantal cellen met DNA 
fragmentatie gevonden. Ook werd in sommige casus een verhoogd aantal cellen 
met een aneuploïdie beschreven. Ondanks deze bevindingen wordt er geen 
verhoogd aantal miskramen of aangeboren afwijkingen beschreven bij zwanger-
schappen die uit ICSI ontstonden. Waarschijnlijk ontstaat het beeld van globo-
zoöspermie tijdens de spermiogenese, in het bijzonder tijdens de vorming van 
het acrosoom wanneer de spermkop zich begint te verlengen. Bij diverse knock- out 
muismodellen werd een soortgelijk fenotype van globozoöspermie gevonden 
als bij mensen. Deze bevindingen wijzen in de richting van een genetische 
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oorsprong, wat wordt bevestigd door het vóórkomen van aangedane broers. 
We roepen op tot het doen van meer onderzoek om de ontstaanswijze van globo-
zoöspermie bij mensen te verduidelijken, maar ook om de spermatogenese en 
spermiogenese in het algemeen beter te leren begrijpen. Op basis van het literatuur-
onderzoek is het echter nog steeds onduidelijk of partiële globozoöspermie een 
variatie is op totale globozoöspermie. Daarom werd deel 2 van dit proefschrift 
uitgevoerd.
 
Deel 2
In deel 2 wordt partiële globozoöspermie onderzocht op cellulair, moleculair, and klinisch niveau.
Hoofdstuk 3
Partiële globozoöspermie wordt vaker gediagnosticeerd bij routine semen 
analyse dan totale globozoöspermie. Er is echter maar één beschrijving over een 
gedeeltelijk rondkoppig ejaculaat uit 1973. Het doel van dit hoofdstuk is om 
partiële globozoöspermie te beschrijven, alsmede het te vergelijken met totale 
globozoöspermie en normozoöspermie. Daarvoor werden van 10 patiënten 
geselecteerd van wie de ejaculaten voor meer dan 50% bestonden uit 
acrosoomloze zaadcellen en vergeleken met 3 totale globozoöspermie patiënten 
en negen normozoöspermische controle patiënten door middel van lichtmicros-
copie, transmissie electronenmicroscopie, en flow cytometrie. Kwalitatieve en 
quantitatieve bestudering van de zaadcellen van de 3 groepen laat verschillen 
zien in de percentages van rondkoppige zaadcellen en slecht gevormde 
acrosomen. Totale globozoöspermie presenteert zich als een homogene soort te-
ratozoöspermie. Partiële globozoöspermie is een zaadafwijking met een 
verhoogd percentage van rondkoppige zaadcellen ( >25%) en misvormingen van 
het acrosoom, wat anders is dan totale globozoöspermie. Daarbij komt dat het 
ejaculaat van deze mannen met partiële globozoöspermie ovale en dus normale 
vorm van zaadcellen bevatten die toch afwijkingen hebben van het zaadkopskelet, 
naast normale zaadcellen die, afgaand op de beschreven zwangerschapscijfers 
bij partiële globozoöspermie (Hoofdstuk 5), geschikt zijn voor een klinische 
setting.
Hoofdstuk 4
Bij partiële globozoöspermie worden zowel in normaal ogende zaadcellen als in 
de rondkoppige variant een verhoogd percentage van structurele afwijkingen 
gevonden die duiden op een verstoorde spermiogenese. Daarom werden 10 
partiële globozoöspermie patiënten vergeleken met negen controles door middel 
van computerized karyometric image analysis (CKIA) om de zaadkopstructuur 
de evalueren; door middel van fluorochroom Chromomycine A3 (CMA3) als 
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indicator van protaminering; doormiddel van de TdT-UTP nick end-labelling 
(TUNEL) assay om DNA schade te meten; door middel van testiculair histon 2B 
(TH2B) als indicator van een goede chromatine remodelering en ten slotte door 
middel van KM-2 as indicator van een gestoorde acetylering en spermiogenese 
en mogelijke DNA schade. Hieruit bleek dat het percentage normale zaadcellen 
met betrekking op morfometrie en densitometrie lager was bij partiële globozo-
ospermie, ook bij normaal ogende ovale zaadcelkoppen. Er werd geen significant 
verschil gevonden voor CMA-3 positieve zaadcellen, TUNEL positieve 
zaadcellen of TH2B kleuring tussen controles van partiële globozoöspermie. 
KM-2 kleuring bleek significant hoger bij partiële globozoöspermie. Als de 
scoring plaatsvond op onderscheid van morfologie (normaal of abnormaal na 
decondensatie), bleek het verschil voor KM-2 kleuring vooral te bestaan in de 
normale groep en te verdwijnen als de abnormale cellen werden vergeleken. We 
concluderen op basis van deze gegevens dat we ons altijd bewust moeten zijn 
dat ook normaal gevormde zaadcellen in geval van partiële globozoöspermie 
abnormaal kunnen zijn. Er zijn een aantal aanwijzingen dat sommige processen 
tijdens de spermiogenese gestoord zijn en op basis daarvan de DNA schade 
toegenomen, hoewel de uiteindelijke DNA schade niet significant verschilt van 
zaadcellen bij normozoöspermie. 
Hoofdstuk 5
Tussen 1997 en 2005 werden 42 koppels geïdentificeerd, van wie de man aan 
partiële globozoöspermie bleek te lijden. In dit hoofdstuk beschrijven we de 
klinische zwangerschapsuitkomsten voor deze koppels. Er traden drie spontane 
zwangerschappen op, met een verlengde “time to pregnancy”; twee zwanger-
schappen werden tot stand gebracht door middel van IUI. Van de acht stellen die 
IVF ondergingen, hadden er zeven een laag bevruchtingspercentage en werden 
daarom verwezen voor ICSI bij de tweede cyclus. In totaal ondergingen 27 
koppels een ICSI behandeling. Zij werden gematcht met 263 controle koppels uit 
een algemene ICSI populatie met betrekking tot de leeftijd van de vrouw en het 
jaar waarin de eerste ICSI cyclus plaatsvond. Eén behandeling, welke kon 
bestaan uit 1-10 ICSI cycli, werd geanalyseerd. In de partiële globozoöspermie 
groep was het percentage levendgeborenen en het aantal miskramen 
vergelijkbaar met de controle groep. Er was sprake van één ernstige aangeboren 
afwijking. Eén zwangerschap eindigde in neonatale sterfte vanwege een 
neonatale sepsis bij prematuriteit, vergeleken met vier perinatale sterftes in de 
controle groep. We concluderen dat ICSI een effectieve therapie is in het geval 
van partiële globozoöspermie, indien binnen 1 jaar geen spontane conceptie is 
opgetreden.
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Deel 3
In deel 3 wordt de ontdekking van het eerste gen dat betrokken is bij humane globozoö-
spermie beschreven.
Hoofdstuk 6
In dit hoofdstuk presenteren we een consanguine familie waarvan 3 broers 
aangedaan zijn met totale globozoöspermie. Binnen deze familie konden we een 
homozygote mutatie aantonen in het gen SPATA16, wat specifiek tot uitdrukking 
komt tijdens de spermatogenese.  SPATA16  komt specifiek tot uitdrukking in de 
testis en speelt een belangrijke rol in eiwit interactie. Het SPATA16 eiwit komt tot 
uitdrukking in het Golgiapparaat en de proacrosomale blaasjes welke naar het 
acrosoom van de spermatide getransporteerd worden tijdens de spermiogenese. 
Naast het feit dat dit het eerste geval is van mannelijke onvruchtbaarheid op 
basis van een autosomaal recessieve aandoening welke geen deel uitmaakt van 
een syndroom, is het identificeren van andere globozoöspermie genen zoals 
SPATA16 waarschijnlijk een hele goede manier om de vorming van het acrosoom 
te ontrafelen en daarmee alternatieve wegen voor mannelijke anticonceptie. 
Hoofdstuk 7
In de discussie worden de belangrijkste conclusies en in samenhang gebracht 
met de huidige literatuur. Nieuw ontdekte genen die betrokken zijn bij het 
ontstaan van globozoöspermie worden besproken, evenals de nieuwe muis 
modellen. We speculeren verder over eventuele toekomstige onderwerpen van 
onderzoek met betrekking tot globozoöspermie en het verder uitpluizen van de 
spermatogenese.
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DANKWOORD
Het is net niet op de 11e van de 11e, maar er zijn wel 11 jaar verstreken sinds ik 
mijn eerste stappen deed binnen “het Radboud” in de brandende hitte. Elf jaar: 
dat is een mensenleven. Ondertussen zijn we een heleboel life events en nog 
meer (trein) kilometers verder. Daar horen in alle fases heel veel mensen bij die 
ik heel graag wil bedanken: ik heb getracht compleet te zijn en heb daarbij geen 
volgorde van belangrijkheid aangehouden.
Allereerst alle patiënten: het is nogal wat om je zaad in te leveren, en helemaal 
voor onderzoek. Het is een nogal intiem iets om te vragen. Jullie zijn niet allemaal 
even uitgebreid in dit proefschrift terecht gekomen, maar zonder jullie was dit 
allemaal in den beginne al niet gelukt. Mijn grote dank!
Professor Kremer, beste Jan; wat een traject hebben we gelopen vanaf het eerste 
weifelende begin. Wordt het wel een promotie? Het was voor mij en jou niet 
altijd makkelijk als vreemde eend in patientcentered en kwaliteitsland, maar jij 
zag altijd het positieve met een ware helicopterview. “Beter is de vijand van goed.” 
Ik ben je dankbaar voor je ogenschijnlijk onuitputtelijke geduld en vertrouwen. 
Ik hoop dat ik hiermee waar heb gemaakt dat vertrouwen te verdienen. Dank!
Dr Liliana Ramos; beste Liliana, van het begin af aan ben jij betrokken geweest 
en dan ook echt mijn co-promotor. Je kennis, positieve en actieve instelling en 
opbouwend kritische houding vond ik zeer inspirerend. Je werklust is legendarisch. 
Dank voor al je hulp en begeleiding in het lab, je steun bij schrijven, het heerlijke 
theoretische brainstormen, en zo nu en dan gewoon een kletspraatje. Megadank!
Professor van Bokhoven, beste Hans, een oase van rust en weloverwogenheid, 
me mee begeleidend in de snel veranderende wereld van de genetica. Altijd 
weer enthousiast en een wezenlijk geduld. Dank!
Alle leden van het IVF-team, het oude Fertendo, het nieuwe VPG: “de kelder”. 
Bij jullie heb ik geleerd wat het is om deel te zijn van een team: iedereen even 
belangrijk in zijn eigen rol en taak, en allemaal voor de patiënt. Dat heeft me 
gevormd als dokter en draag ik nog immer met me mee. Superdank voor het 
gunnen van mijn eigen plek bij jullie. Een speciale dank voor het fertiliteitslab, 
in het bijzonder Hans, Leonie en Hannie, voor hun bijdragen in het verzamelen, 
voorbewerken en beoordelen van patiëntenmateriaal. Ook voor de rest, die mij 
heeft geduld om mijn kleuringen en tellingen te kunnen doen op het lab bij 
verhuizingen en ontij.
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Astrid Oudakker; ook wat om een dokter aan je slip te krijgen die echt geen 
verstand heeft van wat en hoe PCR. Van de eerste gels, de -80 en de radioactieve 
ruimte tot aan de SNP array: je hebt me altijd geholpen en begeleid. Tussen de 
bedrijven door hebben we heel wat gedeeld: mijn speciale dank voor je oor en 
steun.
De rest van het antropogeneticalab heeft mij als vreemde eend in de bijt altijd 
geduld en ook geholpen met het zoeken van monsters, zoeken naar de oorzaak 
van een PCR error, niet werkende DNTP-tjes en vervuild water. Uiteindelijk ook 
het uitvoeren van verdere analyses en testen, die uiteindelijk niet tot ontdekking 
hebben geleid en dus niet in dit boekje zijn beland. Zoveel vissen, zo veel werk, 
zo weinig vangst. Dank!
Eerst was er die plek in een stoffig kantoor, waar bierviltjes onder het bureau de 
ladenkast eronder lieten passen met Gwendolyn, Bea, Ineke, Esther en Wouter, 
om na de grote verhuizing vervolgens de kantoortuinbewoners van het eerste 
uur te worden. Samen met  Angèle, Willianne, Arno, Wouter, Selma, Irene, 
Dennis, Charlotte, Sabine en natuurlijk Nel naast soms wat flexonderzoekers en 
studenten . Met eigen lief en leed pot en onderzoekersweekend. Wat een tijden 
waren dat! Menige taart (want publicatie) , koffie, lunchpauze en BBQ zijn er 
gepasseerd, naast alle organisatie voor de stukjes voor een bruiloft of promotie. 
Dank voor die geweldige tijd! 
Dank aan (het lab van) Peter de Boer voor het ideeën-sparren en de wijsheid. 
Dank Godfried voor de gezellige lunches waarbij het over alles en niets ging en 
je kritische biologen blik.Moby Dick heeft het boekje toch gehaald, al is het dan 
niet als omslag. 
Adrienne: dank voor je bijdrage aan hoofdstuk 5en voor je flexibiliteit met een 
artsonderzoeker net in opleiding.
Professeur Escalier: On s’est jamais croisé en persona, mais merci beaucoup à 
livrer sans hésiter l’anticorps de pro-acrosin, parti de chapitre 3.
Professor Tournaye: geweldige filmpjes van een Bar Mitswa en vooral geweldig 
materiaal. Zonder dat materiaal was hoofdstuk 6 er niet geweest. Dank u wel.
Björn, we hebben er veel werk ingestopt en ik heb dat - ondanks mijn moeite 
met je onnavolgbare Brugse accent-  heel erg gewaardeerd. Helaas kwam dat 
voorbereidende werk er niet uit. Dank voor je samenwerking!
Da
nk
w
oo
rd
9
177
Professeur Viville, Stéphane,  merci pour le coopération en chapitre 6.  Je suis 
très heureuse que votre groupe à reussit de découvrir le gène le plus important 
en globozoospermia depuis. Je vous souhaite encore plus de même succès dans 
le futur.
Isabelle; on a beaucoup partager d’une distance et j’étais tres contente à te 
rencontrer à l’ESHRE à Stockholm. Merci pour la coopération et support et 
beaucoup de succès pour ton carrière à Strassbourg.
Dan de opleiding: woelige tijden waarin je jezelf zo vaak tegenkomt: in “ons 
Catrien” twee keer een geweldige tijd gehad met het team op de verloskamers, 
afdelingen, polikliniek en OK. Bij jullie op bezoek gaan voelt nog steeds een 
beetje als thuis op de koffie gaan. De gehele maatschap: dank voor het mij willen 
opleiden, soms goedschiks, danwel kwaadschiks. Ik hoor jullie nog steeds 
dagelijks in mijn achterhoofd....
Vakgroep van het Radboud: niet zo makkelijk, maar wat heb ik veel bij jullie 
geleerd over organisatie, het vak, maar vooral over mezelf. Het was thuiskomen 
na even weg geweest te zijn geweest en toch ook weer helemaal anders. Dank 
voor het me de ruimte geven om te kunnen groeien, die ruimte heb ik naar mijn 
beste kunnen ook echt trachten te benutten. De teams op de verloskamers, OK, 
poli en natuurlijk “de kelder”: dank voor de heerlijke samenwerking. 
Mentor van het eerste uur: Alex. Je hebt mijn tranen niet gedroogd, maar hebt 
me laten lachen door me uit, of was het toe te lachen. Koester die tissuedoos nog 
maar even. Het komt er echt nog wel van dat ik ‘m in zijn setting kom bekijken 
in Rotjeknor!
Olivier: ik had je officieel benoemd als mentor, maar heb je weinig nodig gehad. 
Bedankt dat je het ruimhartig op je wilde nemen. 
Minouche, je nam je taak heel serieus en dat heb ik heel erg gewaardeerd. Dank 
voor je steun bij vervelende tijdingen. Nu ben ik eindelijk ook klaar!
Opleidingsgenoten: ik heb getracht om jullie allemaal; ANIOS, AIOS, BAIOS, 
TAIO’s op te zoeken en jullie van dit feestje op de hoogte te stellen. Wat een 
unieke tijd is die opleiding waarin zoveel gebeurt. Ik ben blij dat ik met jullie 
allemaal heb kunnen samenwerken en wil jullie heel erg danken voor de steun 
die ik heel duidelijk heb ervaren aan alle kanten. Voor de huidige AIOS: pas 
goed op jezelf en elkaar! 
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Beste maten van de maatschap gynaecologie VieCuri, of beter gezegd Dieuwke, 
Annemieke, Iris, Ella, Petra, Erik en Hans. Ik voelde me vanaf het eerste moment 
tijdens de sollicitatie enorm op mijn gemak bij jullie. Dank jullie wel voor de 
kansen en de ruimte die jullie me geven om de gynaecoloog te zijn en te worden, 
die ik wil zijn, met alle voor- en nadelen die ik meebreng. Ik mag zelfs hard 
lachen ;-). Zonder die ruimte had ik dit niet afgekregen.
Beste arts-assistenten gynaecologie, ofwel mijn puppen, chickies of pullekes: 
wat heerlijk dat ik met jullie mag werken en een deel mag hebben in jullie 
opleiding. Het is fantastisch om mensen te zien groeien en gelukkig doen jullie 
dat allemaal stuk voor stuk op je eigen manier. Ondertussen leer ik weer heel 
veel van jullie. Ik hoop nu alleen dat jullie niet met een geit/varken/koe/paard 
voor bij de kippen aan komen zetten...    
Alle medewerkers van de afdeling gynaecologie en verloskunde VieCuri Venlo/ 
Venray: jullie hebben me hartelijk verwelkomd en hebben jullie medewerking 
verleend aan al diverse projecten om het voor de patiënt in VieCuri weer iets 
beter te maken. Ik ben heel blij dat ik met  jullie mag werken. Dit jaar is het dit 
feestje; ik hoop dat volgend jaar augustus beter geschikt is om de verse traditie 
van het ‘zomaar zomer feestje’ voort te zetten. 
Beste leden van Premier Curi; door jullie wordt het (sociale) leven in Noord- 
Limburg wat rooskleuriger. Samen kunnen we het verschil maken in ons ziekenhuis. 
Ik hoop dat we doorgaan t/m het punt dat we een motorclubje worden. Dank 
voor de toegevoegde waarde! 
Fabienne; sommige dingen moet je af en toe eens zeggen en dit is daar de 
gelegenheid voor. Ik ben er superblij mee dat we al zo lang vriendinnen zijn. Ik 
hoop dat dat nog heel lang mag blijven! Jij bent er altijd als het er toe doet en 
accepteert me zoals ik op dat moment ben. Je pen heb ik bij me hoor, deze dag. 
Dank voor het hart onder de riem.
Marieke en Wieteke; niet voor niets zijn jullie mijn paranimfen. Als onnavolgbaar 
roosterteam en assistenten vertegenwoordigers stonden jullie je mannetje (m/v) en 
regelden de boel. Ik heb jullie beiden enorm leren waarderen in die opleidingstijd. 
Voor mij zijn jullie twee prachtige wereldwijven waar je in tijden van nood èn 
plezier op kan bouwen. Ik ben dan ook een zeer dankbaar en gelukkig mens om 
jullie vandaag naast me te hebben. Ennuh: die proefschriften van jullie komen 
ook vast nog wel.
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Lieke, ondanks dat het je niet altijd helemaal meer duidelijk is wat er nu eigenlijk 
gebeurt, ben ik er dankbaar voor dat je er nog bij kunt zijn. Nu heb je nog zo’n 
gepromoveerd schoonkind. Bèr is opnieuw een groot gemis, maar heeft zijn 
eigen plekje in mijn achterhoofd op deze dag.   
  
Broers: alweer zo’n academisch feestje van zuslief. Hierna is het wel een beetje 
klaar hoor! Fijn dat we nog steeds een echte familie vormen samen met mam, 
Christa en Martine en de kids. Laten we dat nog heel lang doen in goede en 
kwade dagen. Sebastiaan, Charlotte, Kyran en Djuna: ik ben er heel trots op dat 
ik jullie Tantan mag zijn. En na de ceremonie kunnen jullie gewoon meefeesten!
Mam: jij en pa hebben altijd gezegd dat je wel hersenen gehad kunt hebben, 
maar dat het om gaat wat je er mee doet. En dat dat een verantwoordelijkheid 
met zich meebrengt. Nou, dat heb ik geweten. Maar nu is het boekje af! Dank 
voor de basis die jullie altijd gevormd hebben,en de wijze woorden nu en dan. 
Pap: je snapte heel goed hoe belangrijk dat praatje was. Om daar nou precies op 
tijd voor te overlijden was ook weer wat overdreven. Maar ik ben gegaan en ik 
heb het gedaan. Ik vind het jammer dat je er niet lijfelijk bij bent, maar je bent 
van harte welkom in elke andere hoedanigheid! 
Raoul, sjattie petattie. We gaan al heel wat jaren samen over de woeste baren van 
het leven, maar niks was zo veeleisend als dit traject en dan ook nog naast de 
opleiding. Je wilt nog niet eens dat ik je bedank in dat verdomde boekje, maar 
aan wie heb ik meer te danken dan aan jou? Je bent die heerlijke lastige man die 
enorm voor me zorgt. Nu is het boekje dan af; eindelijk! Ook al zal jouw pup 
altijd een werkbij blijven, zonder jou zou dat slecht lukken. Jij maakt mijn leven 
mooier. 
Dikke poene: geniet ervan: dit is ook jouw feestje!
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CURRICULUM VITAE 
Anika Dam werd op 16 mei 1976 geboren in Roosendaal en Nispen. Zij groeide 
op in Bergen op Zoom, waar ze in 1995 haar eindexamen Gymnasium behaalde 
aan het RK Gymnasium Juvenaat H. Hart (tegenwoordige Gymnasium Juvenaat). 
Zij werd direct ingeloot voor de studie geneeskunde in Maastricht. Tijdens 
deze studie deed ze een keuzestage kindergeneeskunde  in Dapaong, Togo; een 
 wetenschapsstage psychiatrie bij de Université de Nantes in Nantes, Frankrijk 
en een wetenschappelijke keuzestage bij John Challis’ lab bij Toronto University 
in Toronto, Canada. Ze was 2 jaar betrokken bij de studententoneelvereniging 
“Alles is drama” en als secretaris van de organisatie van het 4th Maastricht 
Medical Students Research Conference in 2000. 
 Ze behaalde in 2002 haar artsexamen en begon als arts-assistent niet in 
opleiding op de verloskamers van het Bernhoven ziekenhuis, locatie Oss en ging 
in Den Bosch wonen. In september 2003 zette ze haar eerste stappen binnen 
UMC St Radboud (het huidige Radboudumc) als IVF-arts en artsonderzoeker 
binnen het project “Morfologische aspecten en genotypering bij globozoö-
spermie”. Dit project leidde uiteindelijk tot dit proefschrift. In juli 2007 mocht 
ze beginnen met de opleiding gynaecologie binnen het Catharina ziekenhuis 
te Eindhoven (opleider: Tom Hasaart) en het UMC St Radboud (opleider: Didi 
Braat). Sinds januari 2013 is zij werkzaam als gynaecoloog binnen het VieCuri 
Medisch Centrum (locaties Venlo en Venray). Zij is sinds 2005 getrouwd met 
Raoul Martin.

“However, a good laugh is a mighty good thing, and rather too scarce a good 
thing; the more’s the pity. So, if any one man, in his own proper person, afford 
stuff for a good joke to anybody, let him not be backward, but let him cheerfully 
allow himself to spend and to be spent in that way. And the man that has 
anything bountifully laughable about him, be sure there is more in that man 
than you perhaps think for.” 
 Herman Melville, Moby-Dick; or, The Whale(1851)

